EPrf John Horowitz
School of Medicine
College of Health
Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.
Professor John Horowitz is a Professor of Cardiology at the University of Adelaide, and Director of Cardiology and Clinical Pharmacology at The Queen Elizabeth Hospital (TQEH). He completed his undergraduate studies in Adelaide, and his postgraduate training in Melbourne and Boston, taking up his current position in 1988.
Project 1. Coronary artery spasm
The research group has recently found that coronary artery spasm, a common cause of cardiac crises, is due to interactions between activated platelets and the vascular surface of the coronary blood vessels, with poor vascular and platelet responsiveness to nitric oxide. We have preliminary data on the underlying mechanisms whereby coronary spasm presents with episodic crises, and wish to validate these pilot data, simultaneously turning the information into the bases for new therapeutic options for these patients, and also possibly for other patients with angina.
Available for Honours, Masters and PhD students
Location: QEH/BHI.
Start: Semester 1 2020
Special requirements: Vaccination required
Project 2 : Preventing heart damage during cancer chemotherapy
The improved results for cancer chemotherapy come at the price of an increased risk of late heart failure. The project will evaluate means of protecting the heart during chemotherapy, by identifying the chemical cause of the damage and neutralising its effects on the heart.
Available for Honours, Masters and PhD students
Location: QEH/BHI.
Start: Semester 1 2020
Special requirements: Vaccination required
Project 3: Maximising protective effects of BNP in patients with heart failure
B-type natriuretic peptide (BNP) is theoretically cardioprotective, bu paradoxically does not work in patients with heart failure. We have identified the cause of this problem, and now wish to develop therapeutic strategies to improve BNP responses, not only in patients with isolated heart failure, but also in those with heart failure secondary to influenza virus infection.
Available for Honours, Masters and PhD students
Location: QEH/BHI.
Start: Semester 1 2020
Special requirements: Vaccination required
Project 4: Variability of anti-aggregatory effects of P2Y12 receptor antagonists: therapeutic adjustments
Clopidogrel and ticagrelor are antagonists at the P2Y12 receptor, which limit platlet aggregation: they are used mainly to prevent thrombosis of coronary stents. However, responses vary substantially. We intend to develop regimens for individual patients who, on theoretical grounds, are at risk for either bleeding or thrombosis when placed on theoretically "standard" treatment regimens.
Available for Honours, Masters and PhD students
Location: QEH/BHI.
Start: Semester 1 2020
Special requirements: Vaccination required
Project 5: Improving outcomes after takotsubo (broken heart) syndrome
Takotsubo syndrome (TTS) affects many ageing patients, especially women, and is often mistaken for heart attacks. We are trying to improve diagnosis, emergency and long-term treatment of TTS, using both clinical and basic investigation strategies.
Available for Honours, Masters and PhD students
Location: QEH/BHI.
Start: Semester 1 2020
Special requirements: Vaccination required
| Date | Position | Institution name |
|---|---|---|
| 2018 - ongoing | Emeritus Professor | University of Adelaide |
| Year | Citation |
|---|---|
| 2025 | Horowitz, J. D., Kucia, A. M., & Nguyen, T. H. (2025). Takotsubo syndrome: be happy, then worry?. Trends in Cardiovascular Medicine, 35(3), 202-203. |
| 2025 | Montinari, M. R., Minelli, S., Horowitz, J. D., & De Caterina, R. (2025). Explosive discovery, surprising future: The extraordinary journey of nitroglycerin, nitroderivatives and nitric oxide. Vascular Pharmacology, 160, 12 pages. |
| 2025 | Wang, Y., Ferdinand, K. C., Gazzaruso, C., Horowitz, J. D., & Ren, M. (2025). Association between the cardiometabolic index and all-cause and cardiovascular mortality in diabetes and prediabetes. Cardiovascular Diagnosis and Therapy, 15(3), 635-652. Scopus1 WoS1 Europe PMC1 |
| 2024 | Horowitz, J. D., & Rogers, N. M. (2024). Editorial commentary: Oral Anticoagulation for hemodialysis patients with atrial fibrillation: the therapeutic conundrum remains. Trends in Cardiovascular Medicine, 34(7), 451-452. |
| 2024 | Liu, S., Lawrie, I. A., Rabia, B., & Horowitz, J. D. (2024). Impairment of Vascular Homeostasis in Acute Heart Failure: Enter the Monocyte? . Cardiovascular drugs and therapy, 38(3), 405-409. |
| 2024 | Julovi, S. M., Trinh, K., Robertson, H., Xu, C., Minhas, N., Viswanathan, S., . . . Rogers, N. M. (2024). Thrombospondin-1 Drives Cardiac Remodeling in Chronic Kidney Disease. Jacc Basic to Translational Science, 9(5), 607-627. Scopus11 WoS10 Europe PMC13 |
| 2024 | Schweiger, V., Vece, D. D., Cammann, V. L., Koleva, I., Würdinger, M., Gilhofer, T., . . . Rottbauer, W. (2024). Cardiac biomarkers for diagnosing Takotsubo syndrome. European Heart Journal, 45(25), 2254-2258. Scopus9 WoS8 Europe PMC9 |
| 2024 | Schweiger, V., Cammann, V. L., Crisci, G., Gilhofer, T., Schlenker, R., Niederseer, D., . . . Thiele, H. (2024). Temporal Trends in Takotsubo Syndrome: Results From the International Takotsubo Registry. Journal of the American College of Cardiology, 84(13), 1178-1189. Scopus16 WoS16 Europe PMC10 |
| 2024 | Liu, S., Horowitz, J. D., Koczwara, B., Sverdlov, A. L., Packer, N., & Clark, R. A. (2024). Cardiac events among a cohort of 17,389 patients receiving cancer chemotherapy: short and long term implications. Cardio Oncology, 10(1), 11 pages. Scopus2 WoS1 |
| 2024 | Stähli, B. E., Schindler, M., Schweiger, V., Cammann, V. L., Szawan, K. A., Niederseer, D., . . . Pieske, B. M. (2024). Cardiac troponin elevation and mortality in takotsubo syndrome: New insights from the international takotsubo registry. European Journal of Clinical Investigation, 54(12), 12 pages. Scopus7 WoS7 Europe PMC4 |
| 2024 | Zeller, J., Loseff-Silver, J., Khoshmanesh, K., Baratchi, S., Lai, A., Nero, T. L., . . . Peter, K. (2024). Shear-Sensing by C-Reactive Protein: Linking Aortic Stenosis and Inflammation. Circulation Research, 135(11), 1033-1047. Scopus14 WoS15 Europe PMC11 |
| 2023 | Horowitz, J. D., & Surikow, S. Y. (2023). Understanding Takotsubo syndrome: first evaluate your mouse model. American Journal of Physiology Heart and Circulatory Physiology, 324(5), H630-H632. |
| 2023 | Iyngkaran, P., Hanna, F., Andrew, S., Horowitz, J. D., Battersby, M., & De Courten, M. P. (2023). Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study. Frontiers in Medicine, 10, 11 pages. Scopus3 WoS4 Europe PMC4 |
| 2023 | Muminovic, A., Chirkov, Y. Y., & Horowitz, J. D. (2023). Effects of Soluble Guanylate Cyclase Stimulators and Activators on Anti-Aggregatory Signalling in Patients with Coronary Artery Spasm. International Journal of Molecular Sciences, 24(11), 11 pages. Scopus2 WoS2 Europe PMC2 |
| 2023 | Kei, C. Y., Singh, K., Dautov, R. F., Nguyen, T. H., Chirkov, Y. Y., & Horowitz, J. D. (2023). Coronary “Microvascular Dysfunction”: Evolving Understanding of Pathophysiology, Clinical Implications, and Potential Therapeutics. International Journal of Molecular Sciences, 24(14), 11287-1-11287-21. Scopus33 WoS31 Europe PMC25 |
| 2023 | Kelly, C. J., Chu, M., Untaru, R., Assadi-Khansari, B., Chen, D., Croft, A. J., . . . Ngo, D. T. M. (2023). Association of Circulating Plasma Secreted Frizzled-Related Protein 5 (Sfrp5) Levels with Cardiac Function. Journal of Cardiovascular Development and Disease, 10(7), 9 pages. Scopus7 WoS6 Europe PMC3 |
| 2023 | De Filippo, O., Cammann, V. L., Pancotti, C., Di Vece, D., Silverio, A., Schweiger, V., . . . Budnik, M. (2023). Machine learning-based prediction of in-hospital death for patients with takotsubo syndrome: The InterTAK-ML model. European Journal of Heart Failure, 25(12), 2299-2311. Scopus31 WoS31 Europe PMC19 |
| 2023 | Ong, G. J., Sellers, A., Mahadavan, G., Nguyen, T. H., Worthley, M. I., Chew, D. P., & Horowitz, J. D. (2023). ‘Bushfire Season’ in Australia: Determinants of Increases in Risk of Acute Coronary Syndromes and Takotsubo Syndrome. American Journal of Medicine, 136(1), 88-95. Scopus5 WoS4 Europe PMC3 |
| 2022 | Ong, G. J., Nguyen, T. H., Surikow, S. Y., & Horowitz, J. D. (2022). Risk factors for a broken heart: understanding drug-induced causes for Takotsubo syndrome and pharmacological treatment options. Expert Review of Clinical Pharmacology, 15(9), 1017-1025. Scopus2 WoS2 Europe PMC1 |
| 2022 | Horowitz, J. D., & Nguyen, T. H. (2022). Takotsubo Syndrome: Severe Early Coronary Vasculitis Predicts Slow Recovery. Jacc Cardiovascular Imaging, 15(10), 1796-1798. Scopus3 WoS2 Europe PMC2 |
| 2022 | Chong, C. -R., Liu, S., Imam, H., Heresztyn, T., Sallustio, B. C., Chirkov, Y. Y., & Horowitz, J. D. (2022). Perhexiline Therapy in Patients with Type 2 Diabetes: Incremental Insulin Resistance despite Potentiation of Nitric Oxide Signaling. Biomedicines, 10(10), 2381-1-2381-10. Scopus1 WoS1 |
| 2022 | Ong, G. J., & Horowitz, J. D. (2022). Ambulance ramping and patients with cardiac-type symptoms: understanding the unloading queue. Medical Journal of Australia, 217(5), 238-239. |
| 2022 | Chirkov, Y. Y., Nguyen, T. H., & Horowitz, J. D. (2022). Impairment of Anti-Aggregatory Responses to Nitric Oxide and Prostacyclin: Mechanisms and Clinical Implications in Cardiovascular Disease. International Journal of Molecular Sciences, 23(3), 1042-1-1042-21. Scopus27 WoS26 Europe PMC21 |
| 2022 | Iyngkaran, P., Hanna, F., Horowitz, J. D., & de Courten, M. P. (2022). Contextualising evidence based medicine in determining the key root for translational effectiveness for chronic disease self-management and heart failure. Reviews in Cardiovascular Medicine, 23(1), 9 pages. Scopus2 WoS3 Europe PMC3 |
| 2022 | Dhakal, B., Li, C. M. Y., Li, R., Yeo, K., Wright, J. A., Gieniec, K. A., . . . Fenix, K. (2022). The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing. Cancers, 14(4), 16 pages. Scopus13 WoS14 Europe PMC13 |
| 2022 | Velagic, A., Li, J. C., Qin, C. X., Li, M., Deo, M., Marshall, S. A., . . . Ritchie, R. H. (2022). Cardioprotective Actions of Nitroxyl Donor Angeli's Salt are Preserved in the Diabetic Heart and Vasculature in the Face of Nitric Oxide Resistance. British Journal of Pharmacology, 179(16), 4117-4135. Scopus7 WoS6 Europe PMC2 |
| 2022 | Laumer, F., Di Vece, D., Cammann, V. L., Würdinger, M., Petkova, V., Schönberger, M., . . . Templin, C. (2022). Assessment of Artificial Intelligence in Echocardiography Diagnostics in Differentiating Takotsubo Syndrome from Myocardial Infarction. JAMA Cardiology, 7(5), 494-503. Scopus60 WoS56 Europe PMC38 |
| 2022 | Tully, P. J., Turnbull, D. A., Horowitz, J. D., Beltrame, J. F., Baune, B. T., Sauer-Zavala, S., . . . Wittert, G. A. (2022). Transdiagnostic Cognitive-Behavioral Therapy for Depression and Anxiety Disorders in Cardiovascular Disease Patients: Results From the CHAMPS Pilot-Feasibility Trial. Frontiers in Psychiatry, 13, 1-12. Scopus9 WoS7 Europe PMC5 |
| 2022 | Iyngkaran, P., Hespe, C., Hanna, F., Horowitz, J. D., Battersby, M., Nelson, C., . . . de Courten, M. P. (2022). The Wider Considerations in Closing Chronic Disease Gaps - Focus on Heart Failure and Implementation. Current Cardiology Reviews, 19(2), e120522204690-11-e120522204690-24. Europe PMC1 |
| 2022 | Aulin, J., Hijazi, Z., Lindbäck, J., Alexander, J. H., Gersh, B. J., Granger, C. B., . . . Wallentin, L. (2022). Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model. American Heart Journal, 251, 13-24. Scopus12 WoS13 Europe PMC14 |
| 2022 | Iyngkaran, P., Calder, R., Nelson, C., Lowthian, J., Hespe, C., Horowitz, J., & de Courten, M. P. (2022). Opportunities to link Heart Failure Guidelines and chronic disease management—preliminary considerations. Reviews in Cardiovascular Medicine, 23(4), 9 pages. |
| 2022 | Girolamo, O. C., Surikow, S. Y., Ong, G. J., Nguyen, T. H., Kucia, A. M., Chirkov, Y. Y., & Horowitz, J. D. (2022). TakoTsubo Syndrome: First an Acute Coronary Vasculitis and Then Prolonged Myocarditis?. Reviews in Cardiovascular Medicine, 23(5), 152-1-152-9. Scopus4 WoS4 Europe PMC3 |
| 2022 | De Caterina, R., Patti, G., Westerbergh, J., Horowitz, J., Ezekowitz, J. A., Lewis, B. S., . . . Wallentin, L. (2022). Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial. European Heart Journal Cardiovascular Pharmacotherapy, 8(3), 227-235. Scopus7 WoS7 Europe PMC5 |
| 2022 | Imori, Y., Kato, K., Cammann, V. L., Szawan, K. A., Wischnewsky, M., Dreiding, S., . . . Poglajen, G. (2022). Ethnic comparison in takotsubo syndrome: novel insights from the International Takotsubo Registry. Clinical Research in Cardiology, 111(2), 186-196. Scopus23 WoS24 Europe PMC20 |
| 2021 | Ananthakrishna, R., Lee, S. L., Foote, J., Sallustio, B. C., Binda, G., Mangoni, A. A., . . . Selvanayagam, J. B. (2021). Randomized controlled trial of perhexiline on regression of left ventricular hypertrophy in patients with symptomatic hypertrophic cardiomyopathy (RESOLVE-HCM trial). American Heart Journal, 240, 101-113. Scopus23 WoS22 Europe PMC21 |
| 2021 | El-Battrawy, I., Cammann, V. L., Kato, K., Szawan, K. A., Di Vece, D., Rossi, A., . . . Templin, C. (2021). Impact of Atrial Fibrillation on Outcome in Takotsubo Syndrome: Data From the International Takotsubo Registry.. Journal of the American Heart Association, 10(15), e014059-1-e014059-12. Scopus31 WoS28 Europe PMC25 |
| 2021 | Schwartz, G. G., Szarek, M., Bittner, V. A., Diaz, R., Goodman, S. G., Jukema, J. W., . . . Dombrowski, K. (2021). Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol. Journal of the American College of Cardiology, 78(5), 421-433. Scopus109 WoS105 Europe PMC96 |
| 2021 | Nguyen, T. H., Ong, G. J., & Horowitz, J. D. (2021). Letter by Nguyen et al Regarding Article, "coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction with Nonobstructive Coronary Arteries in Women". Circulation, 144(12), E205. |
| 2021 | Nguyen, T. H., Ong, G. -J., Girolamo, O. C., deMenezesCaceres, V., Muminovic, A., Chirkov, Y. Y., & Horowitz, J. D. (2021). Angina due to coronary artery spasm (variant angina): diagnosis and intervention strategies.. Expert Review of Cardiovascular Therapy, 19(10), 917-9227. Scopus13 WoS10 Europe PMC7 |
| 2021 | Imam, H., Nguyen, T. H., Stafford, I., Liu, S., Heresztyn, T., Chirkov, Y. Y., & Horowitz, J. D. (2021). Impairment of platelet NO signalling in coronary artery spasm: role of hydrogen sulphide. British Journal of Pharmacology, 178(7), 1639-1650. Scopus13 WoS13 Europe PMC13 |
| 2021 | Visvanathan, V., Kucia, A., Reddi, B., & Horowitz, J. (2021). Late development of Takotsubo syndrome following intensive care unit discharge. Netherlands Journal of Critical Care, 29(1), 14-21. Scopus2 WoS1 |
| 2021 | Kato, K., Cammann, V. L., Napp, L. C., Szawan, K. A., Micek, J., Dreiding, S., . . . Templin, C. (2021). Prognostic impact of acute pulmonary triggers in patients with takotsubo syndrome: new insights from the International Takotsubo Registry. ESC Heart Failure, 8(3), 1924-1932. Scopus18 WoS17 Europe PMC18 |
| 2021 | Ong, G. J., Girolamo, O., Stansborough, J., Nguyen, T. H., & Horowitz, J. D. (2021). Incidence and clinical/laboratory correlates of early hypotension in takotsubo syndrome.. ESC Heart Failure, 8(3), 2009-2015. Scopus3 WoS3 Europe PMC3 |
| 2021 | Kemp-Harper, B. K., Velagic, A., Paolocci, N., Horowitz, J. D., & Ritchie, R. H. (2021). Cardiovascular Therapeutic Potential of the Redox Siblings, Nitric Oxide (NO•) and Nitroxyl (HNO), in the Setting of Reactive Oxygen Species Dysregulation. Handbook of experimental pharmacology, 264, 311-337. Scopus13 Europe PMC9 |
| 2021 | Ong, G. J., Nguyen, T. H., Kucia, A., Liu, S. -F., Surikow, S. Y., Girolamo, O., . . . Horowitz, J. D. (2021). Takotsubo syndrome: Finally emerging from the shadows?. Heart Lung and Circulation, 30(1), 36-44. Scopus13 WoS13 Europe PMC9 |
| 2021 | Iyngkaran, P., Thomas, M., Horowitz, J. D., Komesaroff, P., Jelinek, M., & Hare, D. L. (2021). Common Comorbidities that Alter Heart Failure Prognosis-Shaping New Thinking for Practice. Current Cardiology Reviews, 17(5), 10 pages. Scopus7 WoS7 Europe PMC8 |
| 2021 | Schwarz, K., Parasuraman, S., Singh, S., Horowitz, J. D., Dawson, D. K., & Frenneaux, M. P. (2021). The unspoken benefit of participation in a clinical trial. Clinical Medicine Journal of the Royal College of Physicians of London, 21(6), E645-E647. Scopus9 WoS9 Europe PMC7 |
| 2021 | Cammann, V. L., Scheitz, J. F., von Rennenberg, R., Jäncke, L., Nolte, C. H., Szawan, K. A., . . . Budnik, M. (2021). Clinical correlates and prognostic impact of neurologic disorders in Takotsubo syndrome. Scientific Reports, 11(1), 23555-1-23555-14. Scopus27 Europe PMC21 |
| 2021 | Nguyen, T. H., Surikow, S. Y., & Horowitz, J. D. (2021). Editorial commentary: Takotsubo Syndrome: A key role for inflammation?. Trends in Cardiovascular Medicine, 31(4), 231-232. Scopus3 WoS3 Europe PMC2 |
| 2020 | Napp, L. C., Cammann, V. L., Jaguszewski, M., Szawan, K. A., Wischnewsky, M., Gili, S., . . . Templin, C. (2020). Coexistence and outcome of coronary artery disease in Takotsubo syndrome.. Eur Heart J, 41(34), 3255-3267. Scopus63 WoS55 Europe PMC51 |
| 2020 | Nguyen, T., Chirkov, Y., Liu, S., Stafford, I., & Horowitz, J. (2020). Increased Rate of Hospitalization With Prinzmetal Angina: What Exactly Is Happening?. American Journal of Medicine, 133(4), e162-e163. Scopus1 WoS1 Europe PMC1 |
| 2020 | Cammann, V. L., Szawan, K. A., Stähli, B. E., Kato, K., Budnik, M., Wischnewsky, M., . . . Horowitz, J. D. (2020). Age-Related Variations in Takotsubo Syndrome. Journal of the American College of Cardiology, 75(16), 1869-1877. Scopus68 WoS61 Europe PMC57 |
| 2020 | Ong, G. J., Nguyen, T. H., Stansborough, J., Surikow, S. Y., & Horowitz, J. D. (2020). Incremental "Therapeutic" Myocardial Exposure to Catecholamines: Incidence and Impact in Takotsubo Syndrome.. Cardiovasc Drugs Ther, 34(1), 95-100. Scopus6 WoS6 Europe PMC5 |
| 2020 | Iyngkaran, P., Thomas, M. C., Neil, C., Jelinek, M., Cooper, M., Horowitz, J. D., . . . Kaye, D. M. (2020). The Heart Failure with Preserved Ejection Fraction Conundrum—Redefining the Problem and Finding Common Ground?. Current Heart Failure Reports, 17(2), 34-42. Scopus12 WoS10 Europe PMC10 |
| 2020 | D'Ascenzo, F., Gili, S., Bertaina, M., Iannaccone, M., Cammann, V. L., Di Vece, D., . . . Templin, C. (2020). Impact of aspirin on takotsubo syndrome: a propensity score-based analysis of the InterTAK Registry.. European journal of heart failure, 22(6), 330-337. Scopus41 WoS38 Europe PMC31 |
| 2020 | Bittner, V. A., Szarek, M., Aylward, P. E., Bhatt, D. L., Diaz, R., Edelberg, J. M., . . . Ball, E. (2020). Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 75(2), 133-144. WoS425 Europe PMC348 |
| 2020 | Ntessalen, M., Procter, N. E., Schwarz, K., Loudon, B. L., Minnion, M., Fernandez, B. O., . . . Frenneaux, M. P. (2020). Inorganic nitrate and nitrite supplementation fails to improve skeletal muscle mitochondrial efficiency in mice and humans.. The American journal of clinical nutrition, 111(1), 79-89. Scopus19 WoS18 Europe PMC15 |
| 2020 | Qin, C. X., Anthonisz, J., Leo, C. H., Kahlberg, N., Velagic, A., Li, M., . . . Ritchie, R. H. (2020). Nitric oxide resistance, induced in the myocardium by diabetes, is circumvented by the nitric oxide redox sibling, nitroxyl. Antioxidants and Redox Signaling, 32(1), 60-77. Scopus25 WoS23 Europe PMC21 |
| 2020 | Ong, G. J., Nguyen, T. H., Stansborough, J., Surikow, S., Mahadavan, G., Worthley, M., & Horowitz, J. (2020). The N-AcetylCysteine and RAMipril in Takotsubo Syndrome Trial (NACRAM): Rationale and design of a randomised controlled trial of sequential N-Acetylcysteine and ramipril for the management of Takotsubo Syndrome.. Contemporary clinical trials, 90, 105894. Scopus23 WoS22 Europe PMC18 |
| 2020 | Ding, K. J., Cammann, V. L., Szawan, K. A., Stähli, B. E., Wischnewsky, M., Di Vece, D., . . . Templin, C. (2020). Intraventricular Thrombus Formation and Embolism in Takotsubo Syndrome: Insights From the International Takotsubo Registry.. Arteriosclerosis, thrombosis, and vascular biology, 40(1), 279-287. Scopus59 WoS60 Europe PMC48 |
| 2020 | Horowitz, J. D., & Chong, C. -R. (2020). Matrix metalloproteinase-2 activation: critical to myocardial contractile dysfunction following ischaemia-reperfusion.. Cardiovascular research, 116(5), 876-878. Scopus3 WoS1 Europe PMC3 |
| 2020 | Mannil, M., Kato, K., Manka, R., von Spiczak, J., Peters, B., Cammann, V. L., . . . Templin, C. (2020). Prognostic value of texture analysis from cardiac magnetic resonance imaging in patients with Takotsubo syndrome: a machine learning based proof-of-principle approach. Scientific Reports, 10(1), 20537-1-20537-9. Scopus20 WoS19 Europe PMC14 |
| 2020 | Nooney, V. B., Hurst, N. L., De Caterina, R., Chirkov, Y. Y., & Horowitz, J. D. (2020). Does high on-treatment platelet aggregability reflect poor individual response to clopidogrel?. Thrombosis Research, 196, 510-515. Scopus5 WoS5 Europe PMC4 |
| 2020 | Velagic, A., Qin, C., Woodman, O. L., Horowitz, J. D., Ritchie, R. H., & Kemp-Harper, B. K. (2020). Nitroxyl: a novel strategy to circumvent diabetes associated impairments in nitric oxide signaling. Frontiers in Pharmacology, 11, 727-1-727-18. Scopus19 WoS18 Europe PMC14 |
| 2020 | Aulin, J., Hijazi, Z., Siegbahn, A., Andersson, U., Alexander, J. H., Connolly, S. J., . . . Oldgren, J. (2020). Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials. Journal of Thrombosis and Haemostasis, 18(9), 2287-2295. Scopus17 WoS16 Europe PMC16 |
| 2020 | Liu, S., Ngo, D., Chirkov, Y., Stansborough, J., Chong, C., & Horowitz, J. D. (2020). Prolonged suppression of the anti-oxidant/anti-inflammatory effects of BNP post-Takotsubo syndrome. ESC Heart Failure, 7(5), 2250-2257. Scopus5 WoS5 Europe PMC4 |
| 2019 | Roe, M. T., Li, Q. H., Bhatt, D. L., Bittner, V. A., Diaz, R., Goodman, S. G., . . . Zobouyan, I. (2019). Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes. CIRCULATION, 140(19), 1578-1589. WoS49 Europe PMC33 |
| 2019 | Jurisic, S., Gili, S., Cammann, V. L., Kato, K., Szawan, K. A., D'Ascenzo, F., . . . Templin, C. (2019). Clinical Predictors and Prognostic Impact of Recovery of Wall Motion Abnormalities in Takotsubo Syndrome: Results From the International Takotsubo Registry. Journal of the American Heart Association, 8(21), e011194. Scopus37 WoS37 Europe PMC28 |
| 2019 | White, H. D., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Diaz, R., . . . Schwartz, G. G. (2019). Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial. EUROPEAN HEART JOURNAL, 40(33), 2801-2809. WoS52 Europe PMC42 |
| 2019 | Jukema, J. W., Szarek, M., Zijlstra, L. E., de Silva, H. A., Bhatt, D. L., Bittner, V. A., . . . Zobouyan, I. (2019). Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(9), 1167-1176. WoS191 Europe PMC135 |
| 2019 | Goodman, S. G., Aylward, P. E., Szarek, M., Chumburidze, V., Bhatt, D. L., Bittner, V. A., . . . Ball, E. (2019). Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(9), 1177-1186. WoS53 Europe PMC36 |
| 2019 | Grech, M., Turnbull, D. A., Wittert, G. A., Tully, P. J., & CHAMPS Investigators. (2019). Identifying the internalizing disorder clusters among recently hospitalized cardiovascular disease patients: a receiver operating characteristics study. Frontiers in Psychology, 10, 2829-1-2829-11. Scopus5 WoS2 Europe PMC2 |
| 2019 | Szarek, M., Steg, P. G., DiCenso, D., Bhatt, D. L., Bittner, V. A., Budaj, A., . . . Zobouyan, I. (2019). Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 12(11), 9 pages. WoS23 Europe PMC12 |
| 2019 | Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Bregeault, M. -F., Dalby, A. J., . . . Schwartz, G. G. (2019). Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial. CIRCULATION, 140(2), 103-112. WoS118 Europe PMC89 |
| 2019 | Nguyen, T. H., Stansborough, J., Ong, G. J., Surikow, S., Price, T. J., & Horowitz, J. D. (2019). Antecedent cancer in Takotsubo syndrome predicts both cardiovascular and long-term mortality.. Cardio-Oncology, 5(1), 20-1-20-9. Scopus13 WoS11 Europe PMC5 |
| 2019 | Szarek, M., White, H. D., Schwartz, G. G., Alings, M., Bhatt, D. L., Bittner, V. A., . . . Zobouyan, I. (2019). Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 73(4), 387-396. WoS149 Europe PMC106 |
| 2019 | Wischnewsky, M. B., Candreva, A., Bacchi, B., Cammann, V. L., Kato, K., Szawan, K. A., . . . Templin, C. (2019). Prediction of short- and long-term mortality in takotsubo syndrome: the InterTAK Prognostic Score. European Journal of Heart Failure, 21(11), 1469-1472. Scopus33 WoS32 Europe PMC28 |
| 2019 | Ajaero, C. N., Procter, N. E. K., Chirkov, Y., Heresztyn, T., Arstall, M. A., McGavigan, A. D., . . . Horowitz, J. D. (2019). Endothelial dysfunction and glycocalyx shedding in heart failure: insights from patients receiving cardiac resynchronisation therapy. Heart and Vessels, 35(2), 197-206. Scopus9 WoS9 Europe PMC9 |
| 2019 | Cammann, V. L., Sarcon, A., Ding, K. J., Seifert, B., Kato, K., Di Vece, D., . . . Templin, C. (2019). Clinical Features and Outcomes of Patients With Malignancy and Takotsubo Syndrome: Observations From the International Takotsubo Registry. Journal of the American Heart Association, 8(15), 1-13. Scopus72 WoS65 Europe PMC50 |
| 2019 | Imam, H., Nguyen, T. H., De Caterina, R., Nooney, V. B., Chong, C. R., Horowitz, J. D., & Chirkov, Y. Y. (2019). Impaired adenylate cyclase signaling in acute myocardial ischemia: Impact on effectiveness of P2Y<inf>12</inf> receptor antagonists. Thrombosis Research, 181, 92-98. Scopus7 WoS6 Europe PMC5 |
| 2019 | Di Vece, D., Citro, R., Cammann, V. L., Kato, K., Gili, S., Szawan, K. A., . . . Templin, C. (2019). Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome.. Circulation, 139(3), 413-415. Scopus96 WoS97 Europe PMC79 |
| 2019 | Liu, S., Chirkov, Y. Y., & Horowitz, J. D. (2019). Neutrophil-initiated myocardial inflammation and Its modulation by B-type natriuretic peptide: a potential therapeutic target. International Journal of Molecular Sciences, 20(1), 129-1-129-13. Scopus10 WoS10 Europe PMC8 |
| 2019 | Ajaero, C. N., Ganesan, A., Horowitz, J. D., & McGavigan, A. D. (2019). Electrical remodelling post cardiac resynchronization therapy in patients with ischemic and non-ischemic heart failure. Journal of Electrocardiology, 53, 44-51. Scopus2 WoS2 |
| 2019 | Washam, J. B., Hohnloser, S. H., Lopes, R. D., Wojdyla, D. M., Vinereanu, D., Alexander, J. H., . . . Granger, C. B. (2019). Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial. Journal of Thrombosis and Thrombolysis, 47(3), 345-352. Scopus12 WoS11 Europe PMC9 |
| 2019 | Iyngkaran, P., Chan, W., Liew, D., Zamani, J., Horowitz, J. D., Jelinek, M., . . . Shaw, J. A. (2019). Risk stratification for coronary artery disease in multi-ethnic populations: Are there broader considerations for cost efficiency?. World journal of methodology, 9(1), 1-19. Europe PMC5 |
| 2019 | Nguyen, T. H., Heresztyn, T., & Horowitz, J. D. (2019). Risk indexation and atrial fibrillation. Aging, 11(6), 1607-1608. |
| 2019 | Gili, S., Cammann, V. L., Schlossbauer, S. A., Kato, K., D Ascenzo, F., Di Vece, D., . . . Templin, C. (2019). Cardiac arrest in takotsubo syndrome: Results from the InterTAK Registry. European Heart Journal, 40(26), 2142-2151. Scopus88 WoS87 Europe PMC64 |
| 2019 | Liu, S., & Horowitz, J. D. (2019). Interactions between Influenza and Heart Failure Hospitalizations-Diagnostic and Pathogenetic Issues. JAMA Cardiology, 4(9), 949-950. Scopus1 WoS1 Europe PMC1 |
| 2019 | Ray, K. K., Colhoun, H. M., Szarek, M., Baccara-Dinet, M., Bhatt, D. L., Bittner, V. A., . . . Steg, P. G. (2019). Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet Diabetes and Endocrinology, 7(8), 618-628. Scopus281 WoS274 Europe PMC197 |
| 2018 | Schwartz, G., Steg, P., Szarek, M., Bhatt, D., Bittner, V., Diaz, R., . . . Leone, A. (2018). Alirocumab and cardiovascular outcomes after acute coronary syndrome. New England Journal of Medicine, 379(22), 2097-2107. Scopus2865 WoS2551 Europe PMC2155 |
| 2018 | Bohula, E., Scirica, B., Inzucchi, S., McGuire, D., Keech, A., Smith, S., . . . Savard, D. (2018). Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial. The Lancet, 392(10161), 2269-2279. Scopus74 WoS68 Europe PMC54 |
| 2018 | Surikow, S. Y., Nguyen, T. H., Stafford, I., Chapman, M., Chacko, S., Singh, K., . . . Horowitz, J. D. (2018). Nitrosative stress as a modulator of inflammatory change in a model of Takotsubo syndrome. JACC: Basic to Translational Science, 3(2), 213-226. Scopus60 WoS58 Europe PMC41 |
| 2018 | Ghadri, J. R., Wittstein, I. S., Prasad, A., Sharkey, S., Dote, K., Akashi, Y. J., . . . Templin, C. (2018). International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management. European Heart Journal, 39(22), 2047-2062. Scopus638 WoS586 Europe PMC519 |
| 2018 | Ghadri, J. R., Wittstein, I. S., Prasad, A., Sharkey, S., Dote, K., Akashi, Y. J., . . . Templin, C. (2018). International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. European Heart Journal, 39(22), 2032-2046. Scopus1159 WoS1085 Europe PMC928 |
| 2018 | Horowitz, J., De Caterina, R., Heresztyn, T., Alexander, J., Andersson, U., Lopes, R., . . . Wallentin, L. (2018). Asymmetric and symmetric dimethylarginine predict outcomes in patients with atrial fibrillation: an ARISTOTLE substudy. Journal of the American College of Cardiology, 72(7), 721-733. Scopus38 WoS38 Europe PMC31 |
| 2018 | Ghadri, J., Kato, K., Cammann, V., Gili, S., Jurisic, S., Di Vece, D., . . . Templin, C. (2018). Long-Term Prognosis of Patients With Takotsubo Syndrome. Journal of the American College of Cardiology, 72(8), 874-882. Scopus290 WoS270 Europe PMC233 |
| 2018 | Horowitz, J. D., & Sage, P. R. (2018). Can we improve long-term outcomes postbifurcation stenting by prolonged dual antiplatelet therapy?. Circulation Cardiovascular Interventions, 11(7), 3 pages. Scopus2 WoS3 Europe PMC1 |
| 2018 | Horowitz, J. D., & Liu, S. (2018). ADAM-15 and glycocalyx shedding: a new perspective on sepsis-related vasomotor dysfunction. Cardiovascular research, 114(13), 1694-1695. Scopus3 WoS3 Europe PMC3 |
| 2018 | Ajaero, C., Chong, C. -R., Procter, N., Liu, S., Chirkov, Y., Heresztyn, T., . . . Horowitz, J. (2018). Does cardiac resynchronization therapy restore peripheral circulatory homeostasis?. ESC heart failure, 5(1), 129-138. Scopus1 WoS2 Europe PMC2 |
| 2017 | Schwarz, K., Singh, S., Parasuraman, S., Rudd, A., Shepstone, L., Feelisch, M., . . . Frenneaux, M. (2017). Inorganic nitrate in angina study: a randomized double-blind placebo-controlled trial. Journal of the American Heart Association, 6(9), 006478-1-006478-S. Scopus15 WoS14 Europe PMC8 |
| 2017 | Schwarz, K., Ahearn, T., Srinivasan, J., Neil, C. J., Scally, C., Rudd, A., . . . Dawson, D. K. (2017). Author's Reply. Journal of the American Society of Echocardiography, 30(10), 1042. Scopus1 WoS1 Europe PMC1 |
| 2017 | Vaduganathan, M., Harrington, R. A., Stone, G. W., Deliargyris, E. N., Steg, P. G., Gibson, C. M., . . . Chandra, P. (2017). Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention. Journal of the American College of Cardiology, 69(2), 176-185. Scopus53 WoS54 Europe PMC42 |
| 2017 | Steeds, R. P., Cowie, M. R., Rana, B. S., Chambers, J. B., Ray, S., Srinivasan, J., . . . Russhard, P. (2017). Report from the Annual Conference of the British Society of Echocardiography, November 2016, Queen Elizabeth II Conference Centre, London. ECHO RESEARCH AND PRACTICE, 4(3), M1-M16. |
| 2017 | Nguyen, T. H., Liu, S., Ong, G. J., Stafford, I., Frenneaux, M. P., & Horowitz, J. D. (2017). Glycocalyx shedding is markedly increased during the acute phase of Takotsubo cardiomyopathy. International Journal of Cardiology, 243, 296-299. Scopus38 WoS38 Europe PMC39 |
| 2017 | Amarasekera, A., Assadi-Khansari, B., Liu, S., Black, M., Dymmott, G., Rogers, N., . . . Ngo, D. (2017). Vitamin D supplementation lowers thrombospondin-1 levels and blood pressure in healthy adults. PLoS ONE, 12(5), e0174435-1-e0174435-14. Scopus13 WoS13 Europe PMC14 |
| 2017 | Scuffham, P., Ball, J., Horowitz, J., Wong, C., Newton, P., Macdonald, P., . . . Stewart, S. (2017). Standard vs. intensified management of heart failure to reduce healthcare costs: results of a multicentre, randomized controlled trial. European Heart Journal, 38(30), 2340-2348. Scopus24 WoS18 Europe PMC13 |
| 2017 | Pasupathy, S., Tavella, R., Grover, S., Raman, B., Procter, N. E. K., Du, Y. T., . . . Beltrame, J. F. (2017). Early use of N-acetylcysteine with nitrate therapy in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction reduces myocardial infarct size (the NACIAM trial [N-acetylcysteine in acute myocardial infarction]). Circulation, 136(10), 894-903. Scopus132 WoS121 Europe PMC108 |
| 2017 | Schwarz, K., Ahearn, T., Srinivasan, J., Neil, C., Scally, C., Rudd, A., . . . Dawson, D. (2017). Alterations in cardiac deformation, timing of contraction and relaxation, and early myocardial fibrosis accompany the apparent recovery of acute stress-induced (Takotsubo) cardiomyopathy: an end to the concept of transience. Journal of the American Society of Echocardiography, 30(8), 745-755. Scopus107 WoS101 Europe PMC85 |
| 2017 | Guimarães, P., Wojdyla, D., Alexander, J., Thomas, L., Alings, M., Flaker, G., . . . Lopes, R. (2017). Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial. International Journal of Cardiology, 227, 443-449. Scopus3 WoS3 Europe PMC1 |
| 2017 | Packer, M., McMurray, J. J. V., Krum, H., Kiowski, W., Massie, B. M., Caspi, A., . . . Little, T. (2017). Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE Trials. Jacc Heart Failure, 5(5), 317-326. Scopus124 WoS105 Europe PMC95 |
| 2016 | Dawson, D. K., Neil, C. J., Henning, A., Cameron, D., Jagpal, B., Bruce, M., . . . Frenneaux, M. P. (2016). The Authors Reply. Jacc Cardiovascular Imaging, 9(5), 635-636. |
| 2016 | Dawson, D. K., Neil, C. J., Henning, A., Cameron, D., Jagpal, B., Bruce, M., . . . Frenneaux, M. P. (2016). The Authors Reply. Jacc Cardiovascular Imaging, 9(5), 633. |
| 2016 | Velazquez, E. J., Lee, K. L., Jones, R. H., Al-Khalidi, H. R., Hill, J. A., Panza, J. A., . . . Rouleau, J. L. (2016). Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. NEW ENGLAND JOURNAL OF MEDICINE, 374(16), 1511-1520. WoS796 Europe PMC658 |
| 2016 | Chong, C., Ong, G., & Horowitz, J. (2016). Emerging drugs for the treatment of angina pectoris. Expert Opinion on Emerging Drugs, 21(4), 365-376. Scopus15 WoS12 Europe PMC10 |
| 2016 | Chen, D., Procter, N., Goh, V., Liu, S., Chua, S., Assadi-Khansari, B., . . . Ngo, D. (2016). New onset atrial fibrillation is associated with elevated galectin-3 levels. International Journal of Cardiology, 223, 48-49. Scopus22 WoS15 Europe PMC17 |
| 2016 | Sverdlov, A. L., Figtree, G. A., Horowitz, J. D., & Ngo, D. T. M. (2016). Interplay between oxidative stress and inflammation in cardiometabolic syndrome. Mediators of Inflammation, 2016, 8254590-1-8254590-3. Scopus21 WoS21 Europe PMC22 |
| 2016 | Tee, S., & Horowitz, J. (2016). Angina pectoris: Why differentiating the type is so important. Medicine Today, 7(6), 27-34. |
| 2016 | Procter, N. E. K., & Horowitz, J. D. (2016). Authors' reply. Journal of Geriatric Cardiology, 13(5), 471-472. |
| 2016 | Nguyen, T. H., Liu, S., Ong, G., Stafford, I., Frenneaux, M., & Horowitz, J. D. (2016). Glycocalyx shedding is markedly increased during the acute phase of Takotsubo cardiomyopathy. Abstracts of the American Heart Association Scientific Sessions and Resuscitation Science Symposium 2016, as published in Circulation, 134(Suppl. 1), A11912. |
| 2016 | Schwarz, K., Singh, S., Parasuraman, S. K., Bruce, M., Shepstone, L., Feelisch, M., . . . Frenneaux, M. P. (2016). A randomized double-blind placebo-controlled crossover trial of sodium nitrate in patients with stable angina INAS. Future Cardiology, 12(6), 617-626. Scopus4 WoS4 Europe PMC4 |
| 2016 | Iyngkaran, P., Toukhsati, S., Thomas, M., Jelinek, M., Hare, D., & Horowitz, J. (2016). A review of the external validity of clinical trials with beta-blockers in heart failure. Clinical Medicine Insights: Cardiology, 10, 163-171. Scopus3 WoS3 Europe PMC3 |
| 2016 | Kemp-Harper, B., Horowitz, J., & Ritchie, R. (2016). Therapeutic potential of nitroxyl (HNO) donors in the management of acute decompensated heart failure. Drugs, 76(14), 1337-1348. Scopus35 WoS36 Europe PMC28 |
| 2016 | Scally, C., Ahearn, T., Rudd, A., Neil, C. J., Srivanasan, J., Jagpal, B., . . . Dawson, D. K. (2016). Right ventricular involvement and recovery after acute stress-induced (Tako-tsubo) cardiomyopathy. American Journal of Cardiology, 117(5), 775-780. Scopus33 WoS30 Europe PMC27 |
| 2016 | Iyngkaran, P., Kangaharan, N., Zimmet, H., Arstall, M., Minson, R., Thomas, M., . . . Ilton, M. (2016). Heart failure in minority populations - Impediments to optimal treatment in Australian aborigines. Current Cardiology Reviews, 12(3), 166-179. Scopus5 WoS4 Europe PMC5 |
| 2016 | Procter, N. E., & Horowitz, J. D. (2016). Platelet reactivity in patients with atrial fibrillation Reply. JOURNAL OF GERIATRIC CARDIOLOGY, 13(5), 471-472. |
| 2016 | Phuong, H., Choi, B., Chong, C., Raman, B., & Horowitz, J. (2016). Can perhexiline be utilized without long-term toxicity? A clinical practice audit. Therapeutic Drug Monitoring, 38(1), 73-78. Scopus15 WoS13 Europe PMC14 |
| 2016 | Procter, N., Ball, J., Ngo, D., Chirkov, Y., Isenberg, J., Hylek, E., . . . Horowitz, J. (2016). Platelet hyperaggregability in patients with atrial fibrillation: Evidence of a background proinflammatory milieu. Herz, 41(1), 57-62. Scopus9 WoS11 Europe PMC9 |
| 2016 | Tully, P. J., Turnbull, D. A., Horowitz, J. D., Beltrame, J. F., Selkow, T., Baune, B. T., . . . Wittert, G. A. (2016). Cardiovascular Health in Anxiety or Mood Problems Study (CHAMPS): study protocol for a randomized controlled trial. Trials, 17(1), 18-1-18-10. Scopus15 WoS11 Europe PMC9 |
| 2016 | Hijazi, Z., Aulin, J., Andersson, U., Alexander, J., Gersh, B., Granger, C., . . . Wallentin, L. (2016). Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation. Heart, 102(7), 508-517. Scopus85 WoS77 Europe PMC73 |
| 2016 | De Caterina, R., Andersson, U., Alexander, J., Al-Khatib, S., Bahit, M., Goto, S., . . . Wallentin, L. (2016). History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial. American Heart Journal, 175, 175-183. Scopus22 WoS17 Europe PMC13 |
| 2016 | Procter, N., Goh, V., Mahadevan, G., Stewart, S., & Horowitz, J. (2016). Platelet reactivity is independent of left atrial wall deformation in patients with atrial fibrillation. Mediators of Inflammation, 2016, 9754808-1-9754808-5. Scopus3 WoS3 Europe PMC4 |
| 2016 | Chong, C., Sallustio, B., & Horowitz, J. (2016). Drugs that Affect Cardiac Metabolism: focus on Perhexiline. Cardiovascular Drugs and Therapy, 30(4), 399-405. Scopus27 WoS24 Europe PMC23 |
| 2016 | Procter, N., Ball, J., Ngo, D., Isenberg, J., Hylek, E., Chirkov, Y., . . . Horowitz, J. (2016). Gender and tachycardia: independent modulation of platelet reactivity in patients with atrial fibrillation. Journal of Geriatric Cardiology, 13(3), 202-208. WoS5 Europe PMC4 |
| 2016 | Procter, N., Stewart, S., & Horowitz, J. (2016). New-onset atrial fibrillation and thromboembolic risk: Cardiovascular syzygy?. Heart Rhythm, 13(6), 1355-1361. Scopus16 WoS15 Europe PMC13 |
| 2016 | Procter, N. E. K., Hurst, N. L., Nooney, V. B., Imam, H., De Caterina, R., Chirkov, Y. Y., & Horowitz, J. D. (2016). New developments in platelet cyclic nucleotide signalling: therapeutic Implications. Cardiovascular drugs and therapy, 30(5), 505-513. Scopus11 WoS10 Europe PMC7 |
| 2016 | Chua, S. J., Ajaero, C., Assadi-Khansari, B., Mcgavigan, A., Horowitz, J. D., Ngo, D. T., & Sverdlov, A. L. (2016). Galectin 3 predicts improvement in LV volumes after Cardiac Resynchronisation Therapy. EUROPEAN JOURNAL OF HEART FAILURE, 18, 232. |
| 2016 | Amarasekera, A., Sverdlov, A., Horowitz, J., & Ngo, D. (2016). Elevated parathyroid hormone predicts high asymmetric dimethylarginine (ADMA) concentrations in obese diabetic patients. Diabetes and Metabolism, 42(5), 378-381. Scopus3 WoS3 Europe PMC3 |
| 2015 | Horowitz, J., Chong, C., Ngo, D., & Sverdlov, A. (2015). Effects of acute hyperglycaemia on cardiovascular homeostasis: Does a spoonful of sugar make the flow-mediated dilatation go down?. Journal of Thoracic Disease, 7(12), 607-611. Scopus4 WoS4 Europe PMC4 |
| 2015 | Chong, C., Drury, N., Licari, G., Frenneaux, M., Horowitz, J., Pagano, D., & Sallustio, B. (2015). Stereoselective handling of perhexiline: implications regarding accumulation within the human myocardium. European Journal of Clinical Pharmacology, 71(12), 1485-1491. Scopus11 WoS9 Europe PMC7 |
| 2015 | Procter, N., Ball, J., Liu, S., Hurst, N., Nooney, V., Goh, V., . . . Horowitz, J. (2015). Impaired platelet nitric oxide response in patients with new onset atrial fibrillation. International Journal of Cardiology, 179, 160-165. Scopus21 WoS23 Europe PMC20 |
| 2015 | Chong, C., Liu, S., Licari, G., Heresztyn, T., Chirkov, Y., Ngo, D., & Horowitz, J. (2015). Reversal of hyperglycemia: effects on nitric oxide signaling. American Journal of Medicine, 128(4), 427-430. Scopus6 WoS6 Europe PMC5 |
| 2015 | Singh, K., Chong, C. R., Nguyen, T. H., Stansborough, J., & Horowitz, J. D. (2015). Reply: Takotsubo syndrome is a systemic, rather than merely a cardiac, disease: Possible effects on the systemic and pulmonary vasculature. Heart Lung and Circulation, 24(4), 417-418. |
| 2015 | Procter, N. E., Ball, J., Heresztyn, T., Nooney, V. B., Liu, S., Chong, C. -R., . . . Horowitz, J. D. (2015). Subtle renal dysfunction and bleeding risk in atrial fibrillation: symmetric dimethylarginine predicts HAS-BLED score.. American journal of cardiovascular disease, 5(2), 101-109. WoS1 |
| 2015 | Hijazi, Z., Siegbahn, A., Andersson, U., Lindahl, B., Granger, C., Alexander, J., . . . Wallentin, L. (2015). Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy. Clinical Chemistry, 61(2), 368-378. Scopus47 WoS46 Europe PMC35 |
| 2015 | Liu, S., Ngo, D., Chong, C., Amarasekera, A., Procter, N., Licari, G., . . . Horowitz, J. (2015). Suppression of neutrophil superoxide generation by BNP is attenuated in acute heart failure: a case for 'BNP resistance'. European Journal of Heart Failure, 17(5), 475-483. Scopus15 WoS14 Europe PMC13 |
| 2015 | Neil, C., Nguyen, T., Singh, K., Raman, B., Stansborough, J., Dawson, D., . . . Horowitz, J. (2015). Relation of delayed recovery of myocardial function after takotsubo cardiomyopathy to subsequent quality of life. American Journal of Cardiology, 115(8), 1085-1089. Scopus48 WoS41 Europe PMC36 |
| 2015 | Nooney, V., Hurst, N., Chirkov, Y., De Caterina, R., & Horowitz, J. (2015). Post receptor determinants of acute platelet response to clopidogrel in patients with symptomatic myocardial ischemia. Vascular Pharmacology, 65-66, 17-22. Scopus5 WoS5 Europe PMC1 |
| 2015 | Surikow, S., Raman, B., Licari, J., Singh, K., Nguyen, T., & Horowitz, J. (2015). Evidence of nitrosative stress within hearts of patients dying of Tako-tsubo cardiomyopathy. International Journal of Cardiology, 189(1), 112-114. Scopus28 WoS30 Europe PMC26 |
| 2015 | Tully, P., Wittert, G., Turnbull, D., Beltrame, J., Horowitz, J., Cosh, S., & Baumeister, H. (2015). Panic disorder and incident coronary heart disease: a systematic review and meta-analysis protocol. Systematic Reviews, 4(1), 33-1-33-8. Scopus8 WoS6 Europe PMC4 |
| 2015 | Stewart, S., Ball, J., Horowitz, J., Marwick, T., Mahadevan, G., Wong, C., . . . Carrington, M. (2015). Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial. The Lancet, 385(9970), 775-784. Scopus121 WoS117 Europe PMC99 |
| 2015 | Arif, S., Borgognone, A., Lin, E., O'Sullivan, A., Sharma, V., Drury, N., . . . Madhani, M. (2015). Role of aldehyde dehydrogenase in hypoxic vasodilator effects of nitrite in rats and humans. British Journal of Pharmacology, 172(13), 3341-3352. Scopus13 WoS11 Europe PMC12 |
| 2015 | Ahearn, T., Jagpal, B., Cameron, D., Ng, B. K., Scally, C., Higgins, D. M., . . . Dawson, D. K. (2015). Dynamic changes of the extracellular matrix after acute tako-tsubo cardiomyopathy. Journal of Cardiovascular Magnetic Resonance, 17(Suppl 1), 1. |
| 2015 | Tully, P., Turnbull, D., Beltrame, J., Horowitz, J., Cosh, S., Baumeister, H., & Wittert, G. (2015). Panic disorder and incident coronary heart disease: a systematic review and meta-regression in 1 131 612 persons and 58 111 cardiac events. Psychological Medicine, 45(14), 2909-2920. Scopus76 WoS54 Europe PMC47 |
| 2015 | Hurst, N. L., Nooney, V. B., Chirkov, Y. Y., De Caterina, R., & Horowitz, J. D. (2015). Determinants of subacute response to clopidogrel: Relative impact of CYP2C19 genotype and PGE(1)/adenylate cyclase signalling. Thrombosis Research, 136(2), 308-314. Scopus8 WoS8 Europe PMC5 |
| 2015 | Bonaca, M. P., Bhatt, D. L., Cohen, M., Steg, P. G., Storey, R. F., Jensen, E. C., . . . Stepanov, N. (2015). Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction. New England Journal of Medicine, 372(19), 1791-1800. WoS1561 Europe PMC1213 |
| 2015 | Beadle, R., Williams, L., Kuehl, M., Bowater, S., Abozguia, K., Leyva, F., . . . Frenneaux, M. (2015). Improvement in cardiac energetics by perhexiline in heart failure due to dilated cardiomyopathy. JACC: Heart Failure, 3(3), 202-211. Scopus88 Europe PMC76 |
| 2015 | Chang, S., Davidson, P., Newton, P., Macdonald, P., Carrington, M., Marwick, T., . . . On behalf of the WHICH Investigators. (2015). Composite outcome measures in a pragmatic clinical trial of chronic heart failure management: a comparative assessment. International Journal of Cardiology, 185, 62-68. Scopus9 WoS9 Europe PMC9 |
| 2015 | Ball, J., Carrington, M., Thompson, D., Horowitz, J., & Stewart, S. (2015). Post-discharge electrocardiogram Holter monitoring in recently hospitalised individuals with chronic atrial fibrillation to enhance therapeutic monitoring and identify potentially predictive phenotypes. European Journal of Cardiovascular Nursing, 14(5), 384-394. Scopus4 WoS3 Europe PMC2 |
| 2015 | Scally, C., Neil, C. J., Srinivasan, J., Jagpal, B., Ng, B. K., Frenneaux, M. P., . . . Dawson, D. K. (2015). Right ventricular involvement in Tako-tsubo cardiomyopathy - insights from cardiovascular magnetic resonance. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 17(Suppl 1), P280. |
| 2015 | Dawson, D. K., Neil, C. J., Henning, A., Cameron, D., Jagpal, B., Bruce, M., . . . Frenneaux, M. P. (2015). Tako-Tsubo cardiomyopathy: A heart stressed out of energy?. JACC: Cardiovascular Imaging, 8(8), 983-989. Scopus65 WoS65 Europe PMC57 |
| 2015 | Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., . . . Califf, R. M. (2015). Ezetimibe added to statin therapy after acute coronary syndromes. New England Journal of Medicine, 372(25), 2387-2397. Scopus3836 Europe PMC2779 |
| 2014 | Singh, S., Schwarz, K., Horowitz, J., & Frenneaux, M. (2014). Cardiac energetic impairment in heart disease and the potential role of metabolic modulators a review for clinicians. Circulation: Cardiovascular Genetics, 7(5), 720-728. Scopus20 WoS17 Europe PMC15 |
| 2014 | Singh, K., Neil, C., Nguyen, T., Stansborough, J., Chong, C., Dawson, D., . . . Horowitz, J. (2014). Dissociation of early shock in Takotsubo cardiomyopathy from either right or left ventricular systolic dysfunction. Heart, Lung and Circulation, 23(12), 1141-1148. Scopus27 WoS25 Europe PMC23 |
| 2014 | Siddiqi, N., Neil, C., Bruce, M., MacLennan, G., Cotton, S., Papadopoulou, S., . . . Frenneaux, M. (2014). Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI). European Heart Journal, 35(19), 1255-+. Scopus134 WoS121 Europe PMC112 |
| 2014 | Bailey, J., Feelisch, M., Horowitz, J., Frenneaux, M., & Madhani, M. (2014). Pharmacology and therapeutic role of inorganic nitrite and nitrate in vasodilatation. Pharmacology and Therapeutics, 144(3), 303-320. Scopus48 WoS46 Europe PMC35 |
| 2014 | Goto, S., Zhu, J., Liu, L., Oh, B., Wojdyla, D., Aylward, P., . . . Alexander, J. (2014). Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: A subanalysis of the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial. American Heart Journal, 168(3), 303-309. Scopus142 WoS138 Europe PMC108 |
| 2014 | Christersson, C., Wallentin, L., Andersson, U., Alexander, J., Ansell, J., De Caterina, R., . . . Siegbahn, A. (2014). D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation - observations from the ARISTOTLE trial. Journal of Thrombosis and Haemostasis, 12(9), 1401-1412. Scopus86 WoS85 Europe PMC70 |
| 2014 | Raman, B., Singh, K., Zeitz, C. J., & Horowitz, J. D. (2014). Takotsubo cardiomyopathy presenting as S-T elevation myocardial infarction: Not gone but forgotten?. International Journal of Cardiology, 172(1), e261-e262. Scopus11 WoS11 Europe PMC11 |
| 2014 | Wallentin, L., Lopes, R. D., Hanna, M., Thomas, L., Hellkamp, A., Nepal, S., . . . Granger, C. B. (2014). Response to letter regarding article, "efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation". Circulation, 129(2), e21-e22. Scopus1 Europe PMC1 |
| 2014 | Procter, N., Chong, C., Sverdlov, A., Chan, W., Chirkov, Y., & Horowitz, J. (2014). Aging of platelet nitric oxide signaling: pathogenesis, clinical implications, and therapeutics. Seminars in Thrombosis and Hemostasis, 40(6), 660-668. Scopus14 WoS13 Europe PMC9 |
| 2014 | Sverdlov, A., Ngo, D., Chan, W., Chirkov, Y., & Horowitz, J. (2014). Aging of the nitric oxide system: are we as old as our NO?. Journal of the American Heart Association, 3(4), e000973-1-e000973-12. Scopus81 WoS76 Europe PMC65 |
| 2014 | Liu, S., Ngo, D., Stewart, S., Horowitz, J., & Chirkov, Y. (2014). B-Type natriuretic peptide suppression of neutrophil superoxide generation: mechanistic studies in normal subjects. Clinical and Experimental Pharmacology and Physiology, 41(10), 739-743. Scopus8 WoS8 Europe PMC8 |
| 2014 | Chong, C., Chan, W., Nguyen, T., Liu, S., Procter, N., Ngo, D., . . . Horowitz, J. (2014). Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetes. Cardiovascular Drugs and Therapy, 28(4), 347-360. Scopus79 WoS76 Europe PMC70 |
| 2014 | Dautov, R., Stafford, I., Liu, S., Cullen, H., Chirkov, Y., & Horowitz, J. (2014). Hypoxic potentiation of nitrite effects in human vessels and platelets. Nitric Oxide: Biology and Chemistry, 40, 36-44. Scopus20 WoS18 Europe PMC14 |
| 2014 | Stewart, S., Carrington, M., Horowitz, J., Marwick, T., Newton, P., Davidson, P., . . . Scuffham, P. (2014). Prolonged impact of home versus clinic-based management of chronic heart failure: extended follow-up of a pragmatic, multicentre randomized trial cohort. International Journal of Cardiology, 174(3), 600-610. Scopus30 WoS27 Europe PMC23 |
| 2014 | Ali, O., Chapman, M., Thanh, H., Chirkov, Y., Heresztyn, T., Mundisugih, J., & Horowitz, J. (2014). Interactions between inflammatory activation and endothelial dysfunction selectively modulate valve disease progression in patients with bicuspid aortic valve. Heart, 100(10), 800-805. Scopus43 WoS41 Europe PMC39 |
| 2014 | Kayacelebi, A., Nguyen, T., Neil, C., Horowitz, J., Jordan, J., & Tsikas, D. (2014). Homoarginine and 3-nitrotyrosine in patients with takotsubo cardiomyopathy. International Journal of Cardiology, 173(3), 546-547. Scopus28 WoS27 Europe PMC25 |
| 2014 | Horowitz, J. D., & Nguyen, T. H. (2014). Role of echocardiography in tako-tsubo cardiomyopathy: Beyond diagnosis?. Jacc Cardiovascular Imaging, 7(2), 130-132. Scopus1 WoS1 Europe PMC1 |
| 2014 | Mahadavan, G., Nguyen, T., & Horowitz, J. (2014). Brain natriuretic peptide: a biomarker for all cardiac disease?. Current Opinion in Cardiology, 29(2), 160-166. Scopus34 WoS30 Europe PMC27 |
| 2014 | Sheikh, A. R., Westley, I., Sallustio, B., Horowitz, J. D., & Beltrame, J. F. (2014). Interaction of terbinafine (anti-fungal agent) with perhexiline: a case report. Heart, Lung and Circulation, 23(6), e149-e151. Scopus9 WoS7 Europe PMC5 |
| 2014 | Drury, N., Licari, G., Chong, C., Howell, N., Frenneaux, M., Horowitz, J., . . . Sallustio, B. (2014). Relationship between plasma, atrial and ventricular perhexiline concentrations in humans: insights into factors affecting myocardial uptake. British Journal of Clinical Pharmacology, 77(5), 789-795. Scopus9 WoS9 Europe PMC9 |
| 2014 | Hijazi, Z., Wallentin, L., Siegbahn, A., Andersson, U., Alexander, J., Atar, D., . . . Granger, C. (2014). High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin. Journal of the American College of Cardiology, 63(1), 52-61. Scopus144 WoS137 Europe PMC118 |
| 2014 | Wallentin, L., Hijazi, Z., Andersson, U., Alexander, J., De Caterina, R., Hanna, M., . . . Siegbahn, A. (2014). Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial. Circulation, 130(21), 1847-1858. Scopus273 WoS267 Europe PMC225 |
| 2014 | Nicholls, S. J., Kastelein, J. J. P., Schwartz, G. G., Bash, D., Rosenson, R. S., Cavender, M. A., . . . Nissen, S. E. (2014). Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial. JAMA - Journal of the American Medical Association, 311(3), 252-262. Scopus288 WoS267 Europe PMC241 |
| 2014 | Nicholls, S. J., Kastelein, J. J. P., Schwartz, G. G., Bash, D., Rosenson, R. S., Cavender, M. A., . . . Nissen, S. E. (2014). Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial. JAMA - Journal of the American Medical Association, 311(3), 252-262. Scopus288 WoS267 Europe PMC241 |
| 2014 | Hijazi, Z., Siegbahn, A., Andersson, U., Granger, C., Alexander, J., Atar, D., . . . Wallentin, L. (2014). High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: Insights from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial. Circulation, 129(6), 625-634. Scopus117 WoS111 Europe PMC99 |
| 2014 | Singh, K., Carson, K., Usmani, Z., Sawhney, G., Shah, R., & Horowitz, J. (2014). Systematic review and meta-analysis of incidence and correlates of recurrence of takotsubo cardiomyopathy. International Journal of Cardiology, 174(3), 696-701. Scopus217 WoS208 Europe PMC184 |
| 2014 | Singh, K., Carson, K., Shah, R., Sawhney, G., Singh, B., Parsaik, A., . . . Horowitz, J. (2014). Meta-analysis of clinical correlates of acute mortality in takotsubo cardiomyopathy. American Journal of Cardiology, 113(8), 1420-1428. Scopus171 WoS150 Europe PMC132 |
| 2013 | Chong, C. R., Neil, C. J., Nguyen, T. H., Singh, K., & Horowitz, J. D. (2013). Reply. Clinical Cardiology, 36(10), E33. |
| 2013 | Chong, C. R., & Horowitz, J. D. (2013). Letters to the editor. Clinical Cardiology, 36(8), 492-493. |
| 2013 | Beltrame, J. F., & Horowitz, J. D. (2013). Why do nitrates have limited efficacy in coronary microvessels?. Cardiovascular Drugs and Therapy, 27(3), 187-188. Scopus7 WoS5 Europe PMC3 |
| 2013 | Carrington, M., Ball, J., Horowitz, J., Marwick, T., Mahadevan, G., Wong, C., . . . Stewart, S. (2013). Navigating the fine line between benefit and risk in chronic atrial fibrillation: rationale and design of the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY). International Journal of Cardiology, 166(2), 359-365. Scopus14 WoS17 Europe PMC16 |
| 2013 | Singh, K., Marinelli, T., & Horowitz, J. (2013). Takotsubo cardiomyopathy after anti-influenza vaccination: catecholaminergic effects of immune system. American Journal of Emergency Medicine, 31(11), 1627.e1-1627.e4. Scopus23 WoS23 Europe PMC26 |
| 2013 | Das, D., Holmes, A., Mishra, K., Rosenkranz, A., Horowitz, J., & Kennedy, J. (2013). TGF-β1-induced MAPK activation promotes collagen synthesis, nodule formation, redox stress and cellular senescence in porcine aortic valve interstitial cells. Journal of Heart Valve Disease, 22(5), 621-630. Scopus35 WoS31 Europe PMC29 |
| 2013 | Ngo, D., Horowitz, J., & Sverdlov, A. (2013). Heart failure: a corin-deficient state?. Hypertension, 61(2), 284-285. Scopus15 WoS15 Europe PMC11 |
| 2013 | Nguyen, T., Neil, C., Sverdlov, A., Ngo, D., Chan, W., Heresztyn, T., . . . Horowitz, J. (2013). Enhanced NO signaling in patients with Takotsubo cardiomyopathy: short-term pain, long-term gain?. Cardiovascular Drugs and Therapy, 27(6), 541-547. Scopus39 WoS34 Europe PMC29 |
| 2013 | Sorich, M., Horowitz, J., Sorich, W., Wiese, M., Pekarsky, B., & Karnon, J. (2013). Cost-effectiveness of using CYP2C19 genotype to guide selection of clopidogrel or ticagrelor in Australia. Pharmagenomics, 14(16), 2013-2021. Scopus33 WoS31 Europe PMC25 |
| 2013 | Hurst, N., Nooney, V., Raman, B., Chirkov, Y., De Caterina, R., & Horowitz, J. (2013). Clopidogrel "resistance": Pre- vs post-receptor determinants. Vascular Pharmacology, 59(5-6), 152-161. Scopus21 WoS19 Europe PMC12 |
| 2013 | Sverdlov, A., Chan, W., Procter, N., Chirkov, Y., Ngo, D., & Horowitz, J. (2013). Reciprocal regulation of NO signaling and TXNIP expression in humans: Impact of aging and ramipril therapy. International Journal of Cardiology, 168(5), 4624-4630. Scopus32 WoS36 Europe PMC32 |
| 2013 | Dautov, R., Ngo, D., Licari, G., Liu, S., Sverdlov, A., Ritchie, R., . . . Chirkov, Y. (2013). The nitric oxide redox sibling nitroxyl partially circumvents impairment of platelet nitric oxide responsiveness. Nitric Oxide-Biology and Chemistry, 35, 72-78. Scopus22 WoS23 Europe PMC15 |
| 2013 | Chan, W., Ngo, D., Sverdlov, A., Rajendran, S., Stafford, I., Heresztyn, T., . . . Horowitz, J. (2013). Premature aging of cardiovascular/platelet function in polycystic ovarian syndrome. American Journal of Medicine, 126(7), 1-7. Scopus14 WoS6 Europe PMC8 |
| 2013 | Chong, C., Neil, C., Nguyen, T., Stansborough, J., Law, G., Singh, K., & Horowitz, J. (2013). Dissociation between severity of takotsubo cardiomyopathy and presentation with shock or hypotension. Clinical Cardiology, 36(7), 401-406. Scopus44 WoS40 Europe PMC38 |
| 2013 | Horowitz, J. (2013). Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for Stroke prevention in atrial fibrillation. Circulation, 127(22), 2166-2176. Scopus197 WoS176 Europe PMC152 |
| 2013 | Hijazi, Z., Wallentin, L., Siegbahn, A., Andersson, U., Christersson, C., Ezekowitz, J., . . . Granger, C. (2013). N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: Insights from the aristotle trial (apixaban for the prevention of stroke in subjects with atrial fibrillation). Journal of the American College of Cardiology, 61(22), 2274-2284. Scopus211 WoS202 Europe PMC171 |
| 2013 | Maher, A., Arif, S., Madhani, M., Abozguia, K., Ahmed, I., Fernandez, B., . . . Frennaux, M. (2013). Impact of chronic congestive heart failure on pharmacokinetics and vasomotor effects of infused nitrite. British Journal of Pharmacology, 169(3), 659-670. Scopus23 WoS21 Europe PMC19 |
| 2013 | Whitty, J., Stewart, S., Carrington, M., Calderone, A., Marwick, T., Horowitz, J., . . . Scuffham, P. (2013). Patient preferences and willingness-to-pay for a home or clinic based program of chronic heart failure management: findings from the which? trial. PLoS One, 8(3), 1-8. Scopus32 WoS31 Europe PMC31 |
| 2013 | Irvine, J., Cao, N., Gossain, S., Alexander, A., Love, J., Qin, C., . . . Ritchie, R. (2013). HNO/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: Potential therapeutic advantages of HNO over NȮ. American Journal of Physiology - Heart and Circulatory Physiology, 305(3), 365-377. Scopus27 WoS27 Europe PMC22 |
| 2013 | Figtree, G., Bagnall, R., Abdulla, I., Buchholz, S., Galougahi, K., Yan, W., . . . Ward, M. (2013). No association of G-protein-coupled receptor kinase 5 or β-adrenergic receptor polymorphisms with Takotsubo cardiomyopathy in a large Australian cohort. European Journal of Heart Failure, 15(7), 730-733. Scopus50 WoS49 Europe PMC42 |
| 2013 | Siddiqi, N., Bruce, M., Neil, C. J., Jagpal, B., Maclennon, G., Cotton, S. C., . . . Frenneaux, M. P. (2013). Protocol: Does sodium nitrite administration reduce ischaemia-reperfusion injury in patients presenting with acute ST segment elevation myocardial infarction? Nitrites in acute myocardial infarction (NIAMI). Journal of Translational Medicine, 11(1), 8 pages. Scopus14 WoS14 Europe PMC11 |
| 2013 | Kitoh, H., Achiwa, M., Kaneko, H., Mishima, K., Matsushita, M., Kadono, I., . . . Ishiguro, N. (2013). Perhexiline maleate in the treatment of fibrodysplasia ossificans progressiva: an open-labeled clinical trial. Orphanet Journal of Rare Diseases, 8(1), 163-1-163-7. Scopus15 WoS16 Europe PMC13 |
| 2013 | Ritchie, R., Irvine, J., Cao, N., Gossain, S., Alexander, A., Love, J., . . . Kemp-Harper, B. K. (2013). The nitroxyl donor isopropylamine-NONOate elicits soluble guanylyl cyclase-dependent antihypertrophic actions: comparison of the potential therapeutic advantages of HNO over NO•. BMC pharmacology & toxicology, 14(Suppl 1), P56. |
| 2012 | Iachini Bellisarii, F., Radico, F., Muscente, F., Horowitz, J., & De Caterina, R. (2012). Nitrates and other nitric oxide donors in cardiology - Current positioning and perspectives. Cardiovascular Drugs and Therapy, 26(1), 55-69. Scopus15 WoS13 Europe PMC9 |
| 2012 | Irvine, J., Ganthavee, V., Love, J., Alexander, A., Horowitz, J., Stasch, J., . . . Ritchie, R. (2012). The soluble guanylyl cyclase activator bay 58-2667 selectively limits cardiomyocyte hypertrophy. PLoS ONE, 7(11), 1-11. Scopus55 WoS49 Europe PMC43 |
| 2012 | Lopes, R., Al-Khatib, S., Wallentin, L., Yang, H., Ansell, J., Bahit, M., . . . Alexander, J. (2012). Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial. Lancet, 380(9855), 1749-1758. Scopus183 WoS163 Europe PMC133 |
| 2012 | Sverdlov, A., Ngo, D., Chan, W., Chirkov, Y., Gersh, B., McNeil, J., & Horowitz, J. (2012). Determinants of aortic sclerosis progression: implications regarding impairment of nitric oxide signalling and potential therapeutics. European Heart Journal, 33(19), 2419-2425. Scopus28 WoS26 Europe PMC26 |
| 2012 | Gilutz, H., & Horowitz, J. (2012). Erythropoietin studies should not be abandoned. American Heart Journal, 164(3), 5. |
| 2012 | Stewart, S., Carrington, M., Marwick, T., Davidson, P., Macdonald, P., Horowitz, J., . . . Scuffham, P. (2012). Impact of home versus clinic-based management of chronic heart failure: the WHICH? (Which heart failure intervention is most cost-effective & consumer friendly in reducing hospital care) multicenter, randomized trial. Journal of the American College of Cardiology, 60(14), 1239-1248. Scopus116 WoS104 Europe PMC98 |
| 2012 | Willoughby, S., Rajendran, S., Chan, W., Procter, N., Leslie, S., Liberts, E., . . . Horowitz, J. (2012). Ramipril sensitizes platelets to nitric oxide: Implications for therapy in high-risk patients. Journal of the American College of Cardiology, 60(10), 887-894. Scopus46 WoS45 Europe PMC38 |
| 2012 | Neil, C., Nguyen, T., Kucia, A., Crouch, B., Sverdlov, A., Chirkov, Y., . . . Horowitz, J. (2012). Slowly resolving global myocardial inflammation/oedema in Tako-Tsubo cardiomyopathy: evidence from T2-weighted cardiac MRI. Heart, 98(17), 1278-1284. Scopus106 WoS103 Europe PMC90 |
| 2012 | Ngo, D., Sverdlov, A., & Horowitz, J. (2012). Prevention of aortic valve stenosis: a realistic therapeutic target?. Pharmacology & Therapeutics, 135(1), 78-93. Scopus20 WoS18 Europe PMC17 |
| 2012 | Rogers, N., Stephenson, M., Kitching, A., Horowitz, J., & Coates, P. (2012). Amelioration of renal ischaemia-reperfusion injury by liposomal delivery of curcumin to renal tubular epithelial and antigen-presenting cells. British Journal of Pharmacology, 166(1), 194-209. Scopus47 WoS46 Europe PMC39 |
| 2012 | Rosenson, R., Horowitz, J., Kaski, J., Krum, H., & Remme, W. (2012). Clinical Trials Update Esc Congress 2011. Cardiovascular Drugs and Therapy, 26(1), 77-84. Scopus2 WoS1 Europe PMC1 |
| 2012 | Gilutz, H., Frenneaux, M., & Horowitz, J. (2012). A case series of concomitant treatment of perhexiline with Amiodarone. Therapeutic Drug Monitoring, 34(2), 227-231. Scopus1 WoS1 |
| 2012 | Neil, C., Nguyen, T., Sverdlov, A., Chirkov, Y., Chong, C., Stansborough, J., . . . Horowitz, J. (2012). Can we make sense of takotsubo cardiomyopathy? An update on pathogenesis, diagnosis and natural history. Expert Review of Cardiovascular Therapy, 10(2), 215-221. Scopus20 WoS14 Europe PMC13 |
| 2012 | Chan, W., & Horowitz, J. (2012). Thrombospondin-1 in pulmonary arterial hypertension: what ails NOS?. Cardiovascular Research, 93(4), 540-542. |
| 2012 | Neil, C., Chong, C., Nguyen, T., & Horowitz, J. (2012). Occurrence of Tako-Tsubo cardiomyopathy in association with ingestion of serotonin/noradrenaline reuptake inhibitors. Heart, Lung & Circulation (Print Edition), 21(4), 203-205. Scopus46 WoS40 Europe PMC32 |
| 2012 | Sverdlov, A., Ngo, D., & Horowitz, J. (2012). Pathogenesis of aortic sclerosis: association with low BMI, tissue nitric oxide resistance, but not systemic inflammatory activation. American Journal of Cardiovascular Disease, 2(1), 43-49. WoS6 Europe PMC6 |
| 2012 | Nguyen, T., Horowitz, J., & Unger, S. (2012). Tachycardic vs. pharmacologic stress myocardial perfusion imaging: differential implications in multi-vessel ischemia. American Journal of Cardiovascular Disease, 2(1), 34-42. Europe PMC2 |
| 2012 | Sverdlov, A., Ngo, D., & Horowitz, J. (2012). Redefining the natural history of calcific aortic stenosis: lessons from Laennec. Journal of Internal Medicine, 271(6), 569-572. Scopus1 WoS1 Europe PMC1 |
| 2012 | Willoughby, S. R., Rajendran, S., Chan, W. P., Procter, N., Leslie, S., Liberts, E. A., . . . Horowitz, J. D. (2012). Ramipril Sensitazes Platelets to Nitric Oxide. Implication for Therapy in High-Risk Patients. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 8(4), 595-603. |
| 2011 | Horowitz, J., Rosenson, R., McMurray, J., Marx, N., & Remme, W. (2011). Clinical Trials Update AHA Congress 2010. Cardiovascular Drugs and Therapy, 25(1), 69-76. Scopus9 WoS9 Europe PMC10 |
| 2011 | Ling, L., Chik, W., Averbuj, P., Pati, P., Sverdlov, A., Ngo, D., . . . Horowitz, J. (2011). Effects of aging, renal dysfunction, left ventricular systolic impairment, and weight on steady state pharmacokinetics of perhexiline. Therapeutic Drug Monitoring, 33(2), 251-256. Scopus4 WoS4 Europe PMC3 |
| 2011 | Ngo, D., Stafford, I., Sverdlov, A., Qi, W., Wuttke, R., Zhang, Y., . . . Horowitz, J. (2011). Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations. British Journal of Pharmacology, 162(3), 722-732. Scopus33 WoS32 Europe PMC31 |
| 2011 | Nightingale, A., Sverdlov, A., Rajendran, S., Mishra, K., Heresztyn, T., Ngo, D., & Horowitz, J. (2011). Lack of association between aortic sclerosis and left ventricular hypertrophy in elderly subjects. International Journal of Cardiology, 150(1), 33-38. Scopus9 WoS7 Europe PMC5 |
| 2011 | Lopes, R., Horowitz, J., Garcia, D., Crowther, M., & Hylek, E. (2011). Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility. Blood, 118(24), 6269-6273. Scopus30 WoS25 Europe PMC23 |
| 2011 | Nordin, B., Lewis, J., Daly, R., Horowitz, J., Metcalfe, A., Lange, K., & Prince, R. (2011). The calcium scare - what would Austin Bradford Hill have thought?. Osteoporosis International, 22(12), 3073-3077. Scopus42 WoS37 Europe PMC30 |
| 2011 | Nguyen, T., Neil, C., Sverdlov, A., Mahadevan, G., Chirkov, Y., Kucia, A., . . . Horowitz, J. (2011). N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy. American Journal of Cardiology, 108(9), 1316-1321. Scopus126 WoS110 Europe PMC107 |
| 2011 | Ngo, D., Chan, W., Rajendran, S., Heresztyn, T., Amarasekera, A., Sverdlov, A., . . . Horowitz, J. (2011). Determinants of insulin responsiveness in young women: Impact of polycystic ovarian syndrome, nitric oxide, and vitamin D. Nitric Oxide-Biology and Chemistry, 25(3), 326-330. Scopus57 WoS48 Europe PMC41 |
| 2011 | Granger, C., Alexander, J., McMurray, J., Lopes, R., Hylek, E., Hanna, M., . . . Wallertin, L. (2011). Apixaban versus Warfarin in patients with atrial fibrillation. New England Journal of Medicine, 365(11), 981-992. Scopus8026 WoS6999 Europe PMC5781 |
| 2011 | Stewart, S., Carrington, M., Marwick, T., Davidson, P., Macdonald, P., Horowitz, J., . . . Scuffham, P. (2011). The WHICH? trial: rationale and design of a pragmatic randomized, multicentre comparison of home- vs. clinic-based management of chronic heart failure patients. European Journal of Heart Failure, 13(8), 909-916. Scopus37 WoS34 Europe PMC33 |
| 2011 | Sverdlov, A., Ngo, D., Nightingale, A., Rajendran, S., Mishra, K., Heresztyn, T., . . . Horowitz, J. (2011). The endogenous NOS inhibitor asymmetric dimethylarginine (ADMA) predicts LV mass independent of afterload. Nitric Oxide-Biology and Chemistry, 25(1), 41-46. Scopus14 WoS13 Europe PMC13 |
| 2011 | Sverdlov, A., Ngo, D., Chapman, M., Ali, O., Chirkov, Y., & Horowitz, J. (2011). Pathogenesis of aortic stenosis: not just a matter of wear and tear. American Journal of Cardiovascular Disease, 1(2), 185-199. WoS53 Europe PMC43 |
| 2011 | Ngo, D. T., Drury, N. E., Pagano, D., Frenneaux, M. P., & Horowitz, J. D. (2011). How Does Perhexiline Modulate Myocardial Energetics and Ameliorate Redox Stress?. CIRCULATION, 124(21), 2 pages. WoS6 |
| 2011 | Chan, W. P. A., Sverdlov, A. L., Ngo, D. T., Rajendran, S., Chirkov, Y. Y., & Horowitz, J. D. (2011). Impact of ageing on the platelet and vascular responses in women with polycystic ovary syndrome. EUROPEAN HEART JOURNAL, 32, 171-172. |
| 2011 | Sverdlov, A. L., Ngo, D. T., Chan, W. P., Chapman, M. J., Chirkov, Y. Y., Gersh, B. J., . . . Horowitz, J. D. (2011). Progression of Early Aortic Valve Disease: Are ACE Inhibitors Protective?. CIRCULATION, 124(21), 2 pages. |
| 2010 | Nordin, B. E. C., Daly, R. M., Horowitz, J., & Metcalfe, A. V. (2010). Making too much of a weak case. BMJ, 341(7773), c4997-1. Scopus14 WoS12 Europe PMC9 |
| 2010 | Neil, C. J., Nguyen, T. H., Collings, S., Mahadavan, D., Kucia, A. M., Sverdlov, A., . . . Horowitz, J. D. (2010). Tako-Tsubo Cardiomyopathy: a Slowly Resolving Pancarditis. CIRCULATION, 122(21), 2 pages. |
| 2010 | Kucia, A., Neil, C., Nguyen, T., Beltrame, J., Arstall, M., & Horowitz, J. (2010). Evolution of ECG changes in Tako Tsubo Cardiomyopathy: Arrhythmias first, QT Prolongation later?. Proceedings of the Cardiac Society of Australia and New Zealand and the International Society for Heart Research Australasian Section Annual Scientific meeting, 19(Supplement 2), 225. |
| 2010 | Neil, C., Kucia, A., Nguyen, H., Sverdlov, A., Chan, A., Dautov, R., . . . Horowitz, J. (2010). Relationship between precipitant stressor and timing of clinical diagnosis in Tako-Tsubo Cardiomyopathy. Proceedings of Cardiac Society of Australia and New Zealand and the International Society for Heart Research Australasian Section Annual Scientific Meeting, 19(Supplement 2), 225. |
| 2010 | Lopes, R., Alexander, J., Al-Khatib, S., Ansell, J., Diaz, R., Easton, J., . . . Wallentin, L. (2010). Apixaban for reduction in stroke and other ThromboemboLic events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale. American Heart Journal, 159(3), 331-339. Scopus407 WoS368 Europe PMC321 |
| 2010 | Bansal, M., Chan, J., Leano, R., Pillans, P., Horowitz, J., & Marwick, T. (2010). Effects of perhexiline on myocardial deformation in patients with ischaemic left ventricular dysfunction. International Journal of Cardiology, 139(2), 107-112. Scopus11 WoS7 Europe PMC6 |
| 2010 | Horowitz, J., & Chirkov, Y. (2010). Perhexiline and hypertrophic cardiomyopathy: A new horizon for metabolic modulation. Circulation, 122(16), 1547-1549. Scopus35 WoS32 Europe PMC28 |
| 2010 | Sorich, M., Vitry, A., Ward, M., Horowitz, J., & McKinnon, R. (2010). Prasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: integration of the TRITON-TIMI 38 trial data. Journal of Thrombosis and Haemostasis, 8(8), 1678-1684. Scopus95 WoS79 Europe PMC73 |
| 2010 | Horowitz, J., Chirkov, Y., Kennedy, J., & Sverdlov, A. (2010). Modulation of myocardial metabolism: an emerging therapeutic principle. Current Opinion in Cardiology, 25(4), 329-334. Scopus45 WoS43 Europe PMC42 |
| 2010 | Chirkov, Y., De Sciscio, M., Sverdlov, A., Leslie, S., Sage, P., & Horowitz, J. (2010). Hydralazine does not ameliorate nitric oxide resistance in chronic heart failure. Cardiovascular Drugs and Therapy, 24(2), 131-137. Scopus9 WoS6 Europe PMC8 |
| 2010 | Ngo, D., Sverdlov, A., McNeil, J., & Horowitz, J. (2010). Does Vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations?. American Journal of Medicine, 123(4), 335-341. Scopus114 WoS99 Europe PMC84 |
| 2009 | Kennedy, J., Hua, X., Mishra, K., Murphy, G., Rosenkranz, A., & Horowitz, J. (2009). Inhibition of calcifyin nodule formation in cultured porcine aortic valve cells by nitric oxide donors. European Journal of Pharmacology, 602(1), 28-35. Scopus78 WoS73 Europe PMC64 |
| 2009 | Ritchie, R., Irvine, J., Rosenkranz, A., Patel, R., Wendt, I., Horowitz, J., & Kemp-Harper, B. (2009). Exploiting cGMP-based therapies for the prevention of left ventricular hypertrophy: NO• and beyond. Pharmacology & Therapeutics, 124(3), 279-300. Scopus52 WoS52 Europe PMC45 |
| 2009 | Phan, T., Shivu, G., Choudhury, A., Abozguia, K., Davies, C., Naidoo, U., . . . Frenneaux, M. (2009). Multi-centre experience on the use of perhexiline in chronic heart failure and refractory angina: old drug, new hope. European Journal of Heart Failure, 11(9), 881-886. Scopus50 WoS44 Europe PMC34 |
| 2009 | Ngo, D., Sverdlov, A., Willoughby, S., Nightingale, A., Chirkov, Y., McNeil, J., & Horowitz, J. (2009). Determinants of occurrence of aortic sclerosis in an aging population. JACC: Cardiovascular Imaging, 2(8), 919-927. Scopus42 WoS43 Europe PMC37 |
| 2009 | Ngo, D., Sverdlov, A., McNeil, J., & Horowitz, J. (2009). Correlates of arterial stiffness in an ageing population: Role of asymmetric dimethylarginine. Pharmacological Research, 60(6 Sp Iss), 503-507. Scopus16 WoS12 Europe PMC10 |
| 2009 | Keech, A., & Horowitz, J. (2009). Cost-effectiveness Considerations of Cardiovascular Therapeutics. Heart, Lung & Circulation (Print Edition), 18(2), 118-122. |
| 2009 | Beltrame, J., & Horowitz, J. (2009). The 56th Cardiac Society of ANZ Annual Scientific Meeting: Focused Symposia on Basic and Clinical Science. Heart, Lung & Circulation (Print Edition), 18(1), 2. Europe PMC1 |
| 2009 | Horowitz, J., Remme, W., & Torp-Pedersen, C. (2009). Clinical trials update from the European society of cardiology congress in Munich, 2008: TIME-CHF, CARESS-in-AMI, TRITON-TIMI 38, EUROPA, AF-CHF, and ADVANCE. Cardiovascular Drugs and Therapy, 23(1), 25-29. Scopus2 WoS1 Europe PMC1 |
| 2009 | Rajendran, S., Willoughby, S., Chan, W., Liberts, E., Heresztyn, T., Saha, M., . . . Horowitz, J. (2009). Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects. Atherosclerosis, 204(2), 509-514. Scopus89 WoS86 Europe PMC70 |
| 2009 | Ngo, D. T. M., Sverdlov, A. L., Mcneil, J. J., & Horowitz, J. D. (2009). Low 25-hydroxyvitamin D levels are associated with elevated plasma ADMA and C-reactive protein concentrations: nexus with cardiovascular disease. EUROPEAN HEART JOURNAL, 30, 364. |
| 2009 | Beltrame, J. F., & Horowitz, J. D. (2009). The 56th Cardiac Society of ANZ Annual Scientific Meeting: Focused Symposia on Public Health. Heart Lung and Circulation, 18(2), 93. |
| 2008 | Horowitz, J., Arstall, M., Zeitz, C., & Beltrame, J. (2008). Is there still a role for treatment with β-adrenoceptor antagonists in post-myocardial infarction patients with well-preserved left ventricular systolic function?. Acute Cardiac Care (Print Edition), 10(3), 144-147. Scopus3 Europe PMC2 |
| 2008 | Horowitz, J., & Chirkov, Y. (2008). Identifying clopidogrel resistance during chronic therapy: The case for a biochemical approach. Thrombosis and Haemostasis, 100(4), 519-520. Scopus2 WoS2 Europe PMC2 |
| 2008 | Ngo, D., Stafford, I., Kelly, D., Sverdlov, A., Wuttke, R., Weedon, H., . . . Horowitz, J. (2008). Vitamin D2 supplementation induces the development of aortic stenosis in rabbits: Interactions with endothelial function and thioredoxin-interacting protein. European Journal of Pharmacology, 590(1-3), 290-296. Scopus33 WoS37 Europe PMC31 |
| 2008 | Sverdlov, A., Chan, W., & Horowitz, J. (2008). Management of the metabolic syndrome in cardiovascular disease. Current Treatment Options in Cardiovascular Medicine, 10(1), 27-38. Scopus1 Europe PMC1 |
| 2008 | Chirkov, Y., & Horowitz, J. (2008). Platelet nitric oxide resistance: Pathogenesis and clinical implications. Nitric Oxide-Biology and Chemistry, 19(Suppl 1), 58. |
| 2008 | Horowitz, J. (2008). Therapeutic range for digoxin. Australian Prescriber, 31(5), 116. |
| 2008 | Fox, K., Ford, I., Steg, P. G., Tendera, M., Ferrari, R., Grancelli, H., . . . O'Shea, J. (2008). Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet, 372(9641), 807-816. Scopus999 Europe PMC661 |
| 2007 | Armstrong, P. W., Bett, N., Brieger, D., Chew, D., Dick, R., Farshid, A., . . . Medda, M. (2007). PexeLizumab for Acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: A randomized controlled trial. JAMA, 297(1), 43-51. Scopus420 Europe PMC280 |
| 2007 | Friedell, M. L., Sandler, B. J., Andriole, J. G., Martin, S. P., Cohen, M. J., & Horowitz, J. D. (2007). Carotid angioplasty and stenting is a safe and durable procedure in a community hospital. American Surgeon, 73(6), 543-546. Scopus2 WoS1 Europe PMC1 |
| 2007 | Inglis, S. C., Horowitz, J. D., & Stewart, S. (2007). The natural history of acute heart failure in chronic heart failure. EUROPEAN JOURNAL OF HEART FAILURE, 6(1), 65. |
| 2007 | Chirkov, Y., & Horowitz, J. (2007). Hyperglycemia and platelet function in diabetic patients: Relevance to acute myocardial ischemia and infarction. Cardiology Review, 24(12), 25-29. |
| 2007 | Chirkov, Y. (2007). Impaired tissue responsiveness to organic nitrates and nitric oxide: A new therapeutic frontier?. Pharmacology & Therapeutics, 116(2), 287-305. Scopus84 WoS79 Europe PMC73 |
| 2007 | Recio-Mayoral, A., Kaski, J., McMurray, J., Horowitz, J., van Veldhuisen, D., & Remme, W. (2007). Clinical Trials Update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY. Cardiovascular Drugs and Therapy, 21(6), 459-465. Scopus30 WoS21 Europe PMC20 |
| 2007 | Horowitz, J., & Heresztyn, T. (2007). An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: Methodological considerations. Journal of Chromatography. B, Analytical Techniques in the Biomedical and Life Sciences, 851(1-2), 42-50. Scopus102 WoS98 Europe PMC77 |
| 2007 | Inglis, S., Herbert, M., Davies, B., Coller, J., James, H., Horowitz, J., . . . Sallustio, B. (2007). Effect of CYP2D6 metabolizer status on the disposition of the (+) and (-) enantiomers of perhexiline in patients with myocardial ischaemia. Pharmacogenetics and Genomics (Print Edition), 17(5), 305-312. Scopus8 WoS7 Europe PMC4 |
| 2007 | Rajendran, S., Chirkov, Y., & Horowitz, J. (2007). Potentiation of platelet responsiveness to nitric oxide by angiotensin-(1-7) is associated with suppression of superoxide release. Platelets, 18(2), 158-164. Scopus9 WoS8 Europe PMC8 |
| 2007 | Ashrafian, H., Horowitz, J., & Frenneaux, M. (2007). Perhexiline. Cardiovascular Drug Reviews, 25(1), 76-97. Scopus181 WoS156 Europe PMC132 |
| 2007 | Liberts, E., Willoughby, S., Kennedy, J., & Horowitz, J. (2007). Effects of perhexiline and nitroglycerin on vascular, neutrophil and platelet function in patients with stable angina pectoris. European Journal of Pharmacology, 560(1), 49-55. Scopus15 WoS16 Europe PMC12 |
| 2007 | Ngo, D., Heresztyn, T., Mishra, K., Marwick, T., & Horowitz, J. (2007). Aortic stenosis is associated with elevated plasma levels of asymmetric dimethylarginine (ADMA). Nitric Oxide-Biology and Chemistry, 16(2), 197-201. Scopus39 WoS37 Europe PMC32 |
| 2007 | Worthley, M., Holmes, A., Willoughby, S., Kucia, A., Heresztyn, T., Stewart, S., . . . Horowitz, J. (2007). The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes - Mediation by superoxide production resolution with intensive insulin administration. Journal of the American College of Cardiology, 49(3), 304-310. Scopus152 WoS146 Europe PMC130 |
| 2007 | Worthley, M., Holmes, A., Willoughby, S., Kucia, A., Heresztyn, T., Stewart, S., . . . Horowitz, J. (2007). The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes - Mediation by superoxide production resolution with intensive insulin administration. Journal of the American College of Cardiology, 49(3), 304-310. Scopus152 WoS146 Europe PMC130 |
| 2007 | Inglis, S. C., Horowitz, J. D., & Stewart, S. (2007). Acute heart failure events in a cohort of elderly patients with chronic heart failure. EUROPEAN HEART JOURNAL, 28, 84. |
| 2007 | Ngo, D. T. M., Stafford, I., Wuttke, R. D., Weedon, H., Smith, M. D., Sverdlov, A. L., . . . Horowitz, J. D. (2007). Ramipril retards progression of aortic valve stenosis: association with preservation of nitric oxide effects. EUROPEAN HEART JOURNAL, 28, 513. |
| 2007 | Ngo, D. T. M., Sverdlov, A. L., Willoughby, S. R., Nightingale, A. K., Chirkov, Y. Y., Mcneil, J. J., & Horowitz, J. D. (2007). Aortic valve sclerosis is associated with impaired platelet responsiveness to nitric oxide. EUROPEAN HEART JOURNAL, 28, 513. |
| 2006 | Horowitz, J. (2006). When and why should we employ the pharmacologist?. Dialogues in Cardiovascular Medicine, 11(4), 298-305. |
| 2006 | Inglis, S., Pearson, S., Treen, S., Gallasch, T., Horowitz, J., & Stewart, S. (2006). Extending the horizon in chronic heart failure: Effects of multidisciplinary, home-based intervention relative to usual care. Circulation, 114(23), 2466-2473. Scopus107 WoS89 Europe PMC85 |
| 2006 | Chirkov, Y., Mishra, K., Chandy, S., Holmes, A., Kanna, R., & Horowitz, J. (2006). Loss of anti-aggregatory effects of aortic valve tissue in patients with aortic stenosis. Journal of Heart Valve Disease, 15(1), 28-33. Scopus13 WoS14 Europe PMC13 |
| 2006 | Horowitz, J., & Kennedy, J. (2006). Time to address the cardiac metabolic "triple whammy" - Ischemic heart failure in diabetic patients. Journal of the American College of Cardiology, 48(11), 2232-2234. Scopus14 WoS15 Europe PMC9 |
| 2006 | Ritchie, R., Zeitz, C., Wuttke, R., Hii, J., & Horowitz, J. (2006). Attenuation of the negative inotropic effects of metoprolol at short cycle lengths in humans - Comparison with sotalol and verapamil. Journal of the American College of Cardiology, 48(6), 1234-1241. Scopus8 WoS8 Europe PMC7 |
| 2006 | Mishra, K., Sage, P., Philpott, A., Zeitz, C., & Horowitz, J. (2006). Temporal trends in major angioplasty complications: technical issues and the case for on-site coronary surgery. Internal Medicine Journal, 36(7), 458-461. Scopus2 WoS2 Europe PMC1 |
| 2006 | Morris, R., Jones, T., Goldsworthy, S., Wagner, T., Ho, H., & Horowitz, J. (2006). Suspected DLIS interference in the dimension DGNA digoxin assay method and the clinical application of the revised digoxin target range. Therapeutic Drug Monitoring, 28(3), 454-457. Scopus5 WoS7 Europe PMC4 |
| 2006 | Kennedy, J., Beck-Oldach, K., McFadden-Lewis, K., Murphy, G., Wong, Y., Zhang, Y., & Horowitz, J. (2006). Effect of the anti-anginal agent, perhexiline, on neutrophil, valvular and vascular superoxide formation. European Journal of Pharmacology, 531(1-3), 13-19. Scopus41 WoS41 Europe PMC33 |
| 2006 | Krum, H., Jelinek, M. V., Stewart, S., Sindone, A., Atherton, J. J., Hawkes, A. L., . . . Walsh, W. (2006). Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006. Medical Journal of Australia, 185(10), 549-556. Scopus130 WoS108 Europe PMC84 |
| 2006 | Bhatt, D. L., Fox, K. A. A., Hacke, W., Berger, P. B., Black, H. R., Boden, W. E., . . . Yeoman, G. D. (2006). Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. New England Journal of Medicine, 354(16), 1706-1717. WoS2090 |
| 2005 | Davies, B., Coller, J., James, H., Somogyi, A., Horowitz, J., & Sallustio, B. (2005). The influence of CYP2D6 genotype on trough plasma perhexiline and cis-OH-perhexiline concentrations following a standard loading regimen in patients with myocardial ischaemia. British Journal of Clinical Pharmacology, 61(3), 321-325. Scopus12 WoS12 Europe PMC6 |
| 2005 | Anderson, R., Ellis, G., Evans, L., Morris, K., Chirkov, Y., Horowitz, J., . . . Frenneaux, M. (2005). Platelet nitrate responsiveness in fasting and postprandial type 2 diabetes. Diabetes and Vascular Disease Research, 2(2), 88-93. Scopus15 Europe PMC10 |
| 2005 | Unger, S., Kennedy, J., McFadden-Lewis, K., Minerds, K., Murphy, G., & Horowitz, J. (2005). Dissociation between metabolic and efficiency effects of perhexiline in normoxic rat myocardium. Journal of Cardiovascular Pharmacology, 46(6), 849-855. Scopus31 WoS23 Europe PMC20 |
| 2005 | Willoughby, S., Stewart, S., Holmes, A., Chirkov, Y., & Horowitz, J. (2005). Platelet nitric oxide responsiveness - A novel prognostic marker in acute coronary syndromes. Arteriosclerosis Thrombosis and Vascular Biology, 25(12), 2661-2666. Scopus74 WoS69 Europe PMC63 |
| 2005 | Lee, L., Campbell, R., Scheuermann-Freestone, M., Taylor, R., Gunaruwan, P., Williams, L., . . . Frenneaux, M. (2005). Metabolic modulation with perhexiline in chronic heart failure - a randomized, controlled trial of short-term use of a novel treatment. Circulation, 112(21), 3280-3288. Scopus338 WoS297 Europe PMC259 |
| 2005 | Rajendran, S., Chirkov, Y., Campbell, D., & Horowitz, J. (2005). Angiotensin-(1-7) enhances anti-aggregatory effects of the nitric oxide donor sodium nitroprusside. Journal of Cardiovascular Pharmacology, 46(4), 459-463. Scopus19 WoS17 Europe PMC17 |
| 2005 | Liberts, E., Ahmed, R., & Horowitz, J. (2005). Withdrawal of intravenous glyceryl trinitrate: absence of rebound phenomena with transition to oral isoborbide dinitrate. Clinical and Experimental Pharmacology and Physiology, 32(4), 269-272. Scopus4 WoS3 Europe PMC2 |
| 2005 | Nightingale, A., & Horowitz, J. (2005). Aortic sclerosis: not an innocent murmur but a marker of increased cardiovascular risk. Heart, 91(11), 1389-1393. Scopus61 WoS53 Europe PMC46 |
| 2005 | Holmes, A., Chirkov, Y., Willoughby, S., Poropat, S., Pereira, J., & Horowitz, J. (2005). Preservation of platelet responsiveness to nitroglycerine despite development of vascular nitrate tolerance. British Journal of Clinical Pharmacology, 60(4), 355-363. Scopus21 WoS21 Europe PMC12 |
| 2005 | Cleland, J., Sullivan, J., Ball, S., Horowitz, J., Agoram, B., Rosser, D., . . . Burton, P. (2005). Once-monthly administration of darbepoetin alfa for the treatment of patients with chronic heart failure and anemia - A pharmacokinetic and pharmacodynamic investigation. Journal of Cardiovascular Pharmacology, 46(2), 155-161. Scopus44 WoS39 Europe PMC38 |
| 2005 | Worthley, M., Horowitz, J., & Zeitz, C. (2005). Lack of inotropic effect of nitric oxide on the rat myocardium. Clinical and Experimental Pharmacology and Physiology, 32(7), 526-530. Scopus7 WoS6 Europe PMC6 |
| 2004 | Mishra, K., Unger, S., & Horowitz, J. (2004). Salvage of acutely ischaemic myocardium: individual quantification. Internal Medicine Journal, 34(6), 364-365. |
| 2004 | Horowitz, J. (2004). Tolerance induction during therapy with long-acting nitrates: How extensive is the "collateral damage"?. Cardiovascular Drugs and Therapy, 18(1), 11-12. Scopus8 WoS10 Europe PMC5 |
| 2004 | Campbell, D., Zeitz, C., Esler, M., & Horowitz, J. (2004). Evidence against a major role of angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation. Journal of Hypertension, 22(10), 1971-1976. Scopus83 WoS72 Europe PMC65 |
| 2004 | Inglis, S., McLennan, S., Dawson, A., Birchmore, L., Horowitz, J., Wilkinson, D., & Stewart, S. (2004). A new solution for an old problem? Effects of a nurse-led, multidisciplinary, home-based intervention on readmission and mortality inpatients with chronic atrial fibrillation. Cardiovascular Nursing, 19(2), 118-127. Scopus37 Europe PMC28 |
| 2004 | DeLaLande, I., Stepien, J., Philpott, A., Hughes, P., Stafford, I., & Horowitz, J. (2004). Aldehyde dehrdrogenase, nitric oxide synthase and superoxide in ex vivo nitrate tolerance in rat aorta. European Journal of Pharmacology, 496(1), 141-149. Scopus18 WoS16 Europe PMC15 |
| 2004 | Philpott, A., Chandy, S., Morris, R., & Horowitz, J. (2004). Development of a regimen for rapid initiation of perhexiline therapy in acute coronary syndromes. Internal Medicine Journal, 34(6), 361-363. Scopus7 WoS8 Europe PMC6 |
| 2004 | Ngo, D., Wuttke, R., Turner, S., Marwick, T., & Horowitz, J. (2004). Quantitative assessment of aortic sclerosis using ultrasonic backscatter. Journal of the American Society of Echocardiography, 17(11), 1123-1130. Scopus22 WoS24 Europe PMC22 |
| 2004 | Beltrame, J., Turner, S., Leslie, S., Solomon, P., Freedman, S., & Horowitz, J. (2004). The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon. Journal of the American College of Cardiology, 44(1), 57-62. Scopus112 WoS95 Europe PMC80 |
| 2004 | Chirkov, Y., Holmes, A., Martelli, J., & Horowitz, J. (2004). Effect of Perindopril on platelet nitric oxide resistance in patients with chronic heart failure secondary to ischemic left ventricular dysfunction. American Journal of Cardiology, 93(11), 1438-1440. Scopus30 WoS28 Europe PMC23 |
| 2004 | Heresztyn, T., Worthley, M., & Horowitz, J. (2004). Determination of L-arginine and NG,NG- and NG,NG'-dimethyl-L-arginine in plasma by liquid chromatography as AccQ-FluorTM fluorescent derivatives. Journal of Chromatography. B, Analytical Techniques in the Biomedical and Life Sciences, 805(2), 325-329. Scopus92 WoS91 Europe PMC68 |
| 2004 | DeLaLande, I., Siebert, T., Bennett, C., Stafford, I., & Horowitz, J. (2004). Influence of the endothelium on ex vivo tolerance and metabolism of glyceryl trinitrate in rat aorta. European Journal of Pharmacology, 486(2), 201-207. Scopus8 WoS7 Europe PMC6 |
| 2004 | Jones, T., Morris, R., & Horowitz, J. (2004). Concentration-time profile for perhexiline and hydroxyperhexiline in patients at steady state. British Journal of Clinical Pharmacology, 57(3), 263-269. Scopus4 WoS4 Europe PMC4 |
| 2004 | Anderson, R., Ellis, G., Chirkov, Y., Holmes, A., Payne, N., Blackman, D., . . . Frenneaux, M. (2004). Determinants of platelet responsiveness to nitric oxide in patients with chronic heart failure. European Journal of Heart Failure, 6(1), 47-54. Scopus33 WoS43 Europe PMC26 |
| 2004 | Zhang, Y., Oliver, J., & Horowitz, J. (2004). The role of endothelin in mediating ischemia/hypoxia-induced atrial natriuretic peptide release. Journal of Cardiovascular Pharmacology, 43(2), 227-233. Scopus12 WoS10 Europe PMC10 |
| 2004 | Davies, B., Coller, J., James, H., Gillis, D., Somogyi, A., Horowitz, J., . . . Sallustio, B. (2004). Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexiline. British Journal of Clinical Pharmacology, 57(4), 456-463. Scopus6 WoS6 Europe PMC6 |
| 2004 | Kiu, A., Horowitz, J., & Stewart, S. (2004). Seasonal variation in AF-related admissions to a coronary care unit in a 'hot' climate - fact or fiction?. The Journal of Cardiovascular Nursing, 19(2), 138-141. Scopus17 Europe PMC13 |
| 2004 | Lee, L., Horowitz, J., & Frenneaux, M. (2004). Metabolic manipulation in ischaemic heart disease, a novel approach to treatment. European Heart Journal, 25(8), 634-641. Scopus173 WoS144 Europe PMC114 |
| 2003 | Shah, P., Hare, D., Raman, J., Gordon, I., Chan, R., Horowitz, J., . . . Buxton, B. (2003). Survival after myocardial revascularization for ischemic cardiomyopathy: A prospective ten-year follow-up study. Journal of Thoracic and Cardiovascular Surgery, 126(5), 1320-1327. Scopus44 WoS34 Europe PMC31 |
| 2003 | Zimmermann, A., Jeffries, W., McElroy, H., & Horowitz, J. (2003). Utility of a weight-based heparin nomogram for patients with acute coronary syndromes. Internal Medicine Journal, 33(1-2), 18-25. Scopus15 WoS14 Europe PMC12 |
| 2003 | Worthley, M., Unger, S., Mathew, T., Russ, G., & Horowitz, J. (2003). Usefulness of tachycardic-stress perfusion imaging to predict coronary artery disease in high-risk patients with chronic renal failure. American Journal of Cardiology, 92(11), 1318-1320. Scopus23 WoS21 Europe PMC19 |
| 2003 | Beltrame, J., Limaye, S., Wuttke, R., & Horowitz, J. (2003). Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon. American Heart Journal, 146(1), 84-90. Scopus161 WoS134 Europe PMC111 |
| 2003 | Zeitz, C., Campbell, D., & Horowitz, J. (2003). Myocardial uptake and biochemical and hemodynamic effects of ACE inhibitors in humans. Hypertension, 41(3), 482-487. Scopus26 WoS20 Europe PMC17 |
| 2003 | Stewart, S., & Horowitz, J. (2003). Specialist nurse management programmes - Economic benefits in the management of heart failure. Pharmacoeconomics, 21(4), 225-240. Scopus33 WoS20 Europe PMC18 |
| 2003 | Stepien, J., Prideaux, R., Willoughby, S., Chirkov, Y., & Horowitz, J. (2003). Pilot study examining the effect of cholesterol lowering on platelet nitric oxide responsiveness and arterial stiffness in subjects with isolated mild hypercholesterolaemia. Clinical and Experimental Pharmacology and Physiology, 30(7), 507-512. Scopus21 WoS23 Europe PMC15 |
| 2003 | Beltrame, J., Turner, S., Leslie, S., & Horowitz, J. (2003). Mibefradil: "Has the baby been thrown out with the bath water?". American Heart Journal, 146(1), E3. Scopus1 WoS1 Europe PMC1 |
| 2003 | Horowitz, J. (2003). Amelioration of nitrate tolerance: Matching strategies with mechanisms. Journal of the American College of Cardiology, 41(11), 2001-2003. Scopus16 WoS5 Europe PMC6 |
| 2002 | Willoughby, S., Stewart, S., Chirkov, Y., Kennedy, J., Holmes, A., & Horowitz, J. (2002). Beneficial clinical effects of perhexiline in patients with stable angina pectoris and acute coronary syndromes are associated with potentiation of platelet responsiveness to nitric oxide. European Heart Journal, 23(24), 1946-1954. Scopus52 WoS47 Europe PMC41 |
| 2002 | Beltrame, J., Limaye, S., & Horowitz, J. (2002). The coronary slow flow phenomenon - A new coronary microvascular disorder. Cardiology: international journal of cardiovascular medicine, surgery and pathology, 97(4), 197-202. Scopus287 WoS262 Europe PMC196 |
| 2002 | Beltrame, J., Stewart, S., Leslie, S., Poropat, S., & Horowitz, J. (2002). Resolution of ST-segment elevation following intravenous administration of nitroglycerin and verapamil. American Journal of Cardiology, 89(4), 452-455. Scopus8 WoS8 Europe PMC6 |
| 2002 | Stewart, S., & Horowitz, J. (2002). Home-based intervention in congestive heart failure: Long-term implications on readmission and survival. Circulation, 105(24), 2861-2866. Scopus268 WoS208 Europe PMC198 |
| 2002 | Stewart, S., & Horowitz, J. (2002). Detecting early clinical deterioration in chronic heart failure patients post-acute hospitalisation - a critical component of multidisciplinary, home-based intervention?. European Journal of Heart Failure, 4(3), 345-351. Scopus44 WoS33 Europe PMC26 |
| 2002 | Barraclough, D., Bertouch, J., Brooks, P., Brown, M., Cleland, L., Clemens, L., . . . Yeomans, N. (2002). Considerations for the safe prescribing and use of COX-2-specific inhibitors. Medical Journal of Australia, 176(7), 328-331. Scopus23 WoS11 Europe PMC5 |
| 2002 | Chirkov, Y., Holmes, A., Willoughby, S., Stewart, S., & Horowitz, J. (2002). Association of aortic stenosis with platelet hyperaggregability and impaired responsiveness to nitric oxide. American Journal of Cardiology, 90(5), 551-554. Scopus38 WoS41 Europe PMC36 |
| 2002 | Dudman, N., Hunt, D., MacMahon, S., Neal, B., Richards, M., Simes, J., . . . Bruning, J. (2002). Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease. European Heart Journal, 23(19), 1509-1515. Scopus33 Europe PMC19 |
| 2001 | Ahuad-Guerrero, R., Basara, M., Bastianelli, R., Beloscar, J., Bono, J. O., Castellanos, R., . . . Coelho, O. R. (2001). Erratum: Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina (Journal of the American College of Cardiology (2000) 37 (475-484)). Journal of the American College of Cardiology, 37(3), 973. Scopus2 |
| 2001 | Friedell, M. L., Joseph, B. P., Cohen, M. J., & Horowitz, J. D. (2001). Surgery for carotid artery stenosis following neck irradiation. Annals of Vascular Surgery, 15(1), 13-18. Scopus46 Europe PMC31 |
| 2001 | Horowitz, J., & Stewart, S. (2001). Heart failure in older people: the epidemic we had to have. Medical Journal of Australia, 174(9), 432-433. Scopus6 WoS4 Europe PMC2 |
| 2001 | Chirkov, Y., Holmes, A., Willoughby, S., Stewart, S., Wuttke, R., Sage, P., & Horowitz, J. (2001). Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets. Journal of the American College of Cardiology, 37(7), 1851-1857. Scopus74 WoS62 Europe PMC53 |
| 2001 | Ellis, G., Anderson, R., Chirkov, Y., Morris-Thurgood, J., Jackson, S., Lewis, M., . . . Frenneaux, M. (2001). Acute effects of vitamin c on platelet responsiveness to nitric oxide donors and endothelial function in patients with chronic heart failure. Journal of Cardiovascular Pharmacology, 37(5), 564-570. Scopus47 WoS46 Europe PMC38 |
| 2001 | Kucia, A., Taylor, K., & Horowitz, J. (2001). Can a nurse trained in coronary care expedite emergency department management of patients with acute coronary syndromes?. Heart & Lung, 30(3), 186-190. Scopus12 WoS8 Europe PMC9 |
| 2001 | Stewart, S., Blue, L., Capewell, S., Horowitz, J., & McMurray, J. (2001). Poles apart, but are they the same? A comparative study of Australian and Scottish patients with chronic heart failure. European Journal of Heart Failure, 3(2), 249-255. Scopus14 WoS12 Europe PMC11 |
| 2001 | Cleland, J., Thygesen, K., Uretsky, B., Armstrong, P., Horowitz, J., Massie, B., . . . Ryden, L. (2001). Cardiovascular critical event pathways for the progression of heart failure; A report from the ATLAS study. European Heart Journal, 22(17), 1601-1612. Scopus59 WoS50 Europe PMC36 |
| 2001 | Massie, B., Armstrong, P., Cleland, J., Horowitz, J., Packer, M., Poole-Wilson, P., & Ryden, L. (2001). Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure - Results from the ATLAS trial. Archives of Internal Medicine, 161(2), 165-171. Scopus79 WoS63 Europe PMC56 |
| 2001 | Beltrame, J. F., Turner, S. P., & Horowitz, J. D. (2001). Persistence of the coronary slow flow phenomenon. American Journal of Cardiology, 88(8), 938. Scopus13 WoS12 Europe PMC10 |
| 2000 | Chirkov, Y., Holmes, A., Chirkova, L., & Horowitz, J. (2000). Nitrate resistance in platelets from patients with stable angina pectoris - Response. Circulation, 102(11), E87. |
| 2000 | Kennedy, J., Kiosoglous, A., Murphy, G., Pelle, M., & Horowitz, J. (2000). Effect of perhexiline and oxfenicine on myocardial function and metabolism during low-flow ischemia/reperfusion in the isolated rat heart. Journal of Cardiovascular Pharmacology, 36(6), 794-801. Scopus87 WoS73 Europe PMC64 |
| 2000 | Sculpher, M., Poole, L., Cleland, J., Drummond, M., Armstrong, P., Horowitz, J., . . . Ryden, L. (2000). Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) Study. European Journal of Heart Failure, 20(2), 447-454. Scopus36 WoS33 Europe PMC25 |
| 2000 | Zeitz, C., Ritchie, R., Jarrett, R., Hii, J., Wuttke, R., & Horowitz, J. (2000). The positive inotropic effects of milrinone but not of digoxin are attenuated at short cycle lengths. Journal of Cardiovascular Pharmacology, 35(3), 427-433. Scopus1 WoS1 Europe PMC1 |
| 2000 | Kucia, A., & Horowitz, J. (2000). Is informed consent to clinical trials an "upside selective" process in acute coronoary syndromes?. American Heart Journal, 140(1), 94-97. Scopus42 WoS35 Europe PMC24 |
| 2000 | Uretsky, B., Thygesen, K., Armstrong, P., Cleland, J., Horowitz, J., Massie, B., . . . Ryden, L. (2000). Acute coronary findings at autopsy in heart failure patients with sudden death : results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation, 102(6), 611-616. Scopus311 WoS252 Europe PMC212 |
| 2000 | Sage, P., DeLaLande, I., Stafford, I., Bennett, C., Phillipov, G., Stubberfield, J., & Horowitz, J. (2000). Nitroglycerin tolerance in human vessels: evidence for Impaired Nitroglycerin Bioconversion. Circulation, 102(23), 2810-2815. Scopus145 WoS128 Europe PMC99 |
| 2000 | Horowitz, J. (2000). Home-based intervention: the next step in treatment of chronic heart failure?. European Heart Journal, 21(22), 1807-1809. Scopus20 WoS18 Europe PMC10 |
| 2000 | Ryden, L., Armstrong, P., Cleland, J., Horowitz, J., Massie, B., Packer, M., & Poole-Wilson, P. (2000). Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. European Heart Journal, 21(23), 1967-1978. Scopus150 WoS128 Europe PMC103 |
| 2000 | Cleland, J. G. F., Armstrong, P., Horowitz, J. D., Massie, B., Packer, M., Poole-Wilson, P. A., & Rydén, L. (2000). Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival study. European Journal of Heart Failure, 1(1), 73-79. Scopus15 WoS11 Europe PMC10 |
| 2000 | Anderson, R. A., Ellis, G. R., Chirkov, Y. Y., Blackman, D. J., Jackson, S. K., Lewis, M. J., . . . Frenneaux, M. P. (2000). Primary nitric oxide resistance and oxidative stress in patients with chronic heart failure. Heart, 83(SUPPL. 1), P60. |
| 2000 | Stewart, S., Marley, J. E., & Horowitz, J. D. (2000). A multidisciplinary, home based intervention reduced deaths and readmissions in patients with chronic congestive heart failure. Evidence Based Medicine, 5(3), 84. |
| 1999 | Stewart, S., Vandenbroek, A. J., Pearson, S., & Horowitz, J. D. (1999). A home-based intervention reduced out-of-hospital deaths and hospitalizations in CHF. Evidence Based Medicine, 4(4), 115. |
| 1999 | Horowitz, J. D. (1999). The ATLAS study: low-dose versus high-dose lisinopril in heart failure.. International journal of clinical practice. Supplement, 100, 15-16. Europe PMC2 |
| 1999 | Tornvall, P., Chirkova, L., Toverud, K., Horowitz, J., Chirkov, Y., & Gustaf, K. (1999). Native and oxidized low density lipoproteins enhance platelet aggregation in whole blood. Thrombosis Research, 95(4), 177-183. Scopus5 WoS5 Europe PMC4 |
| 1999 | Stewart, S., Marley, J., & Horowitz, J. (1999). Effects of a multidisciplinary, home-based intervention on planned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study. Lancet, 354(9184), 1077-1083. Scopus548 WoS440 Europe PMC365 |
| 1999 | Kennedy, J., Mohan, P., Pelle, M., Wade, S., & Horowitz, J. (1999). The effects of perhexiline on the rat coronary vasculature. European Journal of Pharmacology, 370(3), 263-270. Scopus3 WoS3 Europe PMC3 |
| 1999 | de la Lande, I., Stafford, I., & Horowitz, J. (1999). Tolerance induction by transdermal glyceryl trinitrate in rats. European Journal of Pharmacology, 374(1), 71-75. Scopus19 WoS19 Europe PMC15 |
| 1999 | de la Lande, I., Stafford, I., & Horowitz, J. (1999). Effects of guanylyl cyclase and protein kinase G inhibitors on vasodilatation in non-tolerant and tolerant bovine coronary arteries. European Journal of Pharmacology, 370(1), 39-46. Scopus5 WoS5 Europe PMC5 |
| 1999 | Chirkov, Y., Holmes, A., Chirkova, L., & Horowitz, J. (1999). Nitrate Resistance in platelets from patients with stable angina pectoris. Circulation, 100(2), 129-134. Scopus86 WoS81 Europe PMC56 |
| 1999 | Packer, M., Poole-Wilson, P., Armstrong, P., Cleland, J., Horowitz, J., Massie, B., . . . Uretsky, B. (1999). Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril on morbidity and mortality in chronic heart failure. Circulation, 100(23), 2312-2318. Scopus1209 WoS893 Europe PMC725 |
| 1999 | Beltrame, J. F., Horowitz, J. D., & Murakami, H. (1999). ST elevation secondary to microvascular dysfunction [4] (multiple letters). Journal of the American College of Cardiology, 34(1), 312-313. Scopus10 |
| 1999 | Uretsky, B. F., Cleland, J. G. F., Horowitz, J. D., Massie, B. M., Packer, M., Poole-Wilson, P. A., & Ryden, L. (1999). The effect of performing an autopsy on classifying the cause of death in patients with heart failure. CIRCULATION, 100(18), 861. WoS1 |
| 1999 | Uretsky, B. F., Thygesen, K., Cleland, J. G. F., Horowitz, J. D., Massie, B. M., Packer, M., . . . Ryden, L. (1999). Clinical-pathological correlation in the diagnosis of coronary disease as the cause of heart failure. CIRCULATION, 100(18), 860. |
| 1999 | Uretsky, B. F., Thygesen, K., Cleland, J. G. F., Horowitz, J. D., Massie, B. M., Packer, M., . . . Ryden, L. (1999). Causes of sudden death in heart failure patients: Results from the ATLAS trial. CIRCULATION, 100(18), 580. WoS2 |
| 1999 | de la Lande, I. S., Stafford, I., & Horowitz, J. D. (1999). Tolerance induction by transdermal glyceryl trinitrate in rats (vol 374, pg 71, 1999). EUROPEAN JOURNAL OF PHARMACOLOGY, 379(1), 115. |
| 1999 | Beltrame, J. F., & Horowitz, J. D. (1999). ST elevation secondary to microvascular dysfunction. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 34(1), 312-313. WoS8 Europe PMC5 |
| 1999 | Stewart, S., Marley, J. E., & Horowitz, J. D. (1999). Does multidisciplinary, home-based intervention reduce unplanned readmissions and prolong event-free survival among congestive heart failure patients?. CIRCULATION, 100(18), 31. |
| 1999 | De la Lande, I. S., Stafford, I., & Horowitz, J. D. (1999). Erratum: Tolerance induction by transdermal glyceryl trinitrate in rats (European Journal of Pharmacology (1999) 374 (71x-75x) PII: S0014299999003192). European Journal of Pharmacology, 379(1), 115. |
| 1999 | Saccoia, N. C., Kennedy, J. A., Horowitz, J. D., & Ruffin, R. E. (1999). Effect of amiodarone on carnitine palmitoyltransferasei activity in pulmonary tissue. Respirology, 4(SUPPL. 1), A35. |
| 1999 | Sage, P., Kiosoglous, A., Wuttke, R., & Horowitz, J. (1999). Early treatment with verapamil or diltiazem in patients with acute myocarial infarction: safety and possible beneficial effects. Cardiovascular Drugs and Therapy, 13(4), 309-313. Scopus3 WoS3 Europe PMC3 |
| 1999 | Stewart, S., Vandenbroek, A., Pearson, S., & Horowitz, J. (1999). Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among patients with congestive heart failure. Archives of Internal Medicine, 159(3), 257-261. Scopus230 WoS182 Europe PMC150 |
| 1998 | Penglis, P., Russ, G., Horowitz, J., Seymour, A., & Kirkham, B. (1998). Dilated cardiomyopathy associated with anti-neutrophil cytoplasmic antibodies. Australian and New Zealand Journal of Medicine, 28(2), 217. WoS1 |
| 1998 | Stewart, S., Pearson, S., & Horowitz, J. (1998). Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. Archives of Internal Medicine, 158(10), 1067-1072. Scopus385 WoS306 Europe PMC259 |
| 1998 | Beltrame, J. F., Zeitz, C. J., Moran, J. L., Horowitz, J. D., Archbold, R. A., Cotter, G., . . . Golik, A. (1998). Nitrates for myocardial infarction (multiple letters) [2]. Lancet, 351(9117), 1731-1732. Scopus1 Europe PMC2 |
| 1998 | Beltrame, J. F., Limaye, S. B., Wuttke, R. D., & Horowitz, J. D. (1998). The coronary slow flow phenomenon: A small vessel disorder which presents as an acute coronary syndrome. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 31(2), 358A-359A. WoS3 |
| 1998 | Uretsky, B. F., Armstrong, P. W., Cleland, J. G., Horowitz, J. D., Massie, B. M., Ryden, L., . . . Poole-Wilson, P. A. (1998). Ischemia as a 'Trigger' for sudden death in patients with cardiomyopathy and heart failure secondary to coronary artery disease: Results from the ATLAS trial. CIRCULATION, 98(17), 199. WoS6 |
| 1998 | Zeitz, C. J., Ritchie, R. H., Jarrett, R. G., Hii, J. T. Y., & Horowitz, J. D. (1998). Mechanical restitution predicts response to tachycardia in humans. CIRCULATION, 98(17), 760. |
| 1998 | Cleland, J. G. F., Massie, B. M., Packer, M., Armstrong, P. W., Horowitz, J. D., Ryden, L., & Poole-Wilson, P. A. (1998). Health economic benefits of treating patients with heart failure with high dose lisinopril versus low dose: The ATLAS study. CIRCULATION, 98(17), 135. WoS4 |
| 1998 | Zhang, Y., Oliver, J., & Horowitz, J. (1998). Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist. Cardiovascular Research, 39(3), 665-673. Scopus20 WoS22 Europe PMC16 |
| 1998 | Kennedy, J., & Horowitz, J. (1998). Effect of trimetazidine on carnitine palmitoyltransferase-1 in the rat heart. Cardiovascular Drugs and Therapy, 12(4), 359-363. Scopus30 WoS25 Europe PMC21 |
| 1998 | Ritchie, R., & Horowitz, J. (1998). Elimination but not accumulation of metoprolol by rat isolated perfused heart is selectively impaired by hypoxia. Clinical and Experimental Pharmacology and Physiology, 25(August), 548-551. Scopus1 WoS1 Europe PMC1 |
| 1998 | Willoughby, S., Chirkov, Y., Kennedy, J., Murphy, G., Chirkova, L., & Horowitz, J. (1998). Inhibition of long-chain fatty acid metabolism does not affect platelet aggregation responses. European Journal of Pharmacology, 356(2-3), 207-213. Scopus13 WoS14 Europe PMC8 |
| 1998 | Ritchie, R., Sallustio, B., Hii, J., & Horowitz, J. (1998). Short-term myocardial uptake of d- and l-Sotalol in humans: relation to hemodynamic and electrophysiologic effects. Journal of Cardiovascular Pharmacology, 31(6), 876-884. |
| 1998 | Ritchie, R., Hii, J., & Horowitz, J. (1998). Relationship between myocardial milrinone content and its acute hemodynamic and electrophysiologic effects. Journal of Cardiovascular Pharmacology, 31(6), 885-893. Scopus4 WoS5 Europe PMC5 |
| 1998 | Beltrame, J., Zietz, C., Unger, S., Brennan, R., Hunt, A., Moran, J., & Horowitz, J. (1998). Nitrate therapy is an alternative to furosemide/morphine therapy in the management of acute cardiogenic pulmonary edema. Journal of Cardiac Failure, 4(4), 271-279. Scopus59 Europe PMC39 |
| 1998 | Beltrame, J., Zeitz, C., Moran, J., & Horowitz, J. (1998). Nitrates for myocardial infarction. Lancet, 351(9117), 1731-1732. |
| 1998 | Stewart, S., Pearson, S., Luke, C., & Horowitz, J. (1998). Effects of home-based intervention on unplanned readmissions and out-of-hospital deaths. Journal of the American Geriatrics Society, 46(2), 174-180. Scopus158 WoS128 Europe PMC105 |
| 1998 | Ritchie, R., Morgan, D., & Horowitz, J. (1998). Myocardial effect compartment modeling of metoprolol and sotalol: importance of myocardial subsite drug concentration. Journal of Pharmaceutical Sciences, 87(2), 177-182. Scopus9 WoS9 Europe PMC9 |
| 1998 | Stewart, S., Pearson, S., Luke, C. G., & Horowitz, J. D. (1998). A home-based intervention reduced the frequency of hospital readmissions and out-of-hospital deaths after discharge. Evidence Based Medicine, 3(4), 122. |
| 1998 | Massie, B. M., Cleland, J. G. F., Armstrong, P. W., Horowitz, J. D., Packer, M., Poole- Wilson, P. A., & Ryden, L. (1998). Erratum: Regional differences in the characteristics and treatment of patients participating in an international heart failure trial (Journal of Cardiac Failure (1998) 4:3)). Journal of Cardiac Failure, 4(2), 153. |
| 1998 | Smith, J. R., Friedell, M. L., Cheatham, M. L., Martin, S. P., Cohen, M. J., & Horowitz, J. D. (1998). Peripherally inserted central catheters revisited. American Journal of Surgery, 176(2), 208-211. Scopus99 WoS77 Europe PMC71 |
| 1998 | Massie, B. M., Cleland, J. G., Armstrong, P. W., Horowitz, J. D., Packer, M., Poole-Wilson, P. A., & Ryden, L. (1998). Regional differences in the characteristics and treatment of patients participating in an international heart failure trial. The Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial Investigators.. Journal of cardiac failure, 4(1), 3-8. Europe PMC26 |
| 1997 | Horowitz, J. D., Beltrame, J. F., Stewart, S., Wuttke, R. D., Leslie, S. L., & Poropat, S. (1997). Resolution of ST elevation in evolving acute myocardial infarction without thrombolysis. CIRCULATION, 96(8), 1443. |
| 1997 | Willoughby, S. R., Chirkova, L. P., Horowitz, J. D., & Chirkov, Y. Y. (1997). Erratum: Multiple agonist induction of aggregation: An approach to examine anti-aggregating effects in vitro (Platelets (1996) 7 (329-333)). Platelets, 8(2-3), 191. |
| 1997 | Ritchie, R. H., Zeitz, C. J., Hii, J. T., Tornvall, P., Wuttke, R., Jarrett, R., & Horowitz, J. D. (1997). Use-dependent negative inotropic effects of cardioactive agents in humans. CIRCULATION, 96(8), 4185. |
| 1997 | Zeitz, C. J., Ritchie, R. H., Hii, J. T., Horowitz, J. D., Wuttke, R. D., & Jarrett, R. (1997). Are the positive inotropic effects of digoxin and milrinone maintained at short cycle lengths?. CIRCULATION, 96(8), 4186. |
| 1997 | MacMahon, S., Sharpe, N., Doughty, R., Krum, H., Tonkin, A., Trotter, A., . . . Reid, I. (1997). Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. LANCET, 349(9049), 375-380. WoS608 Europe PMC99 |
| 1997 | Warner, A., & Horowitz, J. (1997). Anomalous left anterior descending coronary artery presenting with acute myocardial infarction.. Australian and New Zealand Journal of Medicine, 27(5), 594-595. Scopus3 WoS2 Europe PMC2 |
| 1997 | Unger, S., Robinson, M., & Horowitz, J. (1997). Perhexiline improves symptomatic status in elderly patients with severe aortic stenosis.. Australian and New Zealand Journal of Medicine, 27(1), 24-28. Scopus44 WoS39 Europe PMC34 |
| 1997 | Chirkov, Y., Chirkova, L., & Horowitz, J. (1997). Nitroglycerin tolerance at the platelet level in patients with angina pectoris.. American Journal of Cardiology, 80(2), 128-131. Scopus33 WoS32 Europe PMC25 |
| 1997 | Willoughby, S. R., Chirkova, L. P., Horowitz, J. D., & Chirkov, Y. Y. (1997). Multiple agonist induction of aggregation: An approach to examine anti-aggregating effects in vitro (vol 7, pg 329, 1996). PLATELETS, 8(2-3), 191. |
| 1997 | Topol, E., Califf, R., Ohman, E., Skene, A., Wilcox, R., Grinfeld, L., . . . Schutzman, J. (1997). A comparison of reteplase with alteplase for acute myocardial infarction. New England Journal of Medicine, 337(16), 1118-1123. Scopus694 Europe PMC357 |
| 1996 | Topol, E., Califf, R., Granger, C., Van De Werf, F., Aylward, P., Simes, J., . . . Dedonis, J. (1996). A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. New England Journal of Medicine, 335(11), 775-782. Scopus802 Europe PMC380 |
| 1996 | Kennedy, J., Unger, S., & Horowitz, J. (1996). Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone.. Biochemical Pharmacology, 52(2), 273-280. Scopus202 WoS180 Europe PMC155 |
| 1996 | Chan, R., Raman, J., Lee, K., Rosalion, A., Hicks, R., Pornvilawan, S., . . . Buxton, B. (1996). Prediction of outcome after revascularization in patients with poor left ventricular function. Annals of Thoracic Surgery, 61(5), 1428-1434. Scopus39 Europe PMC27 |
| 1996 | Simon, K., Szepvolgyi, A., Arstall, M. A., Stafford, I., & Horowitz, J. D. (1996). N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction: Safety and biochemical effects [8]. Circulation, 94(7), 1791. Scopus2 WoS2 Europe PMC1 |
| 1996 | Chirkov, Y., & Horowitz, J. (1996). N-acetylcysteine potentiates nitroglycerin-induced reversal of platelet aggregation.. Journal of Cardiovascular Pharmacology, 28(3), 375-380. Scopus22 WoS19 Europe PMC14 |
| 1996 | Stewart, S., Voss, D., Northey, D., & Horowitz, J. (1996). Relationship between plasma perhexiline concentration and symptomatic status during short-term perhexiline therapy.. Therapeutic Drug Monitoring, 18(6), 635-639. Scopus30 WoS28 Europe PMC24 |
| 1996 | Willoughby, S., Chirkova, L., Horowitz, J., & Chirkov, Y. (1996). Multiple agonist induction of aggregation: an approach to examine anti-aggregating effects in vitro. Platelets, 7(5-6), 329-333. Scopus6 WoS6 Europe PMC5 |
| 1996 | Chirkov, Y., Chirkova, L., & Horowitz, J. (1996). Suppressed anti-aggregating and cGMP-elevating effects of sodium nitroprusside in platelets from patients with stable angina pectoris. Naunyn-Schmiedeberg's Archives of Pharmacology, 354(4), 520-525. Scopus22 WoS24 Europe PMC17 |
| 1996 | de la Lande, I., Philp, T., Stafford, I., & Horowitz, J. (1996). Lack of inhibition of glyceryl trinitrate by diphenyleneiodonium in bovine coronary artery.. European Journal of Pharmacology, 314(3), 347-350. Scopus4 WoS4 Europe PMC4 |
| 1996 | de la Lande, I., Stafford, I., & Horowitz, J. (1996). Heterogeneity of glyceryl trinitrate response in isolated bovine coronoary arteries. European Journal of Phamacology, 318(1), 65-71. Scopus3 WoS2 Europe PMC2 |
| 1996 | Yang, J., Stafford, I., Arstall, M. A., & Horowitz, J. D. (1996). Effects of N-acetylcysteine on oxidation stress in patients with acute myocardial infarction. Chinese Journal of Cardiology, 24(4), 282-284. Scopus1 |
| 1995 | Zhang, Y., Ritchie, R., & Horowitz, J. (1995). Postextrasystolic potentiation in patients with ischaemic heart disease: influence of inotropic agents.. British Journal of Clinical Pharmacology, 40(1), 25-30. Scopus2 WoS1 Europe PMC1 |
| 1995 | Arstall, M., Yang, J., Stafford, I., Betts, W., & Horowitz, J. (1995). N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction. Circulation, 92(10), 2855-2862. Scopus150 WoS142 Europe PMC108 |
| 1995 | Zhang, C., de la Lande, I., & Horowitz, J. (1995). Effects of glyceryl trinitrate tolerance on vascular responsiveness to constrictor agents in bovine isolated coronary artery. Clinical Pharmacology and Physiology, 22(5), 324-329. Scopus3 WoS2 Europe PMC3 |
| 1995 | KRUM, H., TONKIN, A., TROTTER, A., BURTON, R., GARRETT, J., LANE, G., . . . REID, I. (1995). EFFECTS OF CARVEDILOL, A VASODILATOR-BETA-BLOCKER, IN PATIENTS WITH CONGESTIVE-HEART-FAILURE DUE TO ISCHEMIC-HEART-DISEASE. CIRCULATION, 92(2), 212-218. WoS204 Europe PMC28 |
| 1995 | Ritchie, R., Wuttke, R., Hii, J., Jarrett, R., Carey, A., & Horowitz, J. (1995). The force-interval relationship of the left ventricle: a quantitative description in patients with ischemic heart disease. Journal of Cardiac Failure, 1(4), 273-284. Scopus2 Europe PMC3 |
| 1995 | Horowitz, J. D., Button, I. K., & Wing, L. (1995). Is perhexiline essential for the optimal management of angina pectoris?. Australian and New Zealand Journal of Medicine, 25(2), 111-113. Scopus24 WoS21 Europe PMC16 |
| 1995 | Chirkov, Y. Y., Chirkova, L. P., Edward Sage, R., & Horowitz, J. D. (1995). Impaired responsiveness of platelets from patients with stable angina pectoris to antiaggregating and cyclicAMP-elevating effects of prostaglandin E1. Journal of Cardiovascular Pharmacology, 25(6), 961-966. Scopus25 WoS24 Europe PMC15 |
| 1995 | Arstall, M. A., Stewart, S., Haste, M. A., & Horowitz, J. D. (1995). Streptokinase-induced transient aggravation of myocardial injury. International Journal of Cardiology, 50(2), 107-116. Scopus1 WoS2 Europe PMC1 |
| 1995 | Tonkin, A., Aylward, P., Colquhoun, D., Glasziou, P., Harris, P., Hunt, D., . . . Quinn, K. (1995). Design features and baseline characteristics of the LIPID (long-term intervention with pravastatin in ischemic disease) study: A randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris. American Journal of Cardiology, 76(7), 474-479. Scopus115 Europe PMC47 |
| 1994 | Zhang, C. L., De la Lande, I. S., Stafford, I., & Horowitz, J. D. (1994). S-nitrosothiol modulation of tolerance to glyceryl trinitrate in bovine isolated coronary artery. European Journal of Pharmacology, 252(3), 299-304. Scopus5 WoS5 Europe PMC4 |
| 1994 | Ritchie, R. H., Wuttke, R. D., Stafford, I., & Horowitz, J. D. (1994). Relation between acute myocardial uptake and hemodynamic and electrocardiograpic effects of metoprolol in humans. Journal of Cardiovascular Pharmacology, 23(1), 57. Scopus7 WoS6 Europe PMC5 |
| 1994 | Zhang, C. L., Wilson, K. M., Stafford, I., Bochner, F., & Horowitz, J. D. (1994). Absorption Kinetics of Low Dose Aspirin in Patients with Evolving Acute Myocardial Infarction. Drug Investigation, 7(4), 169-174. Scopus8 WoS6 |
| 1994 | Arstall, M. A., Wuttke, R. D., Arthur, J., Whitford, J. A., & Horowitz, J. D. (1994). The prevalence of ST-segment depression on ambulatory electrocardiographic monitoring during daily life in high-risk asymptomatic police officers. European Journal of Cardiovascular Prevention Rehabilitation, 1(2), 143-148. Scopus2 Europe PMC1 |
| 1994 | Arstall, M. A., Barrowman, F. A., & Horowitz, J. D. (1994). Silent ischemia after uncomplicated myocardial infarction: lack of incremental clinical significance. International Journal of Cardiology, 45(1), 45-52. Scopus1 WoS1 |
| 1993 | ARSTALL, M. A., BARROWMAN, F. A., & HOROWITZ, J. D. (1993). Silent myocardial ischaemia is uncommon after uncomplicated acute myocardial infarction. Australian and New Zealand Journal of Medicine, 23(1), 53-54. |
| 1993 | Chirkov, Y. Y., Naujalis, J. I., Edward Sage, R., & Horowitz, J. D. (1993). Antiplatelet effects of nitroglycerin in healthy subjects and in patients with stable angina pectoris. Journal of Cardiovascular Pharmacology, 21(3), 384-389. Scopus50 WoS45 Europe PMC28 |
| 1993 | Meredith, I. T., Alison, J. F., Zhang, F. M., Horowitz, J. D., & Harper, R. W. (1993). Captopril potentiates the effects of nitroglycerin in the coronary vascular bed. Journal of the American College of Cardiology, 22(2), 581-587. Scopus22 WoS20 Europe PMC16 |
| 1993 | Chirkov, Y., Gee, D., Naujalis, J., Sage, R., & Horowitz, J. (1993). Reversal of ADP-induced platelet aggregation by S-nitrosothiols, nitroglycerine and nitroglycerine/N-acetylcysteine. Pharmacology Communications, 3(2), 97-105. Scopus6 |
| 1992 | Horowitz, J. D. (1992). Role of nitrates in unstable angina pectoris. American Journal of Cardiology, 70(8), B64-B71. Scopus23 WoS18 Europe PMC9 |
| 1992 | Chirkov, Y. Y., Naujalis, J. I., Barber, S., Sage, R. E., Gove, D. W., Brealey, J. K., & Horowitz, J. D. (1992). Reversal of human platelet aggregation by low concentrations of nitroglycerin in vitro in normal subjects. American Journal of Cardiology, 70(7), 802-806. Scopus31 WoS27 Europe PMC21 |
| 1992 | Arstall, M. A., Hii, J. T. Y., Lehman, R. G., & Horowitz, J. D. (1992). Sotalol-induced torsade de pointes: Management with magnesium infusion. Postgraduate Medical Journal, 68(798), 289-290. Scopus19 WoS13 Europe PMC10 |
| 1992 | Sallustio, B. C., Morris, R. G., & Horowitz, J. D. (1992). High-performance liquid chromatographic determination of sotalol in plasma. I. Application to the disposition of sotalol enantiomers in humans.. Journal of chromatography, 576(2), 321-327. Europe PMC13 |
| 1992 | Arstall, M. A., Beltrame, J. F., Mohan, P., Wuttke, R. D., Esterman, A. J., & Horowitz, J. D. (1992). Incidence of adverse events during treatment with verapamil for suspected acute myocardial infarction. American Journal of Cardiology, 70(20), 1611-1612. Scopus7 WoS7 Europe PMC6 |
| 1992 | Sallustio, B. C., Morris, R. G., & Horowitz, J. D. (1992). High-performance liquid chromatographic determination of sotalol in plasma. I. Application to the disposition of sotalol enantiomers in humans. Journal of Chromatography B Biomedical Sciences and Applications, 576(2), 321-327. Scopus25 WoS19 |
| 1991 | Mohan, P., Hii, J. T. Y., Wuttke, R. D., Esterman, A. J., Hollington, P., & Horowitz, J. D. (1991). Acute heart failure: determinants of outcome. International Journal of Cardiology, 32(3), 365-375. Scopus15 WoS16 Europe PMC12 |
| 1991 | Horowitz, J. D. (1991). Thiol-containing agents in the management of unstable angina pectoris and acute myocardial infarction. American Journal of Medicine, 91(3 SUPPL. 3), S113-S117. Scopus9 WoS6 Europe PMC4 |
| 1991 | Chirkov, Y. Y., Belushkina, N. N., Tyshchuk, I. A., Severina, I. S., & Horowitz, J. D. (1991). INCREASE IN REACTIVITY OF HUMAN PLATELET GUANYLATE CYCLASE DURING AGGREGATION POTENTIATES THE DISAGGREGATING CAPACITY OF SODIUM NITROPRUSSIDE. Clinical and Experimental Pharmacology and Physiology, 18(7), 517-524. Scopus19 WoS23 Europe PMC11 |
| 1990 | Henry, P. J., Horowitz, J. D., & Louis, W. J. (1990). Nitrate tolerance induced by nicorandil or nitroglycerin is associated with minimal loss of nicorandil vasodilator activity. Journal of Cardiovascular Pharmacology, 15(3), 365-370. Scopus20 Europe PMC14 |
| 1990 | Powell, A. C., Horowitz, J. D., Hasin, Y., & Louis, W. J. (1990). RELATIONSHIP BETWEEN SYSTEMIC AND CORONARY VASCULAR RESPONSES TO DIGOXIN AND CONCURRENT DRUG THERAPY WITH VERAPAMIL/β‐ADRENOCEPTOR ANTAGONISTS IN HUMANS. Clinical and Experimental Pharmacology and Physiology, 17(6), 453-462. Scopus1 |
| 1990 | Powell, A. C., Horowitz, J. D., Kertes, P. J., Hasin, Y., Syrjanen, M. L., Henry, C. A., . . . Louis, W. J. (1990). Determinants of acute hemodynamic and electrophysiologic effects of verapamil in humans: Role of myocardial drug uptake. Journal of Cardiovascular Pharmacology, 16(4), 572-583. Scopus11 Europe PMC10 |
| 1990 | Powell, A. C., Horowitz, J. D., Hasin, Y., Syrjanen, M. L., Horomidis, S., & Louis, W. J. (1990). Acute myocardial uptake of digoxin in humans: Correlation with hemodynamic and electrocardiographic effects. Journal of the American College of Cardiology, 15(6), 1238-1247. Scopus20 Europe PMC15 |
| 1989 | Henry, P. J., Horowitz, J. D., & Louis, W. J. (1989). Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade. Journal of Pharmacology and Experimental Therapeutics, 248(2), 762-768. Scopus64 Europe PMC42 |
| 1989 | Morgan, D. J., Horowitz, J. D., & Louis, W. J. (1989). Prediction of acute myocardial disposition of antiarrhythmic drugs. Journal of Pharmaceutical Sciences, 78(5), 384-388. Scopus5 Europe PMC4 |
| 1989 | Henry, P. J., Drummer, O. H., & Horowitz, J. D. (1989). S-nitrosothiols as vasodilators: Implications regarding tolerance to nitric oxide-containing vasodilators. British Journal of Pharmacology, 98(3), 757-766. Scopus62 Europe PMC54 |
| 1989 | Sewell, R. B., Horowitz, J. D., Grinpukel, S. A., & Martin, G. (1989). PERHEXILENE: EFFECTS ON HEPATIC LYSOSOMAL FUNCTION IN RATS. Clinical and Experimental Pharmacology and Physiology, 16(1), 25-32. Scopus4 Europe PMC2 |
| 1989 | Henry, P. J., Horowitz, J. D., & Louis, W. J. (1989). Determinants of in vitro nitroglycerin tolerance induction and reversal: Influence of dose regimen, nitrate-free period, and sulfhydryl supplementation. Journal of Cardiovascular Pharmacology, 14(1), 31-37. Scopus33 Europe PMC23 |
| 1989 | Phillips, P., Sasadeus, J., Hodsman, G., Horowitz, J., Saltups, A., & Johnston, C. (1989). Plasma atrial natriuretic peptide in patients with acute myocardial infarction: effects of streptokinase. British Heart journal, 61(2), 139-143. Scopus28 Europe PMC20 |
| 1989 | Horowitz, J. D., & Powell, A. C. (1989). Calcium antagonist drugs in the management of cardiovascular disease: Current status. Medical Journal of Australia, 150(10), 591-595. Scopus10 Europe PMC4 |
| 1988 | Horowitz, J. D., Henry, C. A., Syrjanen, M. L., Louis, W. J., Fish, D., Smith, T. W., & Antman, E. M. (1988). Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris. Circulation, 77(4), 787-794. Scopus100 Europe PMC70 |
| 1988 | Powell, A. C., Elliott, S. L., & Horowitz, J. D. (1988). Verapamil in unstable angina pectoris: Failure to demonstrate a relationship between efficacy and plasma levels. Therapeutic Drug Monitoring, 10(1), 34-38. Scopus6 Europe PMC3 |
| 1988 | Horowitz, J. D., Henry, C. A., Syrjanen, M. L., Louis, W. J., Fish, R. D., Antman, E. M., & Smith, T. W. (1988). Nitroglycerin/N-acetylcysteine in the management of unstable angina pectoris. European Heart Journal, 9(SUPPL. A), 95-100. Scopus14 Europe PMC6 |
| 1988 | Lee, K. J., Horowitz, J. D., McKay, W. J., & Goble, A. J. (1988). Myocardial salvage with streptokinase combined with nitroglycerine and verapamil in acute myocardial infarction. International Journal of Cardiology, 21(3), 279-291. Scopus7 Europe PMC5 |
| 1987 | Sia, S., Horowitz, J., & Goble, A. (1987). Non-Q-wave infarction: Prognostic value of exercise test results. Cardiology Board Review, 4(1), 59-64. |
| 1987 | Smith, G. L., Horowitz, J. D., & Henry, P. J. (1987). Nitrate therapy of ischaemic heart disease. Medical Journal of Australia, 146(11), 607-609. |
| 1987 | Horowitz, J. D., & Henry, P. J. (1987). Recent developments in nitrate therapy of ischaemic heart disease. Medical Journal of Australia, 146(2), 93-96. Scopus8 Europe PMC9 |
| 1987 | Thatcher, R. L., Butty, J. S., Whitworth, J. A., Hunt, V. D. U., Shaw, P. F., Skinner, S. L., & Horowitz, J. D. (1987). Potential functions of plasma prorenin; regional activation and tissue extraction. Clinical and Experimental Hypertension, A9(8-9), 1415-1434. Scopus8 Europe PMC3 |
| 1986 | Horowitz, J. D., Sia, S. T. B., Macdonald, P. S., Goble, A. J., & Louis, W. J. (1986). Perhexiline maleate treatment for severe angina pectoris - correlations with pharmacokinetics. International Journal of Cardiology, 13(2), 219-229. Scopus107 Europe PMC90 |
| 1986 | Skinner, S. L., Thatcher, R. L., Whitworth, J. A., & Horowitz, J. D. (1986). EXTRACTION OF PLASMA PRORENIN BY HUMAN HEART. Lancet, 327(8488), 995-997. Scopus24 Europe PMC16 |
| 1986 | Drummer, O. H., Christophidis, N., Horowitz, J. D., & Louis, W. J. (1986). Measurement of penicillamine and N-acetylcysteine in human blood by high-performance liquid chromatography and electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications, 374(C), 251-257. Scopus22 Europe PMC13 |
| 1986 | Horowitz, J. D., & Powell, A. C. (1986). Myocardial Uptake of Drugs and Clinical Effects. Clinical Pharmacokinetics, 11(5), 354-371. Scopus26 Europe PMC21 |
| 1986 | Horowitz, J. D., Dynon, M. K., Woodward, E., Sia, S. T., Macdonald, P. S., Morgan, D. J., . . . Louis, W. J. (1986). Short-term myocardial uptake of lidocaine and mexiletine in patients with ischemic heart disease. Circulation, 73(5), 987-996. Scopus28 |
| 1986 | Sia, S. T. B., MacDonald, P. S., Horowitz, J. D., Goble, A. J., & Doyle, A. E. (1986). Usefulness of early exercise testing after non-Q-wave myocardial infarction in predicting prognosis. American Journal of Cardiology, 57(10), 738-744. Scopus26 Europe PMC20 |
| 1986 | Hare, D. L., & Horowitz, J. D. (1986). Verapamil hepatotoxicity: A hypersensitivity reaction. American Heart Journal, 111(3), 610-611. Scopus13 Europe PMC7 |
| 1985 | Sia, S. T. B., MacDonald, P. S., Triester, B., Oliver, L. E., Horowitz, J. D., & Goble, A. J. (1985). Aggravation of myocardial ischaemia by nifedipine. Medical Journal of Australia, 142(1), 48-50. Scopus18 Europe PMC14 |
| 1985 | Kern, M. J., Horowitz, J. D., Ganz, P., Gaspar, J., Colucci, W. S., Lorell, B. H., . . . Mudge, G. H. (1985). Attenuation of coronary vascular resistance by selective alpha1,-adrenergic blockade in patients with coronary artery disease. Journal of the American College of Cardiology, 5(4), 840-846. Scopus36 Europe PMC29 |
| 1985 | Torresi, J., Horowitz, J. D., & Dusting, G. J. (1985). Prevention and reversal of tolerance to nitroglycerine with N-acetylcysteine. Journal of Cardiovascular Pharmacology, 7(4), 777-783. Scopus100 Europe PMC76 |
| 1985 | Barry, W. H., Horowitz, J. D., & Smith, T. W. (1985). Comparison of negative inotropic potency, reversibility, and effects on calcium influx of six calcium channel antagonists in cultured myocardial cells. British Journal of Pharmacology, 85(1), 51-59. Scopus43 Europe PMC32 |
| 1985 | Kern, M. J., Horowitz, J. D., Ganz, P., Gaspar, J., Colucci, W. S., Lorell, B. H., . . . Mudge, G. H. (1985). Attenuation of coronary vascular resistance by selective alpha<inf>1</inf>-adrenergic blockade in patients with coronary artery disease. Journal of the American College of Cardiology, 5(4), 840-846. Scopus7 |
| 1984 | Horowitz, J. D., Dynon, M. K., Jarrott, B., Brennan, J. B., Oliver, L. E., Goble, A. J., & Louis, W. J. (1984). HAEMODYNAMIC EFFECTS OF A SINGLE LOW DOSE OF PRAZOSIN IN PATIENTS WITH CHRONIC CONGESTIVE CARDIAC FAILURE CORRELATIONS WITH PHARMACOKINETICS. Clinical and Experimental Pharmacology and Physiology, 11(1), 7-15. Scopus1 Europe PMC2 |
| 1984 | GOBLE, A. J., & HOROWITZ, J. D. (1984). PERHEXILENE NEUROPATHY: A REPORT OF TWO CASES. Australian and New Zealand Journal of Medicine, 14(3), 279. Scopus4 Europe PMC3 |
| 1983 | Horowitz, J. D. (1983). Drugs that induce heart problems. Which agents? What effects?. Journal of Cardiovascular Medicine, 8(3), 308-315. |
| 1983 | Nayler, W. G., & Horowitz, J. D. (1983). Calcium antagonists: A new class of drugs. Pharmacology and Therapeutics, 20(2), 203-262. Scopus95 Europe PMC83 |
| 1983 | Horowitz, J. D., Antman, E. M., Lorell, B. H., Barry, W. H., & Smith, T. W. (1983). Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. Circulation, 68(6), 1247-1253. Scopus175 |
| 1983 | Kern, M. J., Ganz, P., Horowitz, J. D., Gaspar, J., Barry, W. H., Lorell, B. H., . . . Mudge, G. H. (1983). Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease. Circulation, 67(6 I), 1178-1184. Scopus153 Europe PMC119 |
| 1982 | Horowitz, J. D., White, H. D., & Goble, A. J. (1982). Liver disease induced by perhexiline maleate.. Medical Journal of Australia, 2(1), 9-10. Scopus3 Europe PMC2 |
| 1982 | Horowitz, J. D., Barry, W. H., & Smith, T. W. (1982). Lack of interaction between digoxin and quinidine in cultured heart cells. Journal of Pharmacology and Experimental Therapeutics, 220(3), 488-493. Scopus9 Europe PMC8 |
| 1982 | Horowitz, J. D., Barry, W. H., & Smith, T. W. (1982). Calcium channel blockade by perhexiline maleate and its M1 metabolite. Journal of Molecular and Cellular Cardiology, 14(Suppl. 2), 8. Scopus5 |
| 1981 | Horowitz, J. D., Morris, P. M., Drummer, O., Goble, A. J., & Louis, W. J. (1981). Saturable metabolism of perhexiline maleate: Correlations with long-term toxicity. American Journal of Cardiology, 47(2 II), 399. Scopus8 |
| 1981 | Horowitz, J. D., Brennan, J. B., Oliver, L. E., Harding, D., Goble, A. J., & Louis, W. J. (1981). Effects of captopril (SQ 14,225) in a patient with primary pulmonary hypertension. Postgraduate Medical Journal, 57(664), 115-116. Scopus12 Europe PMC10 |
| 1981 | Horowitz, J. D., Anavekar, S. N., Morris, P. M., Goble, A. J., Doyle, A. E., & Louis, W. J. (1981). Comparative trial of mexiletine and lignocaine in the treatment of early ventricular tachyarrhythmias after acute myocardial infarction. Journal of Cardiovascular Pharmacology, 3(3), 409-419. Scopus24 Europe PMC17 |
| 1981 | Horowitz, J. D., Goble, A. J., Morris, P. M., Drummer, O. H., & Louis, W. J. (1981). High‐performance liquid chromatographic assay of perhexiline maleate in plasma. Journal of Pharmaceutical Sciences, 70(3), 320-322. Scopus39 Europe PMC29 |
| 1980 | Oliver, L. E., Horowitz, J. D., Dynon, M. K., Jarrott, B., Brennan, J. B., Goble, A. J., & Louis, W. J. (1980). Use of dopamine and prazosin combined in the treatment of cardiogenic shock. Medical Journal of Australia, 2(1 SPEC SUPPL), 42-45. Scopus4 Europe PMC3 |
| 1980 | Horowitz, J. D., & Mashford, M. L. (1980). Purification of a Peptide with Venoconstrictor and Vasodepressor Activity, from Cohn Fraction III‐O of Human Plasma Protein. Vox Sanguinis, 38(5), 259-265. |
| 1980 | Horowitz, J. D., Howes, L. G., Christophidis, N., Lang, W. J., Fennessy, M. R., Rand, M. T., & Louis, W. J. (1980). HYPERTENSIVE RESPONSES INDUCED BY PHENYLPROPANOLAMINE IN ANORECTIC AND DECONGESTANT PREPARATIONS. Lancet, 315(8159), 60-61. Scopus81 Europe PMC58 |
| 1980 | Horowitz, J. D., & Mashford, M. L. (1980). Venoconstrictor Activity of Some Precursor Fractions of Stable Plasma Protein Solution. Vox Sanguinis, 38(5), 266-271. Scopus1 Europe PMC1 |
| 1980 | Horowitz, J. D., Morris, P., Goble, A. J., & Louis, W. J. (1980). Plasma levels of perhexiline maleate during treatment of patients with angina pectoris. Australian and New Zealand Journal of Medicine, 10(3), 376. |
| 1980 | Goble, A. J., Horowitz, J. D., & Morris, P. (1980). A comparative trial of mexiletine and lignocaine in the treatment of ventricular tachyarrhythmias after acute myocardial infarction. Australian and New Zealand Journal of Medicine, 10(3), 392-393. Scopus1 |
| 1980 | Brennan, J., Dynon, M., & Horowitz, J. (1980). Comparison of the acute haemodynamic effects and pharmacokinetic properties of prazosin in patients with stable congestive cardiac failure. Australian and New Zealand Journal of Medicine, 10(3), 375. Scopus1 |
| 1980 | Horowitz, J. D., Morris, P. M., Goble, A. J., & Louis, W. J. (1980). Pharmacokinetics of perhexiline maleate in patients with angina pectoris. Clinical and Experimental Pharmacology and Physiology, 7(6), 679-680. Scopus1 |
| 1979 | Horowitz, J., Anavekar, S., & Morris, P. (1979). Plasma levels of mexiletine in patients treated for acute and chronic ventricular tachyarrhythmias. Clinical and Experimental Pharmacology and Physiology, 6(6), 651-652. Scopus1 |
| 1979 | Horowitz, J. D., McNeil, J. J., Sweet, B., Mendelsohn, F. A., & Louis, W. J. (1979). Hypertension and postural hypotension induced by phenylpropanolamine (Trimolets). Medical Journal of Australia, 1(5), 175-176. Scopus25 Europe PMC14 |
| 1979 | Horowitz, J. D., & Goble, A. J. (1979). Drugs and Impaired Male Sexual Function. Drugs, 18(3), 206-217. Scopus58 Europe PMC37 |
| 1979 | Horowitz, J. D., & Mashford, M. L. (1979). Long-term safety of perhexiline maleate. Medical Journal of Australia, 1(6), 232. Scopus2 Europe PMC1 |
| 1979 | Horowitz, J. D., & Mashford, M. L. (1979). Perhexiline maleate in the treatment of severe angina pectoris. Medical Journal of Australia, 1(11), 485-488. Scopus22 Europe PMC14 |
| 1979 | Horowitz, J. D., & Mashford, M. L. (1979). Venoconstrictor activity of some precursor fractions of stable plasma protein solution (SPPS). Clinical and Experimental Pharmacology and Physiology, 6(6), 661-662. |
| 1977 | Horowitz, J., & Mashford, M. (1977). Purification of a vasodilator peptide in Cohn fraction III O of human plasma proteins. Clinical and Experimental Pharmacology and Physiology, 4(2), 199-200. |
| 1977 | Mashford, M., & Horowitz, J. (1977). Perhexiline maleate, a new anti anginal drug. Clinical and Experimental Pharmacology and Physiology, 4(2), 206. |
| 1977 | Horowitz, J., & Mashford, M. (1977). Effects of prostaglandins on an isolated blood vessel. Clinical and Experimental Pharmacology and Physiology, 4(2), 197-198. |
| 1976 | Brown, M. J., Horowitz, J. D., & Mashford, M. L. (1976). A double blind trial of perhexiline maleate in the prophylaxis of angina pectoris. Medical Journal of Australia, 1(9), 260-263. Scopus14 Europe PMC10 |
| 1976 | Horowitz, J. D., & Mashford, M. L. (1976). A vasodepressor peptide in Cohn fraction III-O of human plasma proteins.. Advances in Experimental Medicine and Biology, 70(0), 15-21. Scopus3 Europe PMC1 |
| 1970 | Horowitz, J. D., Mashford, M. L., & Nunn, M. (1970). Sex differences in level of a vasoactive plasma protein and changes during pregnancy. Experientia, 26(7), 790-791. |
| 1969 | HOROWITZ, J. D., & MASHFORD, M. L. (1969). Bradykinin antagonism by dimethothiazine. Journal of Pharmacy and Pharmacology, 21(1), 51-53. Scopus4 Europe PMC2 |
| 1969 | Horowitz, J. D., & Mashford, M. L. (1969). A perfused vein preparation sensitive to plasma kinins. Naunyn Schmiedebergs Archiv Fur Pharmakologie Und Experimentelle Pathologie, 263(2), 332-339. Scopus10 Europe PMC4 |
| 1969 | Horowitz, J. D., & Mashford, M. L. (1969). The action of adrenal steroids on the pharmacological reactivity of the isolated vein of the rabbit ear. Naunyn Schmiedebergs Archiv Fur Pharmakologie Und Experimentelle Pathologie, 263(2), 324-331. Scopus4 Europe PMC2 |
| 1968 | Horowitz, J. D., & Mashford, M. L. (1968). Vasoactivity of human plasma and plasma protein fractions. Experientia, 24(11), 1126-1127. Scopus5 Europe PMC7 |
| Year | Citation |
|---|---|
| 2022 | Kucia, A. M., & Horowitz, J. D. (2022). Pathogenesis of acute coronary syndromes. In Cardiac Care A Practical Guide for Nurses (pp. 207-215). Wiley. DOI |
| 2013 | Opie, L. H., & Horowitz, J. D. (2013). Nitrates and newer antianginals. In Drugs for the Heart Expert Consult Online and Print (pp. 38-63). Elsevier. DOI Scopus4 |
| 2010 | Chirkov, Y., Sverdlov, A., & Horowitz, J. (2010). Beneficial clinical effects of perhexiline in cardiac patients: Multiple biochemical mechanisms. In Horizons in World Cardiovascular Research Vol. 2, 2010 (pp. 1-27). NOVA Science Publishers. |
| 2010 | Rajendran, S., Chan, W. P. A., & Horowitz, J. D. (2010). Insulin resistance: Relationship with polycystic ovary syndrome. In Insulin Resistance Symptoms Causes and Treatment (pp. 45-78). |
| 2008 | Opie, L. H., & Horowitz, J. D. (2008). Nitrates and Newer Antianginals. In Drugs for the Heart Expert Consult Online and Print (pp. 38-58). DOI |
| 2008 | Opie, L. H., & Horowitz, J. D. (2008). β-Blocking Agents. In Drugs for the Heart Expert Consult Online and Print (pp. 1-37). DOI |
| 2008 | Opie, L. H., & Horowitz, J. D. (2008). β-Blocking Agents. In Drugs for the Heart (pp. 1-37). Elsevier. DOI Scopus2 |
| 2008 | Opie, L. H., & Horowitz, J. D. (2008). Nitrates and Newer Antianginals. In Drugs for the Heart (pp. 38-58). Elsevier. DOI |
| 2004 | Beltrame, J. F., & Horowitz, J. D. (2004). The Management of Acute Cardiogenic Pulmonary Oedema. In S. Stewart, D. K. Moser, & D. R. Thompson (Eds.), Caring for the Heart Failure Patient: A Textbook for the Health Care Professional. (pp. 93-101). London: Martin Dunitz. |
| 2000 | Horowitz, J. (2000). Nitrovasodilators. In J. Loscalzo, & J. Vita (Eds.), Nitric Oxide and the Cardiovascular System (pp. 383-409). New Jersey, USA: Humana Press. |
| Year | Citation |
|---|---|
| 2023 | Velagic, A., Li, J. C., Qin, C. X., Li, M., Deo, M., Marshall, S., . . . Ritchie, R. H. (2023). Therapeutic implications of nitroxyl (HNO) donors as a means of enhancing cGMP-mediated cardioprotection in the insulin-resistant diabetic myocardium. In JOURNAL OF TRANSLATIONAL MEDICINE Vol. 21 (pp. 1 page). Augsburg, Germany: BMC. DOI |
| 2022 | Kelly, C., Chu, M., Untaru, R., Assadi-Khansari, B., Chen, D., Croft, A., . . . Ngo, D. T. M. (2022). Heart failure is associated with low circulating levels of secreted frizzled receptor protein 5 (Sfrp5). In EUROPEAN HEART JOURNAL Vol. 43 (pp. 918). OXFORD UNIV PRESS. DOI |
| 2021 | Chen, D., Untaru, R., Liu, S., Assadi-Khansari, B., Croft, A., Kelly, C., . . . Sverdlov, A. (2021). Follistatin-like 3 (FSTL3) levels are increased in acute heart failure patients. In EUROPEAN HEART JOURNAL Vol. 42 (pp. 1039). OXFORD UNIV PRESS. |
| 2019 | Visvanathan, V., Kucia, A., Reddi, B., & Horowitz, J. (2019). Takotsubo Syndrome Identified in the Intensive Care Unit: A Prospective Observational Study. In AUSTRALIAN CRITICAL CARE Vol. 32 (pp. S17). ELSEVIER SCIENCE INC. DOI |
| 2018 | Goh, V. J. K., Woolley, C., Awford, A., Procter, N., Chong, C. -R., Liu, S., . . . Horowitz, J. (2018). Atrial Fibrillation Ablation May Suppress Systemic Inflammatory Activation by Inhibiting Thioredoxin Interacting Protein Expression. In Circulation. 2016 Vol. 134 (pp. 8 pages). New Orleans, LA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2018 | Nguyen, T. H., Stansborough, J., Ong, G. J., Surikow, S. H., & Horowitz, J. D. (2018). Does Concomitant Malignancy Exacerbate the Course of Takotsubo Syndrome?. In CIRCULATION Vol. 138 (pp. 2 pages). LIPPINCOTT WILLIAMS & WILKINS. |
| 2018 | Aulin, J., Hijazi, Z., Lindback, J., Alexander, J. H., Gersh, B., Granger, C. B., . . . Wallentin, L. (2018). Elevated biomarkers are associated with increased risk of death and heart failure hospitalization in patients with atrial fibrillation: insights from the ARISTOTLE trial. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 196). Munich, GERMANY: OXFORD UNIV PRESS. |
| 2018 | Imam, H., Nguyen, T. H., Tu, S., Tonnu, O., Chirkov, Y., & Horowitz, J. (2018). Pathogenesis of coronary artery spasm: a critical role for impaired platelet nitric oxide signaling. In EUROPEAN HEART JOURNAL Vol. 39 (pp. 336). Munich, GERMANY: OXFORD UNIV PRESS. |
| 2017 | Nguyen, T. H., Stansborough, J., Ong, G. J., Surikow, S., Frenneaux, M. P., & Horowitz, J. D. (2017). Implications of "Secondary" Takotsubo Syndrome on Short and Longterm Event Rates. In CIRCULATION Vol. 136 (pp. 2 pages). Anaheim, CA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2017 | Chong, C. -R., Imam, H., Sallustio, B., Chirkov, Y. Y., & Horowitz, J. D. (2017). Perhexiline enhances cGMP- and cAMP-signaling in diabetics independent of insulin sensitization and ACE inhibition. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 1143). OXFORD UNIV PRESS. |
| 2017 | Aulin, J., Hijazi, Z., Andersson, U., Alexander, J. H., Gersh, B., Granger, C. B., . . . Wallentin, L. (2017). Serial IL-6 levels and risk of death in anticoagulated patients with atrial fibrillation: Insights from the ARISTOTLE trial. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 780). OXFORD UNIV PRESS. |
| 2017 | Imam, H., Nguyen, T. H., Tee, S. -L., Tonnu, O., Chirkov, Y. Y., & Horowitz, J. D. (2017). Impaired cGMP and cAMP signaling in patients with coronary vasospasm: changes during acute crises. In EUROPEAN HEART JOURNAL Vol. 38 (pp. 794). OXFORD UNIV PRESS. |
| 2016 | Qin, C. X., Anthonisz, J., Kahlberg, N., Leo, C. H., Jap, E., Parry, L. J., . . . Ritchie, R. (2016). Approaches for Overcoming Diabetes-Induced Cardiovascular Nitric Oxide Resistance. In FREE RADICAL BIOLOGY AND MEDICINE Vol. 100 (pp. S150-S151). ELSEVIER SCIENCE INC. DOI |
| 2016 | Neil, C. J. A., Ahearn, T., Scully, C., Jagpal, B., Rudd, A., Horowitz, J. D., . . . Dawson, D. (2016). Evidence of diffuse myocardial fibrosis late after tako-tsubo cardiomyopathy: a case-control study using T1-mapping. In EUROPEAN HEART JOURNAL Vol. 37 (pp. 1234). Rome, ITALY: OXFORD UNIV PRESS. |
| 2016 | Liu, S., Assadi-Khansari, B., Ajaero, C., Chua, S. J., Horowitz, J. D., Ngo, D. T., & Sverdlov, A. L. (2016). Follistatin-Like 3 is Elevated In Acute Heart Failure Patients. In CIRCULATION Vol. 134 (pp. 7 pages). Pentagon City, VA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2015 | Schwarz, K., Srinivasan, J., Bruce, M., Neil, C. J., Scally, C., Horowitz, J. D., . . . Dawson, D. K. (2015). Apical variant Tako-tsubo is associated with persistent myocardial strain dysfunction. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 943-944). London, ENGLAND: OXFORD UNIV PRESS. |
| 2015 | Chong, C. -R., Stansbourough, J., Raman, B., Nguyen, T. H., Neil, C. J., & Horowitz, J. D. (2015). Determinants of shock and mortality in Takotsubo cardiomyopathy: a cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1177-1178). London, ENGLAND: OXFORD UNIV PRESS. |
| 2013 | Siddiqi, N., Bruce, M., Neil, C. J., MacLennan, G., Cotton, S., Papadopoulou, S. A., . . . Frenneaux, M. P. (2013). Nitrites in Acute Myocardial Infarction. In CIRCULATION Vol. 128 (pp. 2705). LIPPINCOTT WILLIAMS & WILKINS. WoS1 |
| 2013 | Goto, S., Zhu, J., Lisheng, L., Oh, B. H., Wojdyla, D., Hanna, M., . . . Alexander, J. H. (2013). Efficacy and safety of apixaban compared with warfarin for stroke prevention in atrial fibrillation in East Asia. In EUROPEAN HEART JOURNAL Vol. 34 (pp. 1039). Amsterdam, NETHERLANDS: OXFORD UNIV PRESS. WoS5 |
| 2012 | Siegbahn, A., Christersson, C., Schollin, M., Alexander, J. H., Horowitz, J., Hylek, E. M., . . . Wallentin, L. (2012). Increased levels of D-dimer identify patients with atrial fibrillation at high risk for bleeding an ARISTOTLE substudy. In EUROPEAN HEART JOURNAL Vol. 33 (pp. 51). Munchen, GERMANY: OXFORD UNIV PRESS. WoS5 |
| 2012 | Christersson, C., Schollin, M., Alexander, J. H., Bersh, B. J., Horowitz, J., Hylek, E. M., . . . Siegbahn, A. (2012). Increased levels of D-dimer in atrial fibrillation identify patients with higher risk of thromboembolic events and death. In EUROPEAN HEART JOURNAL Vol. 33 (pp. 969). Munchen, GERMANY: OXFORD UNIV PRESS. |
| 2012 | Wallentin, L. C., Christersson, C., Siegbahn, A., Schollin, M., Alexander, J. H., Hanna, M., . . . Granger, C. B. (2012). NT-proBNP for risk stratification in atrial fibrillation during treatment with apixaban or warfarin. In EUROPEAN HEART JOURNAL Vol. 33 (pp. 51). Munchen, GERMANY: OXFORD UNIV PRESS. WoS2 |
| 2012 | Ritchie, R. H., Irvine, J. C., Ganthavee, V., Love, J. E., Alexander, A. E., Horowitz, J. D., . . . Kemp-Harper, B. K. (2012). The Soluble Guanylyl Cyclase (sGC) Activator BAY 58-2667 Selectively Limits Cardiomyocyte Hypertrophy - A Potential Therapeutic Advantage for Managing Left Ventricular Hypertrophy (LVH). In CIRCULATION Vol. 126 (pp. 1 page). LIPPINCOTT WILLIAMS & WILKINS. |
| 2010 | Das, D., Horowitz, J. D., & Kennedy, J. A. (2010). Nitric oxide inhibits tgf-beta1 induced collagen synthesis in porcine and human aortic valve cells. In EUROPEAN HEART JOURNAL Vol. 31 (pp. 963). Stockholm, SWEDEN: OXFORD UNIV PRESS. |
| 2010 | Sverdlov, A. L., Ngo, D. T., Nightingale, A. K., Rajendran, S., Ritchie, R. H., Marwick, T. H., . . . Horowitz, J. D. (2010). Relationship between LV mass and diastolic function is independent of NO generation. In EUROPEAN HEART JOURNAL Vol. 31 (pp. 121). Stockholm, SWEDEN: OXFORD UNIV PRESS. |
| 2010 | Chan, W. P., Ngo, D. T., Rajendran, S., Heresztyn, T., Amarasekera, A., Sverdlov, A. L., . . . Horowitz, J. D. (2010). Implications of insulin sensitivity on inflammatory activation and atherogenic risk in normal and PCOS females. In EUROPEAN HEART JOURNAL Vol. 31 (pp. 544). Stockholm, SWEDEN: OXFORD UNIV PRESS. |
| 2007 | Philpott, A. C., Sage, P. R., Stafford, I., Murphy, G., de la Lande, I., Stuklis, R., . . . Horowitz, J. D. (2007). Dissociation of aldehyde dehydrogenase activity from nitrate effect, bioconversion, and tolerance in humans. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 49 (pp. 420A). New Orleans, LA: ELSEVIER SCIENCE INC. |
| 2007 | Ngo, D. T., Stafford, I., Wuttke, R. D., Weedon, H., Smith, M. D., Kelly, D. J., . . . Horowitz, J. D. (2007). Ramipril retards development of aortic valve stenosis in a rabbit model: Role of thioredoxin interacting protein. In CIRCULATION Vol. 116 (pp. 679-680). Orlando, FL: LIPPINCOTT WILLIAMS & WILKINS. |
| 2006 | Rosenkranz, A. C., Kennedy, J. A., Murphy, G., Hua, X., Mishra, K., & Horowitz, J. D. (2006). Pivotal role of Rho kinase activation rather than oxidative stress in calcification of aortic valve interstitial cells. In EUROPEAN HEART JOURNAL Vol. 27 (pp. 574). Barcelona, SPAIN: OXFORD UNIV PRESS. |
| 2006 | Ngo, D. T., Wuttke, R. D., Weedon, H., Nightingale, A. K., Sverdlov, A. L., Kennedy, J. A., & Horowitz, J. D. (2006). Vitamin D2 supplementation induces aortic stenosis in rabbits. In EUROPEAN HEART JOURNAL Vol. 27 (pp. 574). Barcelona, SPAIN: OXFORD UNIV PRESS. |
| 2006 | Ngo, D. T., Wuttke, R. D., Stafford, I., Rosenkranz, A. R., Sverdlov, A. L., Chirkov, Y. Y., . . . Horowitz, J. D. (2006). Effects of vitamin D2 supplementation on aortic valvular and vascular endothelial functions in a rabbit model of aortic stenosis. In EUROPEAN HEART JOURNAL Vol. 27 (pp. 127). Barcelona, SPAIN: OXFORD UNIV PRESS. |
| 2006 | Nightingale, A. K., Rajendran, S., Sverdlov, A., Mishra, K., Ngo, D., Heresztyn, T., & Horowitz, J. D. (2006). Aortic sclerosis precedes development of systemic endothelial dysfunction. In EUROPEAN HEART JOURNAL Vol. 27 (pp. 743). Barcelona, SPAIN: OXFORD UNIV PRESS. |
| 2006 | Chirkov, Y. Y., Rajendran, S., Sverdlov, A. L., & Horowitz, J. D. (2006). Potentiation of platelet responsiveness to nitric oxide by angiotensin-(1-7) is mediated by its specific receptor and is associated with the suppression of superoxide release. In EUROPEAN HEART JOURNAL Vol. 27 (pp. 128). Barcelona, SPAIN: OXFORD UNIV PRESS. |
| 2006 | Inglis, S. C., Horowitz, J. D., & Stewart, S. (2006). Ten-year follow-up of a nurse-led, multidisciplinary, home-based intervention in typically old and fragile patients: Cost-benefits and outcomes. In CIRCULATION Vol. 114 (pp. 573). Chicago, IL: LIPPINCOTT WILLIAMS & WILKINS. |
| 2005 | Rajendran, S., Willoughby, S. R., Kelly, E. A., Heresztyn, T., Norman, R. J., & Horowitz, J. D. (2005). Polycystic ovarian syndrome is associated with severe platelet and endothelial dysfunction independent of metabolic syndrome. In CIRCULATION Vol. 112 (pp. U42). Dallas, TX: LIPPINCOTT WILLIAMS & WILKINS. |
| 2005 | Rajendran, S., Willoughby, S. R., Kelly, E. A., Heresztyn, T., Norman, R. J., & Horowitz, J. D. (2005). Polycystic ovarian syndrome is associated with severe platelet and endothelial dysfunction independent of metabolic syndrome. In CIRCULATION Vol. 112 (pp. U435). Dallas, TX: LIPPINCOTT WILLIAMS & WILKINS. WoS1 |
| 2005 | Ngo, D. T., Heresztyn, T., Mishra, K., Marwick, T., & Horowitz, J. (2005). Aortic stenosis is associated with elevated plasma levels of asymmetric dimethylarginine (ADMA). In CIRCULATION Vol. 112 (pp. U753). Dallas, TX: LIPPINCOTT WILLIAMS & WILKINS. |
| 2005 | Willoughby, S. R., Stewart, S., Holmes, A. S., Chirkov, Y. Y., & Horowitz, J. D. (2005). Impaired platelet nitric oxide responsiveness is an independent predictor of cardiovascular related readmission, cardiovascular death and all cause mortality in high risk patients,with acute coronary syndromes. In CIRCULATION Vol. 112 (pp. U127). Dallas, TX: LIPPINCOTT WILLIAMS & WILKINS. |
| 2004 | Campbell, D. J., Zeitz, C. J., Esler, M. D., & Horowitz, J. D. (2004). ACE2 does not play a major role in angiotensin peptide metabolism in the human coronary circulation. In JOURNAL OF HYPERTENSION Vol. 22 (pp. S152). Paris, FRANCE: LIPPINCOTT WILLIAMS & WILKINS. DOI |
| 2004 | Lee, L., Taylor, R., Campbell, R., Williams, L., Gunaruwan, P., Horowitz, J., . . . Frenneaux, M. (2004). Metabolic modulation with perhexiline improves myocardial function in ischemic heart failure. In CIRCULATION Vol. 110 (pp. 679). New Orleans, LA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2004 | Lee, L., Scheurmann-Freestone, M., Campbell, R., Field, R., Gunaruwan, P., Horowitz, J., . . . Frenneaux, M. (2004). Augmentation of glucose metabolism with perhexiline in non-ischaemic heart failure. In HEART Vol. 90 (pp. A2). Manchester, ENGLAND: B M J PUBLISHING GROUP. |
| 2004 | Chirkov, Y. Y., Rajendran, S., & Horowitz, J. D. (2004). Angiotensin-(1-7) potentiates the antiaggregatory effects of nitric oxide. In CIRCULATION Vol. 110 (pp. 216). New Orleans, LA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2004 | Chirkov, Y. Y., Rajendran, S., & Horowitz, J. D. (2004). Angiotensin-(1-7) improves platelet responsiveness to anti-aggregatory effects of nitric oxide. In EUROPEAN HEART JOURNAL Vol. 25 (pp. 90). Munich, GERMANY: W B SAUNDERS CO LTD. |
| 2003 | Chirkov, Y. Y., Holmes, A. S., Chandy, S., & Horowitz, J. D. (2003). Aortic stenosis is associated with valvular endothelial dysfunction. In CIRCULATION Vol. 108 (pp. 431). ORLANDO, FLORIDA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2003 | Stewart, S., Inglis, S., & Horowitz, J. D. (2003). Long-term cost impact of a nurse-led, home-based, multidisciplinary intervention for patients with chronic heart failure. In CIRCULATION Vol. 108 (pp. 504). ORLANDO, FLORIDA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2003 | Willoughby, S. R., Stewart, S., Chirkov, Y. Y., Holmes, A. S., & Horowitz, J. D. (2003). A novel prognostic marker in acute coronary syndromes: Platelet nitric oxide responsiveness. In CIRCULATION Vol. 108 (pp. 681). ORLANDO, FLORIDA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2003 | Inglis, S., Dawson, A. P., Wilkinson, D., Horowitz, J. D., & Stewart, S. (2003). A new solution to an old problem? Effects of a nurse-led home-based intervention in chronic atrial fibrillation. In EUROPEAN HEART JOURNAL Vol. 24 (pp. 484). VIENNA, AUSTRIA: W B SAUNDERS CO LTD. DOI |
| 2003 | Worthley, M. I., Holmes, A. S., Willoughby, S. R., Kucia, A. M., Heresztyn, T., Stewart, S., . . . Horowitz, J. D. (2003). The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndrome: Mediation by superoxide production, resolution with intensive insulin administration. In CIRCULATION Vol. 108 (pp. X). ORLANDO, FLORIDA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2003 | Worthley, M. I., Holmes, A. S., Willoughby, S. R., Kucia, A. M., Heresztyn, T., Chirkov, Y. Y., . . . Horowitz, J. D. (2003). The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndrome: Mediation by superoxide production, resolution with intensive insulin administration. In CIRCULATION Vol. 108 (pp. 311). ORLANDO, FLORIDA: LIPPINCOTT WILLIAMS & WILKINS. WoS1 |
| 2003 | Willoughby, S. R., Stewart, S., Chirkov, Y. Y., Kennedy, J. A., Holmes, A. S., & Horowitz, J. D. (2003). Platelet nitric oxide responsiveness: a novel prognostic indicator for acute coronary syndromes. In EUROPEAN HEART JOURNAL Vol. 24 (pp. 293). VIENNA, AUSTRIA: W B SAUNDERS CO LTD. DOI |
| 2003 | Kucia, A., Zeitz, C., & Horowitz, J. (2003). Time course of incidence of ventricular fibrillation peri-acute ST-segment myocardial infarction: Impact of successful reperfusion.. In CIRCULATION Vol. 108 (pp. A1039). ORLANDO, FLORIDA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2003 | Worthley, M. I., Willoughby, S. R., Kucia, A. M., Holmes, A. S., Chirkov, Y. Y., Zeitz, C. J., & Horowitz, J. D. (2003). Determinants of platelet nitric oxide response and superoxide levels in diabetic patients with acute coronary syndrome. In EUROPEAN HEART JOURNAL Vol. 24 (pp. 128). VIENNA, AUSTRIA: W B SAUNDERS CO LTD. DOI |
| 2002 | Worthley, M., Holmes, A. S., Chirkov, Y. Y., Zeitz, C. J., & Horowitz, J. D. (2002). Acute resolution of hyperglycemia normalizes platelet responsiveness to nitric oxide in diabetics with acute coronary syndromes. In EUROPEAN HEART JOURNAL Vol. 23 (pp. 495). BERLIN, GERMANY: W B SAUNDERS CO LTD. |
| 2002 | Sage, P. R., de la Lande, I. S., Stafford, I., Siebert, T., Stubberfield, J., & Horowitz, J. D. (2002). Nitrate tolerance in human vessels: The role of the endothelium and effect of anti-oxidant therapy. In CIRCULATION Vol. 106 (pp. 412). CHICAGO, ILLINOIS: LIPPINCOTT WILLIAMS & WILKINS. |
| 2002 | Stewart, S., Berry, C., Horowitz, J. D., & McMurray, J. J. V. (2002). Prevalence, characteristics and prognostic signficance of anaemia in heart failure. In EUROPEAN HEART JOURNAL Vol. 23 (pp. 272). BERLIN, GERMANY: W B SAUNDERS CO LTD. |
| 2002 | Stewart, S., & Horowitz, J. D. (2002). Prolonged survival and fewer readmissions: the long-term effects of a home-based intervention in chronic heart failure. In EUROPEAN HEART JOURNAL Vol. 23 (pp. 272). BERLIN, GERMANY: W B SAUNDERS CO LTD. |
| 2002 | Stewart, S., & Horowitz, J. D. (2002). Reduced morbidity, prolonged survival and reduced health care costs: The long-term effects of post-discharge, home-based intervention in chronic heart failure. In CIRCULATION Vol. 106 (pp. 370). CHICAGO, ILLINOIS: LIPPINCOTT WILLIAMS & WILKINS. |
| 2001 | Worthley, M. I., Holmes, A. S., Chirkov, Y. Y., Zeitz, C. J., & Horowitz, J. D. (2001). Glycemic control and platelet function in diabetic patients with threatened myocardial infarction.. In CIRCULATION Vol. 104 (pp. 378). LIPPINCOTT WILLIAMS & WILKINS. |
| 2001 | South, K., Kucia, A. M., & Horowitz, J. (2001). Frequency and clinical significance of T-wave fluctuation immediately following percutaneous transluminal coronary angioplasty. In 49th Annual Scientific Meeting of the Cardiac Society of Australia & New Zealand Vol. 22 (pp. 215). W B SAUNDERS CO LTD. |
| 2001 | Kennedy, J. A., Murphy, G. M., Zhang, Y., & Horowitz, J. D. (2001). The antianginal agent, perhexiline, inhibits the activation of NADPH oxidase in human neutrophils. In EUROPEAN HEART JOURNAL Vol. 22 (pp. 292). W B SAUNDERS CO LTD. |
| 2000 | Anderson, R. A., Gapper, P., Khan, N., Ellis, G. R., Chirkov, Y. Y., Horowitz, J. D., . . . Frenneaux, M. P. (2000). Fasting and postprandial platelet nitrate responsiveness in type 2 diabetes.. In CIRCULATION Vol. 102 (pp. 334). LIPPINCOTT WILLIAMS & WILKINS. |
| 2000 | Anderson, R. A., Ellis, G. R., Blackman, D. J., Chirkov, Y. Y., James, P. E., Jackson, S. K., . . . Frenneaux, M. P. (2000). Primary platelet nitric oxide resistance and oxidative stress in patients with chronic heart failure. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 35 (pp. 222A). ELSEVIER SCIENCE INC. |
| 2000 | Kucia, A., Briggs, J. M., & Horowitz, J. D. (2000). Incidence, duration and outcome of recurrent ST-segment elevation in the first 24 hours post commencement of thrombolytic therapy for acute myocardial infarction. In EUROPEAN HEART JOURNAL Vol. 21 (pp. 32). W B SAUNDERS CO LTD. |
| 2000 | Sage, P. R., De La Lande, I. S., Stafford, I., Stubberfield, J., & Horowitz, J. D. (2000). De novo impairment of vascular responsiveness to nitroglycerin in patients with multiple coronary risk factors.. In CIRCULATION Vol. 102 (pp. 758). LIPPINCOTT WILLIAMS & WILKINS. |
| 2000 | Warner, A., Saint, K., Arstall, M., & Horowitz, J. (2000). Hypoxia-induced iNOS expression in rats is age dependent. In EUROPEAN HEART JOURNAL Vol. 21 (pp. 47). W B SAUNDERS CO LTD. |
| 1999 | Sage, P. R., de la Lande, I. S., Irene, S., Bennett, C. L., Stubberfield, J., & Horowitz, J. D. (1999). Nitrate tolerance to low dose intravenous nitroglycerin is associated with reduced bioconversion. In CIRCULATION Vol. 100 (pp. 186). LIPPINCOTT WILLIAMS & WILKINS. |
| 1999 | Unger, S. A., Robinson, M. A., Wuttke, R. D., & Horowitz, J. D. (1999). Perhexiline improves symptomatic status and survival in elderly patients with critical aortic stenosis. In CIRCULATION Vol. 100 (pp. 18). LIPPINCOTT WILLIAMS & WILKINS. |
| 1999 | Horowitz, J. D. (1999). Part II: The ATLAS study: Low-dose versus high-dose lisinopril in heart failure. In International Journal of Clinical Practice Supplement (pp. 15-16). VIENNA, AUSTRIA: MEDICOM INTERNATIONAL. Scopus2 WoS3 |
| 1998 | Stewart, S., Vandenbroek, A. J., Pearson, S., & Horowitz, J. D. (1998). Prolonged benefits of a home-based intervention on unplanned readmissions and mortality among chronic congestive heart failure patients. In CIRCULATION Vol. 98 (pp. 483). LIPPINCOTT WILLIAMS & WILKINS. |
| 1998 | Zhang, Y., Oliver, J. R., & Horowitz, J. D. (1998). Control of endothelin release within the heart: Vasomotor and inotropic implications during ischemia/reperfusion. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 31 (pp. 134A). ELSEVIER SCIENCE INC. DOI |
| 1998 | Zeitz, C. J., Campbell, D. J., Pelle, M. A., Ninio, D. M., & Horowitz, J. D. (1998). Perindoprilat improves coronary vasodilator reserve during induction of myocardial ischemia.. In CIRCULATION Vol. 98 (pp. 487-488). LIPPINCOTT WILLIAMS & WILKINS. WoS2 |
| 1996 | Chirkov, Y. Y., Willoughby, S. R., Chirkova, L. P., & Horowitz, J. D. (1996). Perhexiline and amiodarone inhibit platelet aggregation in patients with angina pectoris.. In CIRCULATION Vol. 94 (pp. 1338). AMER HEART ASSOC. |
| 1995 | CHIRKOV, Y. Y., CHIRKOVA, L. P., YANG, J. F., & HOROWITZ, J. D. (1995). TOLERANCE TO NITROGLYCERIN AT THE LEVEL OF PLATELET AGGREGABILITY IN PATIENTS WITH STABLE ANGINA-PECTORIS. In CIRCULATION Vol. 92 (pp. 1433). AMER HEART ASSOC. |
| 1993 | CHIRKOV, Y. Y., YANG, J. F., NAUJALIS, J. I., SAGE, R. E., & HOROWITZ, J. D. (1993). IMPAIRED PLATELET RESPONSES TO CGMP-ELEVATING AND ANTI-AGGREGATING ACTION OF NITROGLYCERIN AND SODIUM-NITROPRUSSIDE IN PATIENTS WITH STABLE ANGINA. In CIRCULATION Vol. 88 (pp. 90). AMER HEART ASSOC. |
| 1993 | BETTS, W. H., ZHANG, Y., ROKICINSKI, M., & HOROWITZ, J. D. (1993). N-ACETYLCYSTEINE AND CAPTOPRIL INHIBIT BUT S-NITROSO-N-ACETYLCYSTEINE STIMULATES HUMAN NEUTROPHIL FREE-RADICAL PRODUCTION. In CIRCULATION Vol. 88 (pp. 90). AMER HEART ASSOC. WoS5 |
| 1993 | ZHANG, C. L., STAFFORD, I., ZHANG, Y., & HOROWITZ, J. D. (1993). RELEASE OF 3'5' CYCLIC GUANOSINE-MONOPHOSPHATE ACROSS THE FEMORAL VASCULAR BED IN MAN DURING ACUTE AND CHRONIC NITRATE THERAPY. In CIRCULATION Vol. 88 (pp. 91). AMER HEART ASSOC. |
| 1992 | CHIRKOV, Y. Y., YANG, J. F., NAUJALIS, J. I., SAGE, R. E., & HOROWITZ, J. D. (1992). DIFFERENCES IN EFFECTS OF NITROGLYCERIN AND SODIUM-NITROPRUSSIDE ON HUMAN PLATELETS INVITRO - INTRAPLATELET CGMP CONTENT AND REVERSAL OF AGGREGATION. In CIRCULATION Vol. 86 (pp. 488). AMER HEART ASSOC. |
| Year | Citation |
|---|---|
| 2020 | Qin, C. X., Anthonisz, J., Huei, L. C., Kahlberg, N., Jap, E., Oodman, O. L. W., . . . Ritchie, R. H. (2020). Diabetes-induced myocardial NO<SUP>•</SUP> resistance, is circumvented by the nitric oxide (NO) redox sibling, nitroxyl, HNO. Poster session presented at the meeting of JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. Beijing, PEOPLES R CHINA: ELSEVIER SCI LTD. DOI |
| 2019 | Liu, S., Nguyen, T. H., Imam, H., Heresztyn, T., Stafford, I., Chirkov, Y. Y., & Horowitz, J. D. (2019). Coronary artery spasm: a consequence of impaired nitric oxide/hydrogen sulphide signalling?. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Paris, FRANCE: OXFORD UNIV PRESS. |
| 2019 | Nguyen, T. H., Liu, S., Imam, H., Heresztyn, T., Stafford, I., Chirkov, Y. Y., & Horowitz, J. D. (2019). Pathogenesis of symptomatic crises in patients with coronary artery spasm: evidence for acute damage to vascular glycocalyx and to circulating platelets. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Paris, FRANCE: OXFORD UNIV PRESS. |
| 2019 | Ong, G. J., Stansborough, J., Nguyen, T. H., & Horowitz, J. D. (2019). Iatrogenic takotsubo syndrome: incidence and impact. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Paris, FRANCE: OXFORD UNIV PRESS. |
| 2019 | Liu, S., & Horowitz, J. (2019). N-acetylcysteine reverses peroxynitrite and hydrogen peroxide-induced apoptosis of human myocardial cells. Poster session presented at the meeting of Abstracts of the 68th Annual Scientific Session and Expo of the American College of Cardiology (ACC.19), as published in Journal of the American College Of Cardiology. New Orleans, LA: Elsevier. DOI WoS1 |
| 2018 | Sarcon, A., Templin, C., Ghadri, J., Cammann, V., Ding, K., Kato, K., & Gili, S. (2018). TAKOTSUBO SYNDROME CLASSIFIED: TRIGGERS DETERMINE OUTCOME: RESULTS FROM THE INTERTAK REGISTRY. Poster session presented at the meeting of JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. Orlando, FL: ELSEVIER SCIENCE INC. DOI |
| 2017 | Procter, N. E. K., Pasupathy, S., Stafford, I., Heresztyn, T., Liu, S., Selvanayagam, J., . . . Horowitz, J. D. (2017). Glycocalyx shedding in acute myocardial infarction: interactions with reperfusion and n-acetylcysteine therapy. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS. |
| 2017 | Imam, H., Nguyen, T. H., Chirkov, Y., De Caterina, R., & Horowitz, J. (2017). Adenylate cyclase signaling is an important post-receptor determinant of response to all P2Y12 receptor antagonists. Poster session presented at the meeting of European Heart Journal. Barcelona: Oxford University Press. DOI |
| 2017 | Nguyen, T. H. (2017). Hypotension at admission and extent of release of NT-proBNP and catecholamines are associated with increased medium-term mortality rate in Takotsubo cardiomyopathy.. Poster session presented at the meeting of European Heart Journal. Bardelona: Oxford University Press. |
| 2016 | Procter, N. E. K., Ball, J., Ngo, D. T. M., Chirkov, Y. Y., Stewart, S., & Horowitz, J. D. (2016). Platelet hypo-responsiveness to nitric oxide in new onset atrial fibrillation has a physiological, as opposed to pharmacological, basis. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Rome, ITALY: OXFORD UNIV PRESS. |
| 2016 | Assadi-Khansari, B., Chua, S. J., Chapman, M., Ali, O., Nguyen, H., Horowitz, J. D., . . . Ngo, D. T. M. (2016). Follistatin-like 3 predicts aortic root enlargement in patients with bicuspid aortic valve. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Rome, ITALY: OXFORD UNIV PRESS. |
| 2016 | Chua, S. J., Ajaero, C., Assadi-Khansari, B., McGavigan, A., Horowitz, J. D., Sverdlov, A. L., & Ngo, D. T. M. (2016). Galectin 3 is markedly elevated in severe heart failure and predicts improvement in LV volumes post cardiac resynchronisation therapy. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Rome, ITALY: OXFORD UNIV PRESS. |
| 2015 | Liu, S., Ngo, D. T., Chong, C. R., Chan, W. P., Horowitz, J. D., & Chirkov, Y. Y. (2015). Tachyphylaxis to the anti-inflammatory effects of BNP in acute heart failure:-potential response to therapy. Poster session presented at the meeting of EUROPEAN JOURNAL OF HEART FAILURE. WILEY-BLACKWELL. |
| 2014 | Asberg, S., Hijazi, Z., Siegbahn, A., Andersson, U., Granger, C. B., Hanna, M., . . . Wallentin, L. (2014). Galectin-3 is associated with worse clinical outcome in patients with atrial fibrillation: A substudy from the ARISTOTLE trial. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Barcelona, SPAIN: OXFORD UNIV PRESS. WoS2 |
| 2014 | Aulin, J., Hijazi, Z., Andersson, U., Gersh, B. J., Hanna, M., Horowitz, J. D., . . . Wallentin, L. (2014). Interleukin-6 and C-reactive protein and risk for cardiovascular events and death in anticoagulated patients with atrial fibrillation. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Barcelona, SPAIN: OXFORD UNIV PRESS. |
| 2014 | Nooney, V. B., Chirkov, Y. Y., De Caterina, R., & Horowitz, J. D. (2014). Ticagrelor potentiates the anti-aggregatory effects of adenosine via A2 receptor stimulation. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. SPAIN, Barcelona: OXFORD UNIV PRESS. |
| 2014 | Procter, N. E. K., Ball, J., Ngo, D. T. M., Chirkov, Y. Y., Isenberg, J. S., Hylek, E. M., . . . Horowitz, J. D. (2014). Gender/tachycardia interactions in atrial fibrillation: impact upon platelet aggregation and nitric oxide signalling. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. SPAIN, Barcelona: OXFORD UNIV PRESS. |
| 2014 | Liu, S., Ngo, D., Chong, C. -R., Chirkov, Y., Stewart, S., & Horowitz, J. (2014). Mechanisms of BNP interactions with neutrophil superoxide release: attenuation in acute and chronic heart failure. Poster session presented at the meeting of Global Heart. |
| 2013 | Amarasekera, A. T., Sverdlov, A. L., Roberts, M. S., Horowitz, J. D., & Ngo, D. T. (2013). Elevated parathyroid hormone predicts high asymmetric dimethylarginine (ADMA) concentrations; independent of vitamin D status. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Amsterdam, NETHERLANDS: OXFORD UNIV PRESS. DOI WoS1 |
| 2013 | Raman, B., Singh, K., Neil, C., Nguyen, T. H., Stansborough, J., Zietz, C., & Horowitz, J. D. (2013). Not such a rarity: takotsubo cardiomyopathy as a mimic of ST elevation myocardial infarction. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Amsterdam, NETHERLANDS: OXFORD UNIV PRESS. |
| 2013 | Horowitz, J., Nguyen, T., Neil, C., Singh, K., Chong, C., Licari, J., & Raman, B. (2013). Stress cardiomyopathy: new clinical and pathogenetic insights. Poster session presented at the meeting of Abstracts of the 10th International Congress on Coronary Artery Disease (ICCAD), as published in Cardiology. Florence, Italy: Karger. DOI |
| 2013 | Arif, S., Feelisch, M., Horowitz, J. D., Frenneaux, M. P., & Madhani, M. (2013). Aldehyde dehydrogenase plays an important role in nitrite-mediated vasorelaxation during hypoxic conditions. Poster session presented at the meeting of NITRIC OXIDE-BIOLOGY AND CHEMISTRY. Pittsburgh, PA: ACADEMIC PRESS INC ELSEVIER SCIENCE. DOI WoS1 |
| 2013 | Hijazi, Z., Siegbahn, A., Andersson, U., Granger, C. B., Alexander, J. H., Atar, D., . . . Wallentin, L. (2013). Combining High Sensitivity Troponin I and T Measurements Improves Prediction of Long-Term Clinical Outcomes in Patients With Atrial Fibrillation - An Aristotle Substudy. Poster session presented at the meeting of CIRCULATION. Dallas, TX: LIPPINCOTT WILLIAMS & WILKINS. |
| 2013 | Horowitz, J. D., De Caterina, R., Heresztyn, T., Andersson, U., Lopes, R., Hylek, E., . . . Wallentin, L. (2013). ADMA and SDMA predict outcomes in patients with chronic atrial fibrillation: an ARISTOTLE substudy. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Amsterdam, NETHERLANDS: OXFORD UNIV PRESS. WoS4 |
| 2013 | Liu, S., Ngo, D., Chirkov, Y., Stewart, S., & Horowitz, J. (2013). Impaired B-type natriuretic peptide effets on neutrophil burst in heart failure patients. Poster session presented at the meeting of Abstracts of the American Heart Association 2013 Scientific Sessions and Resuscitation Science Symposium, as publshed in Circulation. Dallas, TX: American Heart Association. |
| 2013 | Licari, G., Singh, K., Chong, C., Thanh, N., Chapman, M., Stafford, I., . . . Horowitz, J. (2013). Increased myocardial expression of thioredoxin-interacting protein, and evidence of nitrosative stress in a rat model of Tako-Tsubo Cardiomyopathy. Poster session presented at the meeting of Abstracts of the American Heart Association 2013 Scientific Sessions and Resuscitation Science Symposium, as publshed in Circulation. Dallas, TX: Amercian Heart Association. |
| 2013 | Amarasekera, A. T., Black, M., Jansen, F., Dymmott, G., Roberts, M. S., Chirkov, Y., . . . Ngo, D. T. (2013). Vitamin D supplementation in healthy adults lowers plasma Thrombospondin-1 levels: a novel vitamin D target?. Poster session presented at the meeting of Abstracts of the American Heart Association 2013 Scientific Sessions and Resuscitation Science Symposium, as publshed in Circulation. US: American Heart Association. |
| 2013 | Chong, C., Liu, S., Licari, G., Chirkov, Y., Ngo, D., & Horowitz, J. (2013). Reversal of acute hyperglycemia restores tissue responsiveness to nitric oxide and improves endothelial progenitor cell function without downregulating platelet thioredoxin interacting protein. Poster session presented at the meeting of Abstracts of the American Heart Association 2013 Scientific Sessions and Resuscitation Science Symposium, as publshed in Circulation. Dallas, TX: American Heart Association. |
| 2013 | Nguyen, T. H., Neil, C., Singh, K., Heresztyn, T., Chirkov, Y., & Horowitz, J. (2013). Determinants of prolonged impairment of global longitudinal strain post Takotsubo cardiomyopathy. Poster session presented at the meeting of Abstracts of the European Society of Cardiology Congress 2013 (ESC 2013), as published in European Heart Journal. Amsterdam, NETHERLANDS: Oxford University Press. DOI |
| 2013 | Nooney, V. B., Hurst, N., Chirkov, Y. Y., & Horowitz, J. H. (2013). Acute effects of clopidogrel are predicted by integrity of prostacyclin signalling. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Amsterdam, NETHERLANDS: OXFORD UNIV PRESS. |
| 2012 | Nguyen, T. H., Neil, A., Sverdlov, A., Ngo, D., Chan, W., Chirkov, Y., . . . Horowitz, J. (2012). Paradoxical preservation of NO signalling in Takotsubo cardiomyopathy. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Munchen, GERMANY: OXFORD UNIV PRESS. |
| 2012 | Neill, C. J., Nguyen, T. H., Stansborough, J., Rong, C. -R., Singh, K., Kucia, A., & Horowitz, J. D. (2012). Utility of a TTC Score to facilitate differentiation of Tako-Tsubo Cardiomyopathy from Ischemic ACS. Poster session presented at the meeting of CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS. |
| 2012 | Neil, C. J., Nguyen, T. H., Mahadavan, G., Chapman, M., Kucia, A. M., Stansborough, J., . . . Horowitz, J. D. (2012). LV functional recovery from Tako-Tsubo cardiomyopathy is incomplete after 3 months: evidence from 2D speckle-tracking echocardiography. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Munchen, GERMANY: OXFORD UNIV PRESS. |
| 2012 | Liu, S., Ngo, D. T., Chirkov, Y. Y., Sheikh, A. R., Licari, G., Stewart, S., & Horowitz, J. D. (2012). Brain Natriuretic Peptide (BNP) Suppresses Neutrophil Superoxide Release: Attenuation in Patients with Congestive Heart Failure (CHF). Poster session presented at the meeting of CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS. |
| 2012 | Procter, N. E. K., Ball, J., Carrington, M., Nguyen, T. H., Ngo, D., Chirkov, Y. Y., . . . Horowitz, J. D. (2012). Determinants of platelet response to nitric oxide in association with atrial fibrillation: evidence for an acute suppression of response. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Munchen, GERMANY: OXFORD UNIV PRESS. |
| 2012 | Stewart, S., Carrington, M. J., Marwick, T. H., Davidson, P. M., Macdonald, P., Horowitz, J. D., . . . Scuffham, P. (2012). Impact of home versus clinic based management of chronic heart failure: the which heart failure intervention is most cost-effective & consumer friendly in reducing hospital care (WHICH?) multicentre. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Munchen, GERMANY: OXFORD UNIV PRESS. |
| 2012 | Bullen, M. L., Miller, A. A., Drummond, G. R., Sobey, C. G., Stasch, J. -P., Chirkov, Y. Y., . . . Kemp-Harper, B. K. (2012). Nitric Oxide-Independent Stimulators of Soluble Guanylyl Cyclase Circumvent Platelet Nitric Oxide Resistance in Hypercholesterolemic Mice. Poster session presented at the meeting of CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS. |
| 2011 | Nguyen, T., Neil, C., Chan, A., & Horowitz, J. (2011). Prolonged mobilization of endothelial progenitor cells post takotsubo cardiomyopathy. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS. |
| 2011 | Sverdlov, A. L., Ngo, D. T. M., Chirkov, Y. Y., & Horowitz, J. D. (2011). Insights into the initiation of aortic stenosis: roles of ACE-inhibitors and vitamin D. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS. |
| 2011 | Chan, W. P. A., Sverdlov, A. L., Ngo, D. T., Chirkov, Y. Y., & Horowitz, J. D. (2011). Does oral contraceptive therapy induce platelet nitric oxide resistance?. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS. |
| 2011 | Ngo, D. T. M., Chan, W. P. A., Sverdlov, A. L., & Horowitz, J. D. (2011). Determinants and cardiovascular correlates of vitamin D deficiency in australian women. Poster session presented at the meeting of AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. AMER THORACIC SOC. |
| 2011 | Ngo, D. T. M., Chan, W. P. A., Sverdlov, A. L., & Horowitz, J. D. (2011). Determinants and cardiovascular correlates of vitamin D deficiency in australian women. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS. |
| 2011 | Sverdlov, A. L., Ngo, D. T. M., Chirkov, Y. Y., & Horowitz, J. D. (2011). Insights into the initiation of aortic stenosis: roles of ACE-inhibitors and vitamin D. Poster session presented at the meeting of AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. AMER THORACIC SOC. |
| 2010 | Kucia, A. M., Neil, C. J. A., Nguyen, T. H., Beltrame, J. F., Arstall, M. A., & Horowitz, J. D. (2010). Evolution of ECG changes in tako tsubo cardiomyopathy: arrhythmias first, QT prolongation later?. Poster session presented at the meeting of EUROPEAN HEART JOURNAL. Stockholm, SWEDEN: OXFORD UNIV PRESS. |
| 2009 | Sverdlov, A. L., Ngo, D. T., Nightingale, A. K., Rajendran, S., Heresztyn, T., & Horowitz, J. D. (2009). Plasma concentrations of asymmetric dimethylarginine (ADMA) predict LV mass independent of afterload. Poster session presented at the meeting of Abstracts of the 82nd Scientific Session of the American Heart Association, as published in Circulation. Orlando, FL: American Heart Association. |
| 2008 | Chirkov, Y. Y., De Sciscio, M., Sverdlov, A. L., Leslie, S., & Horowitz, J. D. (2008). Is there a pharmacological hydralazine/nitrate interaction in chronic heart failure?. Poster session presented at the meeting of Abstracts of ESC Congress 2008, as published in European Heart Journal. Munich, Germany: Oxford University Press. DOI WoS1 |
| Year | Citation |
|---|---|
| 2002 | Beltrame, J. F., & Horowitz, J. D. (2002). Safety of N-Acetylcysteine in Acute Coronary Syndromes. |
| Year | Citation |
|---|---|
| 2017 | Beltrame, J. F. (2017). Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size - The NACIAM Trial (N-acetylcysteine in Acute Myocardial Infarction) Podcastt. |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2025 | Co-Supervisor | Modulation of cellular function via different substrate transport across the mitochondrial membrane: physiological and pathophysiological implications for heart disease. | Doctor of Philosophy | Doctorate | Full Time | Ms Xiaojing Wang |
| 2025 | Co-Supervisor | The integrity of endothelial glycocalyx and platelet responses in normal ageing and cardiovascular disease | Doctor of Philosophy | Doctorate | Full Time | Ms Beidong Huang |
| 2025 | Co-Supervisor | Basis for microvascular dysfunction and its nexus of interactions with cardiac function | Doctor of Philosophy | Doctorate | Full Time | Mr Jiunn Jye Tan |
| 2025 | Co-Supervisor | Modulation of cellular function via different substrate transport across the mitochondrial membrane: physiological and pathophysiological implications for heart disease. | Doctor of Philosophy | Doctorate | Full Time | Ms Xiaojing Wang |
| 2025 | Co-Supervisor | The integrity of endothelial glycocalyx and platelet responses in normal ageing and cardiovascular disease | Doctor of Philosophy | Doctorate | Full Time | Ms Beidong Huang |
| 2025 | Co-Supervisor | Basis for microvascular dysfunction and its nexus of interactions with cardiac function | Doctor of Philosophy | Doctorate | Full Time | Mr Jiunn Jye Tan |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2022 - 2025 | Co-Supervisor | Diabetic Cardiomyopathy: Pathogenetic and Therapeutic Investigations in a Rodent Model | Doctor of Philosophy | Doctorate | Full Time | Mr Getandale Zeleke Negera |
| 2015 - 2018 | Principal Supervisor | Inter-Individual Variability in Platelet Adenylate and Soluble Guanylate Cyclase Signaling: Therapeutic Perspectives | Doctor of Philosophy | Doctorate | Full Time | Mr Md Hasan Imam |
| 2015 - 2022 | Principal Supervisor | Takotsubo Syndrome: Precipitants, Clinical Course and Emerging Treatments | Doctor of Philosophy | Doctorate | Part Time | Mr Gao Jing Ong |
| 2014 - 2018 | Principal Supervisor | Interactions between Cardiac Resynchronisation Therapy and Amelioration of Peripheral Vascular Dysfunction: Impact upon Outcomes | Doctor of Philosophy | Doctorate | Full Time | Dr Chukwudiebube Nnanna Ajaero |
| 2014 - 2019 | Principal Supervisor | Nitrosative Stress and the Pathogenesis of Takotsubo Syndrome: Insights from a Novel Female Rat Model | Doctor of Philosophy | Doctorate | Full Time | Mr Sven Yuri Surikow |
| 2014 - 2016 | Principal Supervisor | Endothelial Dysfunction and Inflammatory Activation in Patients with Bicuspid Aortic Valves | Master of Clinical Science | Master | Part Time | Mr Matthew Chapman |
| 2012 - 2015 | Principal Supervisor | Natural History and Pathogenesis of Takotsubo Cardiomyopathy | Doctor of Philosophy | Doctorate | Full Time | Dr Kuljit Singh |
| 2012 - 2017 | Co-Supervisor | A Pharmacological Approach Towards Myocardial Protection: New Perspectives in Acute and Chronic Cardiac Disease | Doctor of Philosophy | Doctorate | Full Time | Dr Cher-Rin Chong |
| 2011 - 2015 | Principal Supervisor | Effects of Nitrite and Nitroxyl on Human Vascular and Platelet Function | Doctor of Philosophy | Doctorate | Full Time | Dr Rustem Dautov |
| 2010 - 2015 | Principal Supervisor | Variability of Nitric Oxide Signalling in Atrial Fibrillation: Potential Modulation | Doctor of Philosophy | Doctorate | Part Time | Mr Nathan Edward Kevin Procter |
| 2010 - 2015 | Principal Supervisor | Impaired Tissue Responsiveness to B-Type Natriuretic Peptide in Heart Failure: Biochemical Bases | Doctor of Philosophy | Doctorate | Full Time | Saifei Liu |
| 2009 - 2016 | Principal Supervisor | Post-P2Y 12-Receptor Signalling Mechanisms and Platelet Responses to Clopidogrel | Doctor of Philosophy | Doctorate | Full Time | Dr Nicola Hurst |
| 2009 - 2014 | Principal Supervisor | Tako-Tsubo (Stress) Cardiomyopathy: Pathophysiology and Natural History | Doctor of Philosophy | Doctorate | Full Time | Dr Christopher Neil |
| 2008 - 2012 | Principal Supervisor | The Role of Oxidant Stress in a Cellular Model of Aortic Valve Cell Calcification | Master of Medical Science | Master | Part Time | Dr Navin S Kanagasingam |
| 2008 - 2012 | Co-Supervisor | Implications of Catecholamine-related Pathophysiology in Cardiomyopathy | Doctor of Philosophy | Doctorate | Full Time | Dr Ha Thanh Nguyen |
| 2006 - 2013 | Principal Supervisor | Cardiovascular Risk Assessment in Women: Impact of Ageing, Polycystic Ovarian Syndrome and Menopause on Nitric Oxide Signalling | Doctor of Philosophy | Doctorate | Full Time | Dr Alicia Chan |
| 2006 - 2016 | Principal Supervisor | Mechanisms of dyspnoea and poor exercise tolerance in a representative cohort of elderly patients with a relatively normal ejection fraction on echocardiography | Doctor of Philosophy | Doctorate | Full Time | Dr Gnanadevan Mahadevan |
| 2005 - 2009 | Principal Supervisor | Platelet and Endothelial Function: Polycystic Ovary Syndrome and the Renin-Angiotensin System | Doctor of Philosophy | Doctorate | Full Time | Dr Sharmalar Rajendran |
| 2005 - 2012 | Principal Supervisor | Pathogenesis of Aortic Stenosis: Implications Regarding Impairment of Nitric Oxide Signalling | Doctor of Philosophy | Doctorate | Full Time | Dr Aaron Sverdlov |
| 2004 - 2008 | Principal Supervisor | Potential Utility of Changes in Entropy as an Adjunct to the Electrocardiography Diagnosis of Reversible Myocardial Ischaemia | Master of Medical Science | Master | Full Time | Dr Jinlin Zhao |
| 2004 - 2007 | Co-Supervisor | Induction of Myocardial Ischaemia: A Comparison of Pharmacologic and Physiologic Stress Myocardial Perfusion Imaging | Master of Medical Science | Master | Full Time | Dr Ha Thanh Nguyen |
| 2003 - 2007 | Principal Supervisor | Effect of Nitric Oxide on Aortic Valve Calcification in vitro | Master of Clinical Science | Master | Full Time | Mr Xiang Hua |
| 2003 - 2007 | Principal Supervisor | Pathogenesis of Aortic Valve Stenosis: Bench to Bedside Approach | Doctor of Philosophy | Doctorate | Full Time | APrf Doan Ngo |
| 2002 - 2007 | Co-Supervisor | Vasomotor and Anti-Oxidant Effects of Anti-Ischaemic Therapies. | Doctor of Philosophy | Doctorate | Full Time | Miss Elizabeth Liberts |
| 2000 - 2005 | Co-Supervisor | TISSUE RESPONSES TO NITRIC OXIDE DONORS: STUDIES IN PLATELETS AND IN MYOCARDIUM | Doctor of Philosophy | Doctorate | Full Time | APrf Matthew Worthley |
| 1998 - 2002 | Principal Supervisor | Tolerance and Resistance to Organic Nitrates in Human Blood Vessels | Doctor of Philosophy | Doctorate | Full Time | Dr Peter Sage |
| 1998 - 2003 | Principal Supervisor | Pathophysiological and platelet anti-aggregatory effects of nitric oxide | Doctor of Philosophy | Doctorate | Full Time | Dr Andrew Holmes |
Connect With Me
External Profiles
